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Abstract 
Non-enveloped viruses such as picornaviruses must penetrate the host cell membrane without 
the advantage of membrane fusion. This process is thought to involve membrane 
permeabilisation but the mechanism remains poorly understood. 
During picornavirus cell entry, capsid protein VP4 is released from the virus and is implicated in 
the delivery of the viral genome into the cytoplasm. The studies described in this thesis were 
undertaken to improve our understanding of the role of VP4 in cell entry. The approach to 
investigate this used recombinant VP4 and liposome model membranes. 
Recombinant VP4 was shown to induce membrane permeability with characteristics similar to 
that induced by both model pore-forming peptides and infectious virus particles and was 
influenced by pH, membrane composition and VP4 myristoylation. Chemical crosslinking and 
dextran release studies demonstrated that VP4 formed a multimeric size-selective membrane 
pore. The VP4 pore complex was visualised by transmission electron microscopy, which 
confirmed the multimeric nature of the pore and showed a lumen diameter in agreement with 
the dextran release studies and consistent with the dimensions required for the passage of 
viral RNA. 
The structure of VP4 reconstituted in membrane-mimetic detergent micelles was analysed by 
circular dichroism spectroscopy and nuclear magnetic resonance (NMR) spectroscopy. This 
showed VP4 contained predominantly alpha helical content and the acquired 2D NMR 
spectrum was typical of a membrane protein. 
The membrane permeability induced by synthetic peptides showed that VP4 activity maps to 
the N-terminal half of VP4. In addition, VP4 activity was enhanced by the presence of a peptide 
corresponding to the N-terminus of VP1, an additional capsid protein also implicated in cell 
entry. 
These findings present a molecular mechanism for the involvement of VP4 in cell entry and 
provide a model system which will facilitate exploration of VP4 as a novel antiviral target for 
the picornavirus family. 
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1.1  Introduction 
The family Picornaviridae is composed of small, icosahedral, non-enveloped viruses with a 
single-stranded, positive sense RNA genome. Many members of the picornavirus family are 
significant pathogens of humans and livestock. These include foot-and-mouth disease virus, 
poliovirus, human rhinovirus, enterovirus 71 and hepatitis A virus. These viruses cause diverse 
diseases such as foot-and-mouth disease, poliomyelitis, the common cold, hand, foot and 
mouth disease and hepatitis, respectively.  
The picornavirus life cycle can be divided into cell entry, translation, replication, assembly and 
release of virus from the cell. Cell entry involves virus binding to specific receptor(s), 
endocytosis, host-cell membrane penetration and delivery of the genome to the cytoplasm 
(the site of replication). Membrane penetration to deliver the viral genome across the 
membrane is a fundamental step of viral infection, the details of which remain unclear. 
Intracellular viral RNA replication occurs in the cytoplasm and is initiated by translation of the 
viral genome to produce the non-structural viral proteins involved in viral genome replication 
and the structural proteins required for assembly of progeny virus. The virus life cycle involves 
dynamic interactions with host cell proteins and membranes. A better understanding of these 
interactions would facilitate the development of improved disease control measures such as 
better diagnostics, vaccines and antivirals.  
The three viruses of relevance to this thesis are human rhinovirus (HRV), poliovirus (PV) and 
foot-and-mouth disease virus (FMDV), and will be described in more detail in the following 
sections. In addition to the economic significance of these viruses, recent research has made 
them good candidates for understanding picornavirus cell entry. 
 
1.1.1 Clinical features and significance of human rhinovirus, poliovirus and foot-and-
mouth disease virus  
 
Human Rhinovirus  
Human rhinoviruses (HRV) are causative agents of the most common acute infections in man, 
the common cold. HRV infections are reported to be responsible for approximately 50% of 
respiratory tract infections in young adults (Makela et al., 1998). Ninety per cent of children 
become infected with HRV by the time they are two years old (Blomqvist et al., 2002). HRV 
infections are also associated with sinusitis, otitis media, chronic obstructive pulmonary 
disease and exacerbations of asthma (Dougherty and Fahy, 2009). HRV infections can be more 
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serious and occasionally fatal in certain patient groups such as the immunocompromised and 
the elderly (Wald et al., 1995). The newly discovered species of HRV C has been reported to be 
more pathogenic and cause more severe asthmatic attacks compared to the other two existing 
species of HRV, HRV A and HRV B (Bizzintino et al., 2011). HRV infections are associated with 
substantial medical complications, morbidity and economic cost. HRV has approximately 100 
serotypes (Palmenberg et al., 2009) which make them a difficult target for vaccine design. 
Antiviral compounds inhibiting viral replication (e.g. a pyridazinamine) and many capsid 
binding compounds (Winthrop compounds) have been developed but there are as yet no 
licensed effective antivirals for the common cold. 
 
Poliovirus 
Poliovirus (PV) is the causative agent of poliomyelitis. Humans are the only known reservoir of 
PV which is highly contagious and children in endemic areas become infected by 1 year of age 
(Alexander et al., 2004). Most PV infections are asymptomatic where viral replication is limited 
to the alimentary tract. However, when the virus enters the bloodstream and is carried to the 
central nervous system where it replicates in motor neurons, it causes paralytic poliomyelitis 
(Nathanson, 2008). Paralytic poliomyelitis is experienced in less than 1% of PV infections. 
Replication of the virus in the nervous system can result in the loss of muscle function (acute 
flaccid paralysis) in one or more limbs or reduce breathing capacity and causing difficulty in 
swallowing (bulbar polio). PV is a significant pathogen of the last century and the huge impact 
of PV infections on the developed world led to detailed studies of the virus. As a result, PV is 
biochemically and genetically well characterised and has been used as the model virus in 
picornavirus research.  
PV is the subject of a global eradication programme (the global polio eradication initiative) 
which has resulted in the interruption of wild poliovirus transmission from most parts of the 
world. However, poliovirus transmission continues to be prevalent in some developing 
countries, mainly due to political and logistical reasons resulting in poor accessibility to 
vaccines.  
A live attenuated oral polio vaccine (OPV) and an inactivated polio vaccine (IPV) are both used 
as part of the vaccination strategy to prevent wild PV transmission. OPV is a powerful public 
health tool for mass vaccination, however, it has been reported to be genetically unstable 
which results in accumulation of mutations causing vaccine-associated paralytic poliomyelitis 
(VAPP) and outbreaks can occur due to circulating vaccine derived polioviruses (cVDPV) (Kew 
et al., 2005). The ongoing debate over the complete cessation of vaccination is due to the 
associated risks which may facilitate the re-emergence of PV (e.g. from persistently infected 
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individuals) in unvaccinated populations. Therefore, there is an urgent need for the 
development of antivirals which can be used to contain an outbreak, to treat the infected and 
protect the exposed population, or used to complement IPV administration.  Further, efforts to 
develop a new vaccine which is not reliant on infectious virus, are underway. 
 
Foot-and-mouth disease virus 
Foot-and-mouth disease virus (FMDV) infects animals of agricultural and economic importance 
including cattle, goats, sheep and pigs as well as 70 species of wild animals (Grubman and Baxt, 
2004).  
Despite being the first virus of vertebrates to be discovered and recognized as a significant 
disease threatening the cattle industry since the sixteenth century (Mahy, 2005), it continues 
to adversely affect the world’s livestock production. There are seven distinct FMDV serotypes 
and no cross protection between serotypes. Although, the current conventional FMDV 
vaccines can prevent clinical disease, they do not provide long-term immunity, thus often 
requiring frequent revaccination for prophylactic control (Rodriguez and Gay, 2011). Foot-and-
mouth disease (FMD) is controlled in disease-free countries by surveillance and strict controls 
on importation of susceptible animals and animal products. In endemic regions, control 
measures focus on vaccination, however, in endemic regions FMD is associated with high 
disease burden and loss of livelihood. The UK suffered an economic loss of over £6 billion from 
the 2001 FMD outbreak (Mateo et al, 2008), thereby illustrating the significant consequences 
and economic impact of FMD. International trade embargoes are the main threat to areas free 
of FMD, mainly the developed countries. Furthermore, FMDV has a significant impact on the 
developing world. The “stamping out” or slaughter policy followed in the developed world in 
response to an outbreak cannot be afforded by most developing countries. The significant loss 
of yield of meat and milk, in combination with the loss of revenue due to strict restrictions on 
export of animals and animal products to nations free of FMD, makes the control of FMDV of 
paramount importance (Balinda et al., 2009).  
 
1.1.2 Classification of Picornaviruses 
The picornavirus family consists of 37 species, grouped into 17 genera namely Aphthovirus, 
Aquamavirus, Avihepatovirus, Cardiovirus, Cosavirus, Dicipivirus, Enterovirus, Erbovirus, 
Hepatovirus, Kobuvirus, Megrivirus, Parechovirus, Salivirus, Sapelovirus, Senecavirus, 
Teschovirus and Tremovirus (Adams and Carstens, 2012; Adams et al., 2013) 
(www.picornaviridae.com) (Figure 1.1). Further 9 genera have been suggested and will likely 
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be included into the family of picornaviruses in the near future (www.picornaviridae.com). The 
classification is based on phylogenetic relationships and genome organisation. Previously used 
classification methods such as pH stability, receptor usage and host specificity proved to be 
unreliable factors to establish relationships between viruses to categorise into species or 
genera, due to the changes in the virus occurring as a result of virus adaptation to changing 
environments.  
 
 
Figure 1.1 Phylogentic tree of the picornavirus family.  
The picornavirus family consists of 17 genera and 37 species. Black arrows indicate human 
rhinovirus and poliovirus belonging to the Enterovirus genus; foot-and-mouth disease virus 
belonging to the Aphthovirus genus. Figure kindly provided by Nick Knowles, The Pirbright 
Institute. 
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1.2 Genome organisation 
The basic genome organisation of picornaviruses is conserved and shown in Figure 1.2. 
Although, genus and species specific differences exist, they are confined to limited regions of 
the genome. These differences are discussed below. Picornavirus genomes range in length 
from approximately 7,032 nucleotides of avian encephalomyelitis virus (Marvil et al., 1999) to 
8,828 nucleotides of equine rhinitis B virus (Ehrenfeld et al., 2010). The genome normally 
consists of 3 major regions: the 5’ untranslated region (UTR), a single open reading frame 
(ORF) and the 3’UTR. However, canine picodicistrovirus is a recently identified member of the 
Picornaviridae which has two ORFs (Adams et al., 2013). The first IRES is located at the 5’ UTR 
and the second IRES between VP1 and 2A. The first ORF contains the P1 region and the second 
contains the P2 and P3 regions (Woo et al., 2012). 
The proteins encoded by the genome take their names based on their sequential locations in 
the polyprotein (Figure 1.2). The ORF is flanked by UTR located upstream at the 5’ and 
downstream at the 3’ end of the genome. The 5’ terminal sequence, invariably a UU sequence, 
is covalently linked to a small protein, viral protein genome-linked (VPg). In enteroviruses (e.g. 
PV) the viral RNA (vRNA) then folds into a clover leaf shaped secondary structure element 
while that of aphthoviruses (e.g. FMDV) folds to form the S-fragment which is a long stem loop 
structure (Bunch et al., 1994; Newton et al., 1985). The PV clover leaf binds multiple cellular 
and viral proteins, mediating circularisation of the genome necessary for negative strand 
synthesis and replication (Toyoda et al., 2007). The function of the FMDV S-fragment is not 
established but it has been suggested to play a role in genome replication (as reviewed in 
Grubman and Baxt, 2004). A cis-active RNA element (CRE) has been identified in a number of 
picornaviruses and is present at varying locations such as in the 5’ UTR in FMDV, the capsid 
encoding region (P1) in HRV14 and 2C encoding region in PV (Goodfellow et al., 2003). The CRE 
is required for the uridylylation of VPg and is essential for the synthesis of plus strand RNA 
(Steil and Barton, 2009) (section 1.4).  
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Figure 1.2 Picornavirus genome organisation and processing pattern.  
A. The viral genome flanked by the 3’ and 5’ untranslated regions. The viral protein genome-
linked protein at the 5’ end and poly(A) tail at the 3’ end. The regions encoding for viral 
proteins are indicated. B. Patterns of polyprotein processing followed in enteroviruses, 
cardioviruses, aphthoviruses and hepatoviruses. The sources of cleavage activity indicated by 
the curved arrows (2A and 3C/ 3CD proteases). Figure adapted from (De Palma et al., 2008). 
 
The 5’ UTR also contains an internal ribosome entry site (IRES) which directs cap-independent 
translation of the viral polyprotein (section 1.3). Some picornaviruses such as aphthoviruses 
and cardioviruses have a Leader protein (L) encoded at the 5’ of the P1 region. Other 
picornaviruses including the enteroviruses and hepatoviruses do not have the L protein. Most 
picornavirus ORFs have one AUG initiation codon but that of apthoviruses (e.g. FMDV) contain 
two in-frame AUG initiation codons (Clarke et al., 1985). This leads to the generation of two 
alternative forms of the Leader protein (L), Lab and Lb which have the same proteolytic activity 
(section 1.3.1.2). The P1 region encodes the structural proteins 1A, 1B, 1C and 1D (also known 
as VP4, VP2, VP3 and VP1). The middle region is P2 which contains the non-structural proteins 
2A, 2B and 2C.  The P3 region encodes the non-structural proteins 3A, 3B (VPg), 3C and 3D 
(sections 1.3 and 1.4). The 3’ UTR is shorter than the 5’ UTR and has extensively structured 
domains including stem-loop structures and a polyA tail. The polyA tail is involved in 
translation and replication for e.g. binding to the host cellular protein, poly (A) binding protein 
(PABP), provides interactions to coordinate activities of 5’ UTR and 3’ UTR during genome 
translation and replication (Herold and Andino, 2001; Zoll et al., 2009). However, the 3’ UTR of 
HRV and PV was not absolutely required for genome replication (Todd et al., 1997).  
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1.3 Polyprotein translation and processing  
Cellular mRNA translation requires recognition of a 5’ cap structure by the eIF4F complex. The 
eIF4F complex consists of eIF4E which binds to the cap, eIF4A which is a helicase and eIF4G 
which acts as a scaffold protein and interacts with eIF3, eIF4A, eIF4E and coordinates their 
functions (Gingras et al., 1999; Hellen and Sarnow, 2001). The 40S ribosomal subunit bound to 
eIF2 and the initiator methionine tRNA is referred to as the 43S complex. This complex 
associates with eIF3, creating a 48S pre-initiation complex which is recruited to the 5’ end of 
mRNA. This complex and other initiation factors (eIF1, eIF1A, eIF5 and eIF5B) scans along the 
mRNA in the 5’ to 3’ direction until it reaches an appropriate start (AUG) codon which is used 
to initiate translation. When the AUG start codon is recognised, eIF1 is released and a 
conformational change in the 40S ribosomal subunit occurs which prevents further scanning 
along mRNA. Mediated by eIF5B, the 60S ribosomal subunit is recruited to the 40S ribosomal 
subunit, which results in the formation of the 80S ribosome which is competent to begin 
protein synthesis (Hellen and Sarnow, 2001; Thompson, 2012). 
The next part of the viral life cycle, after cell entry when the vRNA is delivered to the 
cytoplasm, is translation of vRNA to produce a single polyprotein. In contrast to cap-dependent 
translation mediated by the mRNA 5’ cap structure, picornaviruses utilise a cap-independent 
translation mechanism which involves the binding of ribosomes to the IRES (a complex RNA 
structure in the 5’ UTR). Picornaviruses have evolved ways of interacting with the host cell 
translation machinery to shut-off cap-dependent translation of host mRNA by cleavage of 
eIF4G and subvert the host cell machinery to preferentially translate vRNA by a cap-
independent mechanism. During infection with aphthoviruses such as FMDV, cleavage of 
eIF4G is carried out by the viral proteases, Leader and 3C, whereas in other picornaviruses 
such as poliovirus, human rhinovirus or coxsackievirus, cleavage of eIF4G is carried out by the 
viral proteases, 2A and 3C (Fitzgerald and Semler, 2011) and (section 1.3.1.2). By employing 
cap-independent translation pathway, ribosomes bind directly to the IRES and initiate viral 
RNA translation. Hence, viral RNA translation does not conform to the 5’ 7-methyl guanosine 
cap recognition by eukaryotic initiation factor 4F (eIF4F) complex and ribosome scanning used 
for cellular mRNA translation (as reviewed in Jackson et al., 1994).  
Host cell proteins such as SRp20, poly(rC) binding protein 2 (PCBP2), polypyrimidine tract-
binding protein (PTB) and La are involved in vRNA translation. Serine arginine protein 20 
(SRp20) is a cellular splicing factor and has been shown to associate with PCBP2 bound to PV 
RNA, which together function to recruit ribosomes to the vRNA for translation. PTB has been 
shown to enhance the activity of picoranviral IRESs (Back et al., 2002; Fitzgerald and Semler, 
2011) During infection, La is cleaved and the C-terminal region is translocated from the nucleus 
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to the cytoplasm where it can bind to the 5’ UTR and initiate translation. Therefore, the above 
mentioned host cell factors, as shown in Figure 1.3, enhance RNA translation of picornaviruses 
(Blyn et al., 1997; Chase and Semler, 2012). 
 
 
Figure 1.3 Cap-independent translation of poliovirus RNA. 
The highly structured 5´ untranslated region and the lack of a cap at the 5´ end prevent cap 
binding and ribosome scanning.  Cap-independent translation is mediated by the disruption of 
the eIF4F cap-binding complex by the cleavage of eIF4G by 2A protease, the recruitment of the 
43S ribosomal subunit to the IRES and recruitment of host cellular proteins such as PTB and La. 
SL: stem loop, eIF: eukaryotic translation initiation factor, PTB: polypyrimidine tract-binding. 
Figure adapted from (Chase and Semler, 2012). 
 
1.3.1 Viral proteins 
The IRES directs translation of the ORF to produce a single polyprotein (section 1.3). The 
polyprotein is processed by viral proteases to form a number of processing intermediates and 
mature viral proteins. Processing involves cleavage of the P1 region to produce the capsid 
proteins; cleavage of P2 and P3 regions by 3CDpro (enteroviruses) or 3Cpro (aphthoviruses) to 
form the individual non-structural proteins and processing intermediates (e.g. 2BC and 3CD) 
that are required for viral replication. 
1.3.1.1 Structural proteins 
Processing of P1 is carried out by 3CDpro in enteroviruses (e.g. PV) or 3Cpro in aphthoviruses 
(e.g. FMDV). This results in the formation of VP0, VP1 and VP3. VP0 is the precursor of VP2 and 
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VP4. Picornavirus VP4 has a molecular weight of 7-10 kDa and is present on the inner surface 
of the capsid. VP4 is myristoylated at the N-terminus, is important for virus infectivity and 
stability, and has been implicated in potential pore-formation during cell entry of 
picornaviruses (section 1.6.4.4). VP1, VP2 and VP3 (approximately 30 kDa) are components of 
the viral capsid that share a similar overall structure (section 1.5.2). VP1 contributes maximum 
to antigenicity and surface features of the virus. VP2 and VP3 are also present on the surface 
of the virus capsid. The picornavirus capsid is composed of 60 copies of each of the four 
structural proteins (section 1.5.2). The assembly and structure of the picornavirus capsid is 
described in more detail in sections 1.5.1 and 1.5.2.  
1.3.1.2 Non-structural proteins 
The non-structural proteins are encoded by the P2 and P3 regions of the genome (Figure 1.2) 
and are involved in intracellular virus replication. A number of processing intermediates are 
also produced which have distinct functions to the final fully processed proteins.  
 2A 
The 2A protein of many picornaviruses (e.g. the enteroviruses) is a protease (2Apro). During 
enterovirus translation 2A cleaves at its own N-terminus thereby separating the capsid 
proteins (encoded by P1) from the non-structural proteins (encoded by P2 and P3). In 
some other viruses such as aphthoviruses and cardioviruses, 2A does not possess protease 
activity. Instead, P1 is released from P2/P3 by a different mechanism called ribosomal 
skipping, where the C terminus of 2A includes a unique amino acid sequence (DxExNPG/P 
motif) that prevents a peptide bond being formed between the C-terminal glycine of 2A 
and the N-terminal proline of 2B.  This results in the generation of structural proteins as a 
P1-2A precursor (Donnelly et al., 1997; Donnelly et al., 2001). During capsid assembly, 
3Cpro cleaves 2A to separate it from P1. In hepatoviruses, 2A does not function as a 
protease (as reviewed in Ryan and Flint, 1997) and the cleavage of P1/2A and 2A/2B is 
performed by 3Cpro (Cohen et al., 2002).  
 
PV 2Apro also mediates the inhibition of cap-dependent cellular mRNA translation by 
cleavage of eukaryotic initiation factor 4G (eIF4G) (Krausslich et al., 1987). The other 
known function of enterovirus 2A is the enhancement of vRNA translation by cleaving the 
host cell protein p220 (protein of the cap-binding complex), thereby making the cap-
binding complex non-functional and inhibiting cap-dependent translation (Hambidge and 
Sarnow, 1992) (section 1.3).  
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In enteroviruses, 2Apro has folds similar to chymotrypsin like proteases. The structures of 
2Apro of HRV2 (Petersen et al., 1999) and coxsackievirus B4 (CVB4) (Baxter et al., 2006) 
have been determined. 
 
 2B 
Picornaviruses replicate their genomes in association with cellular membranes (Gazina et 
al., 2002; Hsu et al., 2010). For most picornaviruses the precise origin of these membranes 
is unclear but viruses of the Enterovirus genus (e.g. PV and CVB3) are believed to utilise 
membranes from the early secretory pathway for replication (Hsu et al., 2010; Rust et al., 
2001). The 2B proteins of all enteroviruses contain an N-terminal hydrophobic region 
predicted to form an amphipathic helix with characteristics consistent with those observed 
in membrane lytic peptides (Shai, 1999). Studies have shown the interaction of the CVB3 
2B amphipathic helix with membranes (vanKuppeveld et al., 1996). Coxsackievirus 2B has 
also been shown to localise to the endoplasmic reticulum and the golgi complex. The 
membrane binding region of 2B has been proposed to form pores in the golgi and 
endoplasmic reticulum (ER) membranes, leading to a reduction in Ca+2 levels in the ER and 
golgi which may provide conditions required for viral RNA replication (Campanella et al., 
2004; Madan et al., 2007; Martinez-Gil et al., 2011; van Kuppeveld et al., 2005).  
The 2B protein of aphthoviruses, cardioviruses and hepatoviruses share <20% sequence 
similarity with enterovirus 2B and do not contain an amphipathic helix. Mechanisms used 
by 2B of viruses such as encephalomyocarditis virus (EMCV) and FMDV to reduce Ca+2 
levels in the ER are yet to be determined. 2B of hepatoviruses did not appear to have an 
effect on the Ca+2 levels in the ER or golgi complex (de Jong et al., 2008).  
 
 2C 
Bioinformatics analysis of PV 2C predicted an amphipathic helical domain at its amino 
terminus, a nucleotide binding domain in the middle and zinc binding domain at its 
carboxy terminus (Rodriguez and Carrasco, 1993). Both termini of PV 2C showed RNA 
binding activity (Teterina et al., 2006). PV 2C is tightly associated with replication 
complexes (the complex between viral and cellular proteins and membranes required for 
viral replication) and is therefore, thought to play a role in viral replication (Bienz et al., 
1990). PV 2C was also shown to interact with other components of the replication 
complex, 3A, 3AB (Yin et al., 2007) and the clover leaf structure present at the 5’ end of 
viral RNA (Banerjee and Dasgupta, 2001).  
Picornavirus 2C is a multifunction protein. For example enterovirus 2C possesses ATPase 
and GTPase activities (Rodriguez and Carrasco, 1993), and PV 2C has also been implicated 
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to play a role in viral RNA encapsidation, though the specific domain responsible for this is 
yet to be defined (Vance et al., 1997).  
Expression of PV 2C or 2BC induces formation of membrane vesicle whereas similar 
proteins in FMDV have not been identified.  In contrast FMDV 2B and 2C are involved in 
blocking the secretory pathway between ER and golgi (section 1.4). 
 
 3AB and 3A  
The 3AB protein is the precursor for 3A and 3B proteins. PV 3AB has been shown to be 
important for the anchoring of replication complexes to cellular membranes by interacting 
with the 5’ cloverleaf and enhancing the functions of 3CD and 3Dpol (Hope et al., 1997; 
Lama et al., 1994; Paul et al., 1994).  
The 3A proteins of different picornaviruses such as Aichi virus, bovine kobuvirus, 
poliovirus, coxsackievirus B3, and human rhinovirus 14 reorganise cellular membranes 
associated with the golgi (Greninger et al., 2012) and inhibit protein export from ER to 
golgi (Doedens et al., 1997). FMDV 3A is significantly longer (153 amino acids) than PV 3A 
(87 amino acids) and does not block the secretory pathway between ER and golgi (Moffat 
et al., 2005).  
 
 3B 
The 3B protein or Viral protein genome-linked (VPg) is a small protein (21 to 23 amino 
acids), covalently linked to the 5’ end of the viral genome (Ambros and Baltimore, 1978). 
Uridylylated VPg functions as a primer for viral RNA synthesis (Andino et al., 1999) 
(described in section 1.4). The genome of aphthoviruses are unique, in that, they encode 
for three sequential copies of 3B (Forss and Schaller, 1982). The biological significance of 
three copies of VPg is not known. It is not clear if 3A or 3C (as 3AB and 3BC) is the donor of 
VPg for replication. Due to the abundance of 3AB in the infected cell, 3A was thought to be 
the source of VPg but recent evidence showed that 3BC and 3BCD are likely donors of VPg 
with 3C serving as a stimulatory factor for 3Dpol in the VPg uridylylation reaction (Pathak 
et al., 2008). 
 
 3C 
The 3C protein (3Cpro) is a cysteine protease with chymotrypsin like folds. The structure of 
3C is known for a few picornaviruses such as FMDV (Birtley et al., 2005), PV (Mosimann et 
al., 1997) and HRV14 (Matthews et al., 1994). 3CD in PV and 3C in FMDV, cleaves the viral 
polyprotein at the 2C/3A junction to release the P3 region. In aphthoviruses, cardioviruses 
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and hepatoviruses, 3C also cleaves at the N-terminus of 2A to release P1 from 2A (Figure 
1.2). 
PV 3C cleavage of transcription factors prevents host cell transcription and degradation of 
PABP by 3C has been shown to inhibit cap-dependent cellular RNA translation (Joachims et 
al., 1999). FMDV 3C carries out host cell protein cleavages of eIF4G and eIF4A which 
affects mRNA transcription and cap-dependent translation (Belsham et al., 2000).  
 
 3CD 
The 3CD protein is an intermediate cleavage product of the P3 region of the polyprotein. It 
is a precursor to 3C protease (3Cpro) and viral RNA dependent RNA polymerase (3Dpol). In 
enteroviruses, 3CD possesses protease activity but not in aphthoviruses. Viral replication 
has been shown to depend on 3CD interactions with replication machinery such as 5’ 
cloverleaf, the CRE and 3’ UTR (Andino et al., 1990; Gamarnik and Andino, 1998; 
Goodfellow et al., 2000). PV 3CD cleaves the host cellular protein, PCBP2, which favours 
the switch from translation to RNA replication (Gamarnik and Andino, 1998; Perera et al., 
2007) (section 1.4).  
 
 3D 
The 3D protein is an RNA dependent RNA polymerase (RDRP). The 3D polymerase (3Dpol) 
transcribes new viral negative sense complement and uses this to produce new positive 
sense (genomic) RNA, and therefore plays a key role in genome replication. Like many 
RDRP, 3Dpol has a high error rate as it lacks proofreading ability, which is related to the 
substantial genetic diversity in picornaviruses (Hicks and Duffy, 2011). The structures of 
3Dpol as a free enzyme and in complex with VPg have been determined for a number of 
viruses and have revealed a common structure which includes three domains referred to 
as finger, palm and thumb (Kerkvliet et al., 2010).  
 
 Leader protein  
The Leader protein is present at the start of the ORF in cardioviruses, aphthoviruses and 
hepatoviruses (Figure 1.2). In aphthoviruses such as FMDV leader protein possesses 
protease activity. FMDV Leader protease (Lpro) is a member of the papain-like family of 
cysteine proteases and its structure has been determined (Guarne et al., 1998).  
Lpro is translated from two in-frame AUG codons, resulting in Labpro and Lbpro, both of which 
are active during infection. Labpro localises to the nucleus and causes degradation of a 
subunit of nuclear factor kappa beta (NF-kB), to reduce the host inflammatory response 
during virus replication. Lpro co-translationally self cleaves, thereby releasing P1. Upon 
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release, Lpro cleaves eIF4G, resulting in the inhibition of capped translation of host cell RNA 
(Belsham, 2013; Medina et al., 1993). This permits continuation of cap-independent 
translation of viral RNA. 
The cardiovirus L protein such as that of mengovirus and encephalomyocarditis virus does 
not function as a protease but plays a role in virus translation, inhibition of interferon 
synthesis and phosphorylation of nucleoporins (Dvorak et al., 2001; Hato et al., 2007). The 
mechanisms for its functions are not well understood. The leader proteins of viruses in the 
Kobuvirus genus do not share sequence identity with any other picornavirus proteins and 
their functions remain to be defined (Yamashita et al., 2003). 
 
1.4 Genome replication 
The purpose of genome replication is the synthesis of new viral RNA to allow increased 
translation of viral proteins and to provide viral genome for assembly into new virus particles. 
Picornavirus infection induces the rearrangement of cellular membranes which serve as a 
scaffold for vRNA replication. Studies with PV suggested such membranes were derived from 
the endoplasmic reticulum (ER) and golgi (Hsu et al., 2010; Schlegel et al., 1996). In PV, ADP 
ribosylation factor (Arf) dependent membrane trafficking in the early secretory pathway and 
coat protein II (COPII) dependent budding of vesicles from the ER were shown to be involved in 
the formation of replication complexes required for RNA replication (Hsu et al., 2010; Rust et 
al., 2001) and (as reviewed in Chase and Semler, 2012). Replication complexes facilitate an 
increase in the local concentration of proteins involved in replication. Also, the association 
with membranes protects the replicating RNA from cellular enzymatic degradation.  
Two significant differences between FMDV and enteroviruses in how they interact with the 
early secretory pathway suggest they use membranes for replication differently. Firstly, 
although FMDV and PV both inhibit the secretory pathway they do so by different mechanisms 
(Moffat et al., 2005; Moffat et al., 2007). PV 3A protein inhibits protein secretion whereas for 
FMDV secretion is not blocked by 3A but instead by 2B and 2C. FMDV 2B and 2C when 
expressed individually, do not block protein transport, however, when expressed together as 
2B with 2C or as 2BC, an inhibitory effect on protein secretion was observed (Moffat et al., 
2005; Moffat et al., 2007). Secondly, PV infection is inhibited by golgi membrane modifying 
drug such as brefeldin A (BFA) while this reagent does not inhibit FMDV infection (Armer et al., 
2008; Cuconati et al., 1998; Gazina et al., 2002; Irurzun et al., 1992). This suggests that in 
contrast to PV, FMDV modifies cellular membranes for replication in an Arf1 (ADP ribosylation 
factor) and GBF1 (Guanine Nucleotide Exchange Factor for Arf) independent way.  
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When sufficient amounts of 3Dpol and other essential viral replication proteins have been 
synthesised, the vRNA is copied starting from the 3’ end to generate a complementary RNA. 
This negative strand RNA is in turn used to generate multiple positive stranded RNA molecules 
which serve as templates for translation or as templates, for negative strand synthesis, or for 
packaging into virions. 
vRNA synthesis is initiated within the membrane-associated replication complex. vRNA is 
synthesised by the viral RNA-dependent-RNA-polymerase, 3Dpol (Section 1.3.2). 3Dpol uses the 
cre as a template to allow VPg uridylylation, resulting in VPg-pU or VPg-pUpU. The location of 
cre varies between picornaviruses for e.g. in HRV14 it is located in the coding region for P1, in 
FMDV it is located in the 5’ UTR (Mason et al., 2002) whereas in HRV2 and PV it is located in 
the coding region encoding for 2A and 2C, respectively (Gerber et al., 2001; Goodfellow et al., 
2000; McKnight and Lemon, 1998; Yang et al., 2002). Since the FMDV cre can function in trans, 
it has been referred to as the 3B uridylylation site (bus). Uridylylated VPg then acts as the 
primer for vRNA replication by annealing at the poly(A) and becoming elongated into the full 
length viral RNA by 3Dpol (Murray and Barton, 2003; Nayak et al., 2006).  Unlike other 
picornaviruses, aphthoviruses (e.g. FMDV) contain three distinct copies of VPg which differ in 
size and amino acid sequences. All three copies of VPg have been shown to be uridylylated in 
vitro but more efficient uridylylation of the third copy of VPg has been observed (Nayak et al., 
2005).  
Genome circularisation is thought to be a general mechanism used by positive strand RNA 
viruses for the initiation of vRNA replication.  In picornaviruses, 3CD interacts with the host 
cellular protein PCBP and binds to the cloverleaf structure present at the 5’ of the vRNA. The 
cellular protein PABP1 binds to the 3’ poly (A) tail of the vRNA. The interaction of PABP1 at the 
3’ end with the proteins at the 5’ end leads to the circularisation of the genome. This results in 
the proximity of 3Dpol and the poly (A) tail which enables the initiation of negative stranded 
RNA synthesis (Herold and Andino, 2001). 3C and 3CD inactivate host transcription and may 
mediate the switch from viral RNA translation to replication. Cleavage of host proteins like 
PABP and PTB by 3C and PCBP2 by 3C/3CD, contributes to the inhibition of cap-dependent 
cellular RNA translation.  Cleavage of host proteins has been proposed to mediate this switch 
(Figure 1.4) (Back et al., 2002; Parsley et al., 1997), (as reviewed in Chase and Semler, 2012).  
In the nucleus of eukaryotes, transcription is carried out by three different RNA polymerases, 
RNA polymerase I, II and III (Pol I, II and III). During enterovirus infection (e.g. PV), viral 
proteases 2A and 3C contribute to the disruption of these RNA polymerases, thereby inhibiting 
host transcription. During FMDV infection, host transcription is also inhibited but by a different 
mechanism to that of PV. Histone H3 is a protein that contributes to eukaryotic cell mitotic 
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progression and regulation (Luo et al., 2010) and FMDV 3Cpro cleaves histone H3 at is N-
terminus. Efficient inhibition of host transcription is essential for efficient replication of viral 
RNA (as reviewed in Chase and Semler, 2012). Picornavirus infections also result in the 
disruption of nucleocytoplasmic trafficking of proteins such as PCBP2, PTB and La which 
accumulate in the cytoplasm as a result of inhibition of their nuclear import. The cytoplasmic 
accumulation of some host proteins such as SRp20 are utilised by the virus during RNA 
replication and also viral translation (section 1.3).  
Thus, picornaviruses subvert host cell machinery to favour viral RNA replication by cleavage of 
host cell proteins, disruption of cellular trafficking and overall alteration of the host cell 
environment. It has been suggested that there are numerous as yet undiscovered host 
proteins that are utilised by viruses to favour viral genome translation and replication over 
that of cellular mRNA. Therefore, the complete picture of template switching between 
translation and replication is yet to be understood.  
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Figure 1.4 Switch from translation to replication.  
A. Viral RNA serves as a template for IRES dependent translation under specific conditions 
which include recruitment of ribosomal subunit to the IRES and recruitment of host cellular 
proteins to mediate viral RNA translation. B. The specific conditions are altered to favour viral 
genome to serve as a template for viral RNA replication. Cleavage of PCBP2 and PTB inhibit 
translation and contribute to the switch from translation to replication. SL: stem loop, PCBP2: 
poly(rC) binding protein 2, PTB: polypyrimidine tract-binding protein, PABP: poly (A) binding 
protein, 3D: 3D polymerase, 3CD: 3CD protein, SRp20: serine arginine protein 20. Figure 
adapted from (Chase and Semler, 2012). 
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1.5 Picornavirus assembly and structure  
Picornaviruses are small, non-enveloped RNA viruses with a capsid of icosahedral symmetry. 
The capsid structures of a number of picornaviruses have been determined by X-ray 
crystallography. These include HRV2 (Verdaguer et al., 2000), HRV3 (Zhao et al., 1996), HRV14 
(Rossmann et al., 1985), HRV16 (Hadfield et al., 1997), PV1 Mahoney (Hogle et al., 1985), PV2 
Lansing and PV3 Sabin (Filman et al., 1989), Echovirus 11 (Stuart et al., 2002), FMDV A10 (Fry 
et al., 2005a) and FMDV SAT1 (Adams et al., 2010). In addition, structures have been 
determined for assembly intermediates, entry intermediates and virus-receptor complexes at 
high resolution by X-ray crystallography and at sub-atomic resolution by electron microscopy 
(Bubeck et al., 2005; Fry et al., 2005b; Hadfield et al., 1999; Lentz and Arnold, 1998; Tuthill et 
al., 2009; Wien and Hogle, 1995; Zhang et al., 2008). These structures have contributed to the 
understanding of picornavirus assembly, antigenic variation and host-cell interactions. 
 
1.5.1 Virus Assembly  
The viral capsid proteins are synthesised as part of a polyprotein which is processed to form 
the individual capsid proteins (section 1.3). In some picornaviruses, such as enteroviruses, the 
2A protease (2Apro) autocleaves to release the region encoding the capsid proteins (P1) from 
the region encoding non-structural proteins (P2 and P3) (Castello et al., 2011). Co-translational 
cleavage of P1 by 3CD results in VP0 (the capsid protein precursor of VP2 and VP4), VP1 and 
VP3 (Blair et al., 1993; Marcotte et al., 2007). In aphthoviruses such as FMDV, 3C carries out 
these cleavages (Birtley et al., 2005). Another important cleavage in FMDV is carried out by the 
leader protease, the first protein to be produced and which cleaves itself from the structural 
proteins (as reviewed in Grubman and Baxt, 2004). Enteroviruses do not have a leader protein 
(Figure 1.2). The function of the structural and non-structural proteins is described in detail in 
section 1.3.1.  
After processing of P1 into VP0, VP1 and VP3 the capsid proteins are unlikely to exist as free 
individual proteins and rapidly assemble into protomers. Virus particles can be distinguished 
from each other based on their sedimentation coefficients (S) in a sucrose gradient. Early 
studies with HRV, PV and EMCV showed that five protomers (6S) assembled to form 
pentamers (12S), and twelve pentamers self-assembled  to form the empty virus particle (80S) 
(McGregor et al., 1975; McGregor and Rueckert, 1977) (Figure 1.5).  The structure of 
pentamers is not known and has only been inferred from capsid structures. Some 
picornaviruses naturally form empty particles in the infected cell which are equivalent to the 
virus but do not contain the vRNA (as reviewed in Putnak and Phillips, 1981). The 
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sedimentation coefficient of 80S varies slightly for empty capsids of different picornaviruses 
and depends on the conditions used. The structure of assembled empty capsids have only 
been determined for PV (Basavappa et al., 1994) and FMDV (Curry et al., 1997; Porta et al., 
2013).  
 
 
Figure 1.5 Structural organisation of the picornavirus capsid.  
A. Each protomer is comprised of one copy of each of the structural proteins VP0, VP1 and VP3 
B. Five protomers assemble to form a pentamer C. Twelve pentamers assemble to form an 
empty capsid with icosahedral symmetry D. Encapsidation of RNA cleaves precursor protein 
VP0 to form VP2 and VP4, forming the mature virus particle. Figure adapted from (Clavijo et 
al., 2004). 
 
Three theories suggest the possible functions of empty capsids. Empty capsids are thought to 
be a storage form of pentamers as empty capsids and have been reported to dissociate into 
pentamers, in-vitro (Marongiu et al., 1981; Putnak and Phillips, 1981). Two alternative theories 
suggest that empty capsids may either be dead-end products when the RNA is limiting or serve 
as immature particles into which RNA is packaged to form the mature virus particle. 
Myristoylation of the capsid precursor protein, VP0, appears to be important for particle 
assembly in both, native  (Marc et al., 1990; Moscufo et al., 1991) and recombinant systems 
(Abrams et al., 1995; Goodwin et al., 2009). However, myristoylation was shown not to be an 
absolute requirement for particle assembly (Ansardi et al., 1992). In infected cells, twelve 
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pentamers assemble to form the empty capsid. As suggested by Rombaut et al., 1991 and 
demonstrated by Li et al., 2012, pentamers purified from infected cells self-assembled to form 
empty capsids, in a cell-free system. Capsid assembly was shown to be dependent only on a 
threshold pentamer concentration, temperature (>24°C) and salt concentration (>500 mM 
NaCl). However, there is also evidence for other cellular factors including chaperones (e.g heat 
shock protein 90) in capsid assembly (Geller et al., 2007; Wang et al., 2013). There may also be 
a potential role for RNA in the process of capsid assembly as the use of two chemicals, 5-(3,4-
dichlorophenyl) methylhydantoin (hydantoin), amino-4,6-dichloropyrimidine (Py 11) and 2-
amino-5-(2-sulfamoylphenyl)-1,3,4-thiadiazole (G413), prevented RNA encapsidation and 
consequently inhibited PV capsid assembly (Verlinden et al., 2000). Only newly synthesised 
RNA is encapsidated (Baltimor.D et al., 1966; Nugent et al., 1999)but signals for RNA 
encapsidation, if present at all, are yet to be identified. Although, a mechanism for capsid 
assembly has been identified, the nature of the interactions that allow self-assembly to 
proceed remain to be fully understood. 
The structure of native HRV16 showed residues in VP1 and VP2 stacking against RNA bases 
(section 1.5.2). This was observed across the twofold axes between pentamers (Hadfield et al., 
1997). Therefore, interactions between RNA and capsid proteins may play a role in capsid 
assembly. Similar electron densities representing RNA have been observed in HRV14 (Arnold 
and Rossmann, 1990), coxsackievirus B3 (Muckelbauer et al., 1995) and PV (Filman et al., 1989)  
After RNA encapsidation, maturation cleavage of VP0 into VP2 and VP4 takes place in most 
picornaviruses except kobuviruses and parechoviruses (Yu et al., 2011) and (as reviewed in 
Stanway and Hyypia, 1999). This final stage of assembly permits internal rearrangements of 
VP2 and VP4 to lock the virus particle into a metastable state which is primed to undergo 
conformational changes, required to release the viral RNA during infection (Hogle, 2002). The 
maturation cleavage of VP0 stabilises the virus and is essential for virus infectivity of most 
picornaviruses such as enteroviruses and aphthoviruses. However, in some aphthoviruses such 
as FMDV A22, the maturation cleavage of VP0 can occur in the absence of packaged RNA, 
resulting in the formation of empty particles containing mature forms of VP2 and VP4 (Curry et 
al., 1997). In PV, the residues forming the VP0 cleavage site are the C-terminal asparagine of 
VP4 (position 68) and the N-terminal serine of VP2 (position 1) (Ansardi and Morrow, 1995). 
Mutations of the histidine residue (position 195) of PV VP2, which is present in the vicinity of 
the VP0 cleavage site, were shown to be lethal as they prevented VP0 cleavage during the final 
stages of virus assembly (Hindiyeh et al., 1999). 
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1.5.2 Virus structure 
The picornavirus capsid is approximately 30 nm in diameter and is composed of sixty copies of 
each of the four capsid proteins VP1, VP2, VP3 and VP4, arranged with icosahedral symmetry. 
VP1, VP2 and VP3 form the outer capsid surface while VP4 is distributed on the inner surface 
of the capsid (Figure 1.6). 
 
 
Figure 1.6 Picornavirus capsid and pentamer showing the location of capsid proteins.            
A. Capsid of icosahedral symmetry comprised of VP1 (blue), VP2 (green), VP3 (red) and VP4 
(not visible). B. A pentamer of icosahedral protomeric units depicting VP1 (blue), VP2 (green) 
and VP3 (red) forming the surface of the capsid, and VP4 (yellow) which is internal to the 
capsid. The view is from the inside of a virus. The N-termini of VP1 are depicted as alpha 
helices (blue). The position of the fivefold (   ), threefold (   ) and twofold (  ) icosahedral 
symmetry axes are shown. Figure adapted from (Tuthill et al., 2009) and (Wang et al., 2012).  
 
VP0 contains the five amino acid myristoylation signal sequence at its N-terminus. 
Myristoylation of VP0 is a feature of all picornaviruses except for hepatoviruses and 
parechoviruses. Hepatitis A virus (the only member of the Hepatovirus genus) is unusual as it 
does not contain a myristoylation signal sequence at the N-terminus of VP0 hence VP0 and 
VP4 are not myristoylated (as reviewed in Stanway and Hyypia, 1999) also see section 1.5.1. 
The myristate groups are clustered in a region that locates to the fivefold symmetry axes of the 
virus. The carbonyl oxygen of the myristate molecules form hydrogen bonds with the hydroxyl 
groups of threonine (position 28) of adjacent VP4 proteins. Substitution of threonine (position 
28) of PV VP4 with different amino acids (valine or serine), resulted in the accumulation of 
assembly inefficient intermediates, decreased virus infectivity and stability of the assembled 
mutant; and substitution with some amino acids (glycine or lysine) were lethal and produced 
non-viable virus particles. Therefore, the interactions between threonine (position 28) in VP4 
and the myristate group of the adjacent VP4, were important for virus structure and stability 
(Moscufo and Chow, 1992).  
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Figure 1.7 Binding of the pocket factor into the pocket located at the base of the canyon.      
A. A capsid protomer depicting VP1 (blue), VP2 (red), VP3 (green) and VP4 (yellow). WIN 
compound shown as space filling model (orange). The pocket factor and WIN compound share 
the same binding site in the pocket. B. Comparison of pocket factor and WIN compound 
occupancy in the pocket. Electron density of the pocket factor shown in red and WIN 
compound model shown in orange. Figure adapted from (Plevka et al., 2013). 
 
The overall capsid structures of members of the picornavirus family are similar (Figure 1.6). 
One of the defining features of enteroviruses is the canyon which is a depression surrounding 
the fivefold axis. The canyon is mostly composed of VP1 residues. The base of the canyon 
forms the binding site for receptors of the immunoglobulin-like superfamily such as the 
poliovirus receptor (PVR, also called CD155) and intercellular adhesion molecule-1 (ICAM-1) for 
PV and major group rhinoviruses, respectively  (Belnap et al., 2000b; He et al., 2003; Kolatkar 
et al., 1999; Olson et al., 1993). Cardioviruses such as mengovirus and Theiler's murine 
encephalomyelitis virus contain a depression similar to the canyon which is not continuous but 
broken into five deep pits. These pits are also involved in receptor binding (Hertzler et al., 
2000; Luo et al., 1987). In contrast, the receptor binding site for minor group rhinoviruses such 
as HRV2 is a small star shaped dome on the fivefold axis and not the base of the canyon 
(Hewat et al., 2000). The majority of enteroviruses, contain a pocket factor which is present 
below the floor of the canyon and contributes to virus particle stability (Plevka et al., 2013) 
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(Figure 1.7). The X-ray crystal structure for bovine enterovirus (BEV) showed the pocket 
contained electron density which was modelled to be myristic acid. The release of the pocket 
factor is a necessary prerequisite for virus uncoating (as reviewed in Smyth and Martin, 2002). 
In contrast, aphthoviruses do not contain a canyon and the receptor (integrin) binding site for 
FMDV is an exposed arginine-glycine-aspartic acid (RGD) motif present on the GH loop of VP1 
(Jackson et al., 1997; Mason et al., 1994).  
VP1-3 adopt a wedge shaped eight stranded beta-barrel structure (Figure 1.8). The narrow 
ends of the VP1 beta barrel cluster around the fivefold axis. The narrow ends of the VP2 and 
VP3 beta barrels alternate around the threefold axis. The beta strands are linked by connecting 
loops, whose lengths and compositions determine virus surface topology which in turn 
influences receptor binding and antigenicity (Hogle et al., 1985) (as reviewed in Tuthill et al., 
2010; as reviewed in Wien et al., 1996) The difference in the length of the connecting loops 
also contributes to the formation of the canyon (in enteroviruses) and capsid thickness which 
varies between 33 Å for FMDV and 42.5 Å for HRV14 (Acharya et al., 1989; Jackson et al., 2003; 
Rossmann et al., 1985), (as reviewed in Tuthill et al., 2010). In contrast to enteroviruses where 
protrusions are formed by the connecting loops at the fivefold, threefold and twofold axis, 
aphthoviruses such as FMDV have shorter surface loops, resulting in a smooth capsid surface 
compared to enteroviruses such as PV (Figure 1.9) (Tuthill et al., 2009; Tuthill et al., 2010).  
 
Figure 1.8 Schematic representation of the structure and organisation shared by VP1, VP2 
and VP3.  
A wedge-shaped antiparallel beta barrel comprised of eight strands. Individual beta strands are 
labelled alphabetically (A-H) and shown as arrows. The cylinders depict the flanking helices. 
Figure reproduced from (Filman et al., 1989). 
  
Chapter 1 Introduction 
44 
 
 
Figure 1.9 Comparison of picornavirus capsid structures.  
Picornavirus particles represented as radial depth cued images with a colour gradient from 
innermost surfaces (dark blue) to outermost surfaces (white). A. Poliovirus. The canyon 
surrounding the fivefold axis is clearly identified. B. Theiler’s murine encephalomyelitis virus. 
Surface depressions spanning the twofold axis clearly identified. C. Foot-and-mouth disease 
virus with a smooth surface relative to poliovirus and theiler’s murine encephalomyelitis virus. 
Figure adapted from (Tuthill et al., 2010). 
 
 
In the virus structures determined by X-ray crystallography, portions of the capsid were 
disordered, suggesting flexibility or multiple adopted conformations. These regions included 
the N-terminus and central portion of VP4 in most picornaviruses, and the N-terminus of VP2 
in some picornaviruses such as FMDV, and N-terminus of VP1 in HRV and PV. In FMDV, the  
VP1 GH loop is a conformationally flexible loop and was not observed in the crystal structure 
other than in the chemically reduced FMDV structure (Rowlands et al., 1994). These flexible 
regions of the capsid proteins are often associated with functions in cell entry (described in 
section 1.6) 
In order for the large size RNA to be contained within the capsid, it has to be tightly packed. 
The interaction between the vRNA and capsid proteins may play a role in virus assembly. In a 
structure of PV2, electron densities tentatively assigned to RNA bases appeared to be stacked 
against the VP4 residues, tyrosine (position 20) and phenylalanine (position 46) (Lentz et al., 
1997).  In a structure of PV3, electron densities which may correspond to RNA bases appeared 
to be stacked against tryptophan (position 38) and phenylalanine (position 41) of VP2. Similarly 
in PV1, RNA bases appeared to be stacked against tryptophan (position 38) and tyrosine 
(position 41) of VP2 (Filman et al., 1989). Also, the structure of HRV16, revealed the stacking of 
RNA bases against the tryptophan (position 38) of VP2 and a tentative identification of RNA 
bases stacking against tyrosine (position 55) of VP1, on the inner surface of the viral capsid 
(Hadfield et al., 1997). Tryptophan (position 38) is a conserved residue across the picornavirus 
family (Lentz et al., 1997) and is present in a depression around the threefold axis. Electron 
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density attributed to RNA was observed stacked against this (tryptophan , position 38) residue. 
This was reminiscent of the trefoil shaped cluster formed by RNA and bound to the capsid 
interior of the bean pod mottle virus, a plant icosahedral virus (Chen et al., 1989). Therefore, 
although RNA is not visible in the above mentioned structures of picornaviruses, the similarity 
with bean pod mottle virus, suggests the electron density stacked against the capsid proteins is 
likely to be that of RNA. 
 
1.6 Virus cell entry 
Viruses are obligate intracellular pathogens and gaining entry into host cells is, therefore, a 
critical part of the viral life cycle. The initial step in virus entry is the attachment of virus to the 
cell surface receptor.  
PV binds to PVR which is expressed in many cells including those of the small intestine, lung, 
liver, heart and motor neurons of the spinal cord. Therefore, the neurotropism of PV cannot be 
explained based solely on the distribution of PVR. The distribution of receptors such as ICAM-
1, integrins and decay accelerating factor (DAF) used as receptors by major group HRV, FMDV 
and the majority of echoviruses, respectively (section 1.6.4.1), suggest that the presence of 
receptors is not the only factor determining tissue tropism of these viruses. A clear 
understanding of the relationship between receptor usage and pathogenesis is lacking, partly 
due the lack of suitable animal models (Evans and Almond, 1998). Some viruses have been 
shown to use more than one receptor which contributes to virus uptake into the cell. The 
receptors used will be discussed in more detail in section 1.6.4.1.  
After binding of viruses to receptors on the cell surface viruses must enter cells to initiate 
infection. Most picornaviruses enter the cells using endocytosis and the nature of the 
endocytic pathway used varies between the viruses. Upon entering the endocytosed vesicle, 
picornaviruses need to overcome the membrane barrier to gain access to the cytoplasm, 
without destroying host cell integrity. Enveloped viruses contain an outer membrane 
(“envelope”) and can enter the cell by a well characterised process of fusion between the viral 
and host cell membranes. Due to the absence of the membrane layer in non-enveloped 
viruses, the mechanism used to gain entry into host cells, must be different to enveloped 
viruses but remains unresolved. The mechanism of membrane permeabilisation by non-
enveloped viruses may involve membrane pore formation or disruption.  
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1.6.1 Membrane penetration by enveloped viruses 
Enveloped viruses gain entry into host cells by fusion of their membrane with that of the host 
cell. Proteins, usually glycoproteins (gp), present in the virus envelope catalyse this process. A 
trigger such as receptor binding or low pH induces conformational changes in an envelope 
protein which result in the exposure and insertion of a fusion peptide into the host cell 
membrane. This leads to the mixing of the viral and host cell membrane (hemifusion) and 
eventually opening of a fusion pore. An overview of this process is shown in Figure 1.10. 
 
Figure 1.10 The stages of enveloped virus membrane fusion.  
A. Alphavirus particle in pre-fusion state. Virus glycoproteins, virus membrane and host cell 
membrane are labelled. B. Upon exposure to low pH, the glycoproteins dissociate and the 
fusion domain becomes exposed. C. The fusion domain inserts into the host cell membrane. D. 
Distortion of the host cell membrane caused by insertion of the fusion domain. E. The virus 
membrane and host cell membrane merge. This stage is the hemifusion stage. F. Complete 
fusion forms the fusion pore. Figure adapted from (Kielian et al., 2010). 
 
HIV is an enveloped virus, consisting of gp120 and gp41 in its envelope. gp120 binds to its 
primary cellular receptor, CD4 and then to a co-receptor which induces conformational 
changes in its structure to expose the N-terminus of gp41 which contains a hydrophobic 
domain that mediates membrane fusion between virus and host cell membrane (as reviewed 
in Chan and Kim, 1998) and (as reviewed in Jones et al., 2011). Herpes simplex virus-1 (as 
reviewed in Spear, 2004) and Sendai virus (Chejanovsky and Loyter, 1985) are other examples 
where viral  glycoproteins  fuse directly with the plasma membrane at the cell surface. Other 
enveloped viruses are endocytosed into acidic compartments (such as endosomes) where the 
prevailing low pH triggers membrane fusion of the virus and host cell membrane. For example, 
the influenza gp, haemagglutinin (HA) undergoes conformational changes at low pH which 
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results in the exposure of hydrophobic fusion peptide that mediates the fusion of viral and 
host cell membranes (Figure 1.11) (Han et al., 2001).  
 
 
Figure 1.11 Changes in the structure of the HA trimer from neutral pH to acidic pH.  
HA1 (blue) and HA2 (multi-coloured). The N and C-termini of each chain are labelled. Upon 
exposure to low pH (fusion pH), HA1 and HA2 are reoriented and refolded. The HA1 
membrane distal domains detrimerise, the fusion peptide becomes relocated to become the 
N-terminus of the alpha helix and mediates the fusion of viral and host cell membranes.  Figure 
adapted from (Russell et al., 2008). 
 
Viral fusion peptides can, therefore, be classified as either pH dependent or pH independent, 
based on the trigger required for the activation of the peptides for membrane fusion. Fusion 
peptides can also be divided into three classes based on their structure and function (Figure 
1.12). Class I fusion peptides occur as fusion inactive precursor molecules that undergo 
proteolytic cleavage to liberate the N-terminus of the fusion peptide necessary to prepare for 
the fusion of the viral envelope with the target membrane. Fusion can be triggered by low pH 
and/or receptor binding and results in the extension of an alpha helical coiled coil which 
pushes the fusion peptide towards the host cell target membrane. All class I fusion peptides 
contain a heptad repeat-derived six helix bundle structure. Examples of class I fusion peptides 
include Influenza HA, HIV-I envelope protein (Env) and paramyxovirus F protein. Class II fusion 
peptides have an elongated plate-like pre-fusion structure running parallel to the virus 
envelope. Upon being triggered by the acidic pH, the complex undergoes a conformational 
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change resulting in the domains near the fusion loops becoming perpendicular to the viral 
envelope and the target host cell membrane. The fusion loops are brought into close proximity 
by the reorganization of this complex into trimeric complexes. Unlike the high alpha helical 
content of class I fusion peptides, the final structure of class II fusion peptides has high beta 
sheet structure. Examples of class II fusion peptides include dengue virus E and alphavirus E 
protein. Class III fusion peptides share similarities with both class I and II fusion peptides. They 
have a pre-fusion native trimeric conformation, an extended conformation enabling viral 
envelope and target membrane interaction and a hair-pin post fusion structure. A 
characteristic of this class of fusion peptides is the reversible refolding of the peptides. 
Therefore, subsequent to the transport through the acidic pH environment which triggers the 
fusion of the viral envelope with that target host cell membrane, the trimer re-adopts its 
native conformation. The post-fusion structure is similar to the six-helix bundle structure of 
class I fusion peptides, but the heptad repeats are absent. Examples of class III fusion peptides 
include Rhabdovirus G and Baculovirus gp64 (Plemper, 2011).  
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Figure 1.12 Classes of fusion peptides.  
A. Class I fusion peptides. B. Class II fusion peptides.  C. Class III fusion peptides. Prefusion, pre-
hairpin and postfusion states are shown in three columns. Triggers for prefusion to pre-hairpin 
and postfusion are indicated on arrows. Figure reproduced from (Plemper, 2011).    
 
1.6.2 Membrane penetration by non-enveloped viruses 
Unlike enveloped viruses, which fuse the viral envelope with the cellular membrane, non-
enveloped viruses must employ other mechanisms to cross the membrane and gain access to 
intracellular sites of replication. Non-enveloped viruses can gain entry into the host cell 
cytoplasm by becoming internalised into an endocytosed vesicle from within which a 
mechanism of membrane permeabilisation permits delivery of viral genetic material into the 
cytoplasm.  
The virus capsid must be stable to allow environmental survival and transmission between 
hosts. Paradoxically, they must be sufficiently unstable to allow capsid disassembly during 
entry.  This is achieved by locking the virus in a so-called metastable state. The conformational 
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changes in the capsid required for virus uncoating (externalisation of VP1 N-terminus and loss 
of VP4), must be spatiotemporally controlled as the premature release of the viral genome 
could miss the target replication site and expose the genome to host sensors which may 
trigger an immune response.  
Capsid uncoating can be triggered by engagement with receptors, other host factors, low pH or 
mechanical stress. PV is an example of a picornavirus where uncoating is triggered by receptor 
binding whereas in FMDV, also a member of the picornavirus family, uncoating is triggered by 
low pH. Triggers for PV and FMDV uncoating will be discussed in more detail in section 1.6.4.2.  
Host factors that play a role in initiating genome release can be receptor binding but also 
others. Simian virus 40 (SV40) is internalised by lipid raft-mediated endocytosis following virus 
binding to its cell surface receptor ganglioside GM1. From here the virus is transported to the 
endoplasmic reticulum (ER), where structural alterations are triggered in the capsid by 
members of the disulphide isomerase family which facilitate exposure of the membrane 
permeabilising N-terminal domain of the capsid protein VP2. This results in the release of viral 
particles into the cytoplasm where they undergo further structural alterations in the capsid, 
mediating the import of viral genome into the nucleus (Engel et al., 2011) and (as reviewed in 
Suomalainen and Greber, 2013). Mechanical stress is used by viruses such as human 
adenovirus (HAdV) to trigger capsid uncoating. HAdV binds to coxsackievirus adenovirus 
receptor (CAR) via fiber proteins and then engages with integrin receptors. The different 
motion patterns of CAR and integrins put a mechanical strain on the virus, resulting in the 
shedding of fibre proteins and exposure of capsid protein VI. The exposure of protein VI is 
required for the release of virus from the endosome by membrane disruption (Burckhardt et 
al., 2011; Wiethoff et al., 2005). 
 
1.6.3 Non-enveloped virus capsid proteins facilitating membrane penetration 
Non-enveloped viruses are metastable and in response to different cues (as described above), 
undergo conformational changes in their capsids leading to the delivery of the viral genetic 
material into the cytoplasm. This uncoating process often involves the exposure of proteins 
from the particle interior to the surface, and mediates membrane permeabilisation which 
facilitates the transfer of viral genetic material across the membrane.  
Membrane permeabilising peptides of different non-enveloped viruses have been reported. 
The examples of some capsid proteins with membrane permeabilising function facilitating the 
cell entry process of non-enveloped are discussed here. 
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 Reovirus µ1  
Following virus binding to cell receptors, reoviruses are internalised by endocytosis. Partial 
disassembly of the capsid occurs in the endocytic compartment, resulting in the exposure 
of the membrane binding protein, µ1, which has been shown to be the principal agent for 
membrane permeabilisation by reoviruses (Guglielmi et al., 2006; Odegard et al., 2004). 
Protease cleavage of µ1 leads to the release of the N-terminally myristoylated, µ1N. 
Studies have shown that the release of µ1N is essential and it directly contributes to 
membrane permeability mediating reovirus core delivery into the cytoplasm. Synthetic 
µ1N peptide has been shown to mediate the formation of size-restrictive pores in 
liposomes. These pores appear too small for the transfer of the core. Therefore, pore 
formation has been suggested as an initial step towards endosomal disruption. It has been 
suggested that docking of viral particles onto the pores formed by µ1N, allow the particles 
to access host cell factors to facilitate widening of the pore for the delivery of cores from 
the endosome into the cytoplasm. Alternatively, the µ1N concentration in endosomes may 
itself be high enough to form large pores or that the endosomal membrane is lysed 
following formation of pores (Chandran et al., 2002; Ivanovic et al., 2008; Zhang et al., 
2009). 
 
 Flock house virus γ1  
During virus maturation, a capsid precursor protein (α) is cleaved to form a small peptide, 
γ, and other cleavage products.  The γ peptide is located on the inner surface of the virus 
particle. Flock house virus binds its cellular receptors, enters the cell by endocytosis and 
undergoes conformational changes. The resulting altered particles are sensitive to pH and 
have lost a proportion of the γ peptide (Walukiewicz et al., 2006). The γ peptide becomes 
transiently externalised during capsid breathing and irreversibly exposed when the virus 
particle encounters low pH during entry. The N-terminal 21 residues of γ peptide, have 
been predicted to form an amphipathic alpha helix and shown to disrupt membranes 
when synthetically generated (Bong et al., 1999; Bong et al., 2000; Maia et al., 2006). More 
recent studies using VLPs containing only the amphipathic N-terminal region or that and 
additional regions of the C-terminus of γ peptide, showed that the N- terminal region of γ 
peptide was not sufficient to induce membrane permeability. Though the role of the C-
terminal region of the γ peptide in entry is as yet undetermined, it was also required for 
membrane permeabilisation and efficient FHV entry (Banerjee et al., 2009). The findings 
above demonstrate the crucial role played by flock house virus γ peptide in permeabilising 
biological membranes during cell entry.  
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 Rotavirus VP5* 
For rotavirus infection to be initiated, translocation of the virus particle across the 
membrane and into the cytoplasm is essential. The proteins VP4 and VP7 are exposed on 
the surface of the virion (Prasad and Chiu, 1994). The spike protein VP4 is the principal 
agent for attachment to host cells and membrane penetration (Ludert et al., 1996). Trypsin 
cleaves VP4 into VP5* and VP8*, both of which remain associated with the virion. This 
cleavage is essential as it primes rotavirus for cell entry. VP5* was shown to induce size-
selective membrane permeability in model membranes (Dowling et al., 2000) whereas 
membrane permeability was not observed with VP8* or VP4 (Denisova et al., 1999). The 
use of mononclonal antibodies against VP5*, neutralised infectivity and prevented the 
association with liposomes by VP5* (Trask et al., 2010). These findings suggested the 
importance of VP5* in rotavirus entry and provided a link between uncoating, membrane 
interaction and rotavirus entry. 
 
 Adenovirus protein VI 
Adenovirus fiber proteins bind to host cell receptors CAR or CD46 followed by interaction 
with integrins to initiate virus internalisation via endocytosis (as reviewed in Meier and 
Greber, 2004). Protein VI is internal to the capsid and released during capsid disassembly 
within endosomes. The capsid disassembly induced by lowering pH or elevating 
temperature was required for adenovirus mediated membrane disruption, suggesting that 
protein VI was necessary for membrane disruption. Protein VI induced pH independent 
membrane disruption. The amino terminus of protein VI has a predicted amphipathic 
helical structure and was essential for induction of membrane disruption (Moyer et al., 
2011; Wiethoff et al., 2005). Antibodies against protein VI neutralised adenovirus 
infectivity and reduced membrane permeability induced by adenovirus (Maier et al., 
2010). Similar to other non-enveloped viruses, the mechanism of membrane 
permeabilisation induced by protein VI is not known.  
 
Common themes in non-enveloped virus membrane penetration 
Capsid proteins that mediate membrane permeabilisation for the delivery of genetic material 
across the cellular membrane, share several common features. Non-enveloped virus capsids 
are stable structures which become metastable upon processing of capsid proteins. During 
infection, non-enveloped viruses undergo priming which involves conformational changes in 
the capsid triggered by a range of factors including low pH or receptor binding (section 1.6.2). 
The conformational changes result in the exposure or release of hydrophobic proteins (or 
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protein regions) which subsequently mediate interactions with cellular membranes, thereby 
facilitating the delivery of viral genetic material across the membrane and into the cytoplasm.  
From the examples of membrane permeabilising non-enveloped virus proteins described 
above, it can be gathered that generally, the membrane binding hydrophobic peptide is 
present on the inner surface of the virion and protected from the external environment. It only 
becomes exposed when the capsid undergoes conformational changes upon receiving the 
appropriate trigger in the right environment. For example, membrane permeability is induced 
by rotaviruses only when capsid conformational changes take place in the presence of 
membrane. If membranes are added in later to pre-treated virus particles, membrane 
permeability is not induced (Trask et al., 2010). Uncoating of HRV2 only occurs in the late 
endosome as it requires the acidic pH to trigger conformational changes necessary to mediate 
the delivery of the viral genome across the membrane and into the cytoplasm for replication 
(Prchla et al., 1994). Many of these membrane permeabilising viral proteins are products of 
precursor proteins and are released as a result of protease cleavage or autocleavage. 
Membrane binding proteins of non-enveloped viruses are often co or post-translationally 
modified by the addition of a palmitoyl or myristoyl group at the N-terminus (e.g. N-terminally 
myristoylated µ1 of reovirus and VP4 of picornaviruses) and predicted to form amphipathic 
alpha helices.  
Therefore, cell entry of non-enveloped viruses appears to follow a common paradigm of viral 
protein mediated membrane permeabilisation. However, the details of the mechanism of the 
membrane permeabilisation induced by non-enveloped viruses, remains to be defined.   
 
1.6.4 Picornavirus entry 
Picornaviruses serve as good models to study cell entry of non-enveloped viruses as many 
members of the picornavirus family can be readily grown in cell culture, many of their their 
receptors are identified and the capsid structures of many resolved. However, defining the 
mechanism of cell entry used by picornaviruses has been complicated by the expanding and 
newly identified endocytic pathways and the ability of a given virus to use multiple pathways 
to gain cell entry. So far, HRV and PV have been used as models to elucidate picornavirus 
entry. 
1.6.4.1 Receptors and endocytosis 
A virus receptor can be defined as a molecule that interacts with the virus particle at the cell 
surface to promote infection. Receptor interactions allow viruses to attach to cells, provide the 
signal for cellular processes that internalise the virus particle and in some cases provide a 
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trigger for conformational changes in the capsid. Picornavirus receptor molecules are 
structurally diverse. Some picornavirus species such as HRV are classified into different groups 
based on the receptors used. Major group HRVs bind intrercellular adhesion molecule-1 and 
minor group HRVs bind members of the low density lipoprotein receptor family. Poliovirus 
bind to poliovirus receptor, also called cluster of differentiation 155 (CD155). Intercellular 
adhesion molecule-1 (ICAM-1), coxsackievirus-adenovirus receptor (CAR) and poliovirus 
receptor (PVR) belong to the immunoglobulin (Ig) superfamily. Receptors that do not belong to 
the Ig superfamily include the low-density lipoprotein receptor (LDLR) which binds minor 
group HRV, and decay-accelerating factor (DAF) which binds some echoviruses and coxsackie B 
viruses (Evans and Almond, 1998; Rossmann et al., 2002).  A schematic of some of the known 
picornavirus receptors is shown in Figure 1.13. Poliovirus and major group human rhinovirus 
binding to receptors are two of the best studied examples. The receptors are anchored to the 
membrane, single span glycoproteins with three (PVR) or five (ICAM-1) extracellular domains. 
The amino terminal domain (D1) of the receptors bind into the canyon present around the 
fivefold axis of HRV and PV (Figure 1.14) (also described in section 1.5.2). Minor group HRVs 
bind three members of LDLR family:  LDLR, very low density lipoprotein receptor (VLDLR) and 
low density lipoprotein receptor related protein (LRP) (Hofer et al., 1994). The structure of 
LDLR contains amino terminal repeats, which enables it to make contact with several capsid 
proteins. Unlike receptor binding at base of the canyon in major group rhinoviruses, LDLRs 
bind to the star shaped protrusion observed at the fivefold axis (Hewat et al., 2000). Despite 
the relative similarities in sequence and structure between major and minor group HRVs, they 
bind to different receptors. This may be due to the differences in charges present at the base 
of the canyon in major and minor group HRVs (Kolatkar et al., 1999; Vlasak et al., 2003). It is 
possible that the lack of charge complementarity inhibits binding of minor group HRVs to 
ICAM-1.   
Enteroviruses other than PV often use multiple receptors to mediate cell entry. For example, 
coxsackie B viruses can infect cells by binding coxsackievirus and adenovirus receptor (CAR) or 
heparin sulphate proteoglycans. Additionally, DAF functions as an attachment receptor 
(Bergelson et al., 1997; Shafren et al., 1995; Zautner et al., 2003). Some echoviruses can bind 
integrin α2β1 (VLA-2) (Bergelson et al., 1992; Xing et al., 2004) or DAF (Powell et al., 1998; 
Ward et al., 1994). Enterovirus 71 uses scavenger receptor class B member 2 
(SCARB2)(Yamayoshi et al., 2009) and P-selectin glycoprotein (PSGL-1) as receptors (Nishimura 
and Shimizu, 2009). Field isolates of FMDV have been reported to use a range of RGD binding 
integrins such as αvβ6, αvβ3, αvβ8, αvβ1. αvβ6 is expressed to high levels on epithelial tissues 
(site of FMDV infection) and is the predominant receptor used by FMDV isolates to initiate 
infection in vivo (Monaghan et al., 2005). Cell-culture adapted isolates of FMDV were shown to 
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bind heparan sulphate glycan (HSG), an integrin independent route to initiate infection 
(Jackson et al., 1996).  
 
 
 
Figure 1.13 Schematic representation of receptors used by members of the picornavirus 
family.  
Regions involved in virus binding are shown in black. Regions not known to be involved in virus 
binding are shown in white. Regions for which no information is available are shown in grey. 
CAR: coxsackie-adenovirus receptor, DAF: decay-accelerating factor, GPI: 
glycosylphosphatidylinositol, HAVcr-1: hepatitis cellular receptor type 1, ICAM-1: intracellular 
adhesion molecule type 1, LDL: low density lipoprotein, LDLR: low density lipoprotein receptor, 
PVR: poliovirus receptor, SCR: short consensus repeat, T/S/P: threonine/serine/proline, VCAM-
1: vascular cell adhesion molecule type 1. Figure reproduced from (Evans and Almond, 1998). 
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Figure 1.14 Domain 1 of the receptor binds in the canyon surrounding the fivefold axis.  
A. Cryo-EM reconstructions of poliovirus bound to its receptor (PVR). B. Two views of a single 
PVR molecule showing its domains, labeled domain 1, 2 and 3. Domain 1 inserts into the base 
of the canyon present around the fivefold. The fivefold axis indicated by a black triangle. Figure 
adapted from (Belnap et al., 2000b). 
 
After binding to cell receptors, many picornaviruses become internalised by endocytosis. For 
example, after FMDV binds to its cell surface receptors of epithelial cells, FMDV gains entry 
into the cell by clathrin-dependent endocytic pathway (Berryman et al., 2005), whereas cell-
culture adapted FMDV uses caveolin-dependent endocytic pathway (O'Donnell et al., 2008). 
Upon binding to PVR, PV enters the cell using receptor-mediated endocytosis which is clathrin, 
caveolin, flotillin and microtubule independent but tyrosine kinase and actin-dependent 
(Brandenburg et al., 2007). Major and minor group HRVs bind to ICAM-1 or LDLR, respectively 
and enter the cells via clathrin dependent or independent endocytic pathway or 
macropinocytosis (Fuchs and Blaas, 2010).  
 
1.6.4.2 Particle alterations and uncoating 
In enteroviruses such as PV and HRV, VP4 and the N-terminus of VP1 are internal to the capsid. 
At physiological temperature these internal capsid proteins are transiently externalised and 
this phenomenon is referred to as capsid “breathing”. Capsid breathing demonstrates that 
picornavirus capsids are in a metastable state and ready to undergo conformational 
rearrangements required for the release of RNA, when the appropriate trigger is received.  
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The conformational changes in the capsid involve the irreversible externalisation of N-terminus 
of VP1 and the release of VP4. The conversion of native particle to an altered “A” particle 
involves the loss of VP4. The “A” particle is characterised by increased hydrophobicity, altered 
antigenicity and sensitivity to proteases and a lower sedimentation coefficient of 135S relative 
to the native particle (160S) (Basavappa et al., 1998). The “A” particle is 4% larger than the 
native particle at the twofold and fivefold axes and 1% larger at the threefold axis. The particle 
expansion occurs due to structural rearrangements of capsid proteins (Belnap et al., 2000a).  
Picornaviruses such as PV, BEV (and most enteroviruses) have a pocket factor present in a 
hydrophobic pocket formed by VP1 below the floor of the canyon (Figure 1.7).  The pocket 
factor has been suggested to be important for particle stability and its release from the pocket 
a prerequisite for virus uncoating (Rossmann et al., 2002). Binding sites for the pocket factor 
and receptors such as ICAM1 and PVR overlap (section 1.5.2). Receptor binding displaces the 
pocket factor, contributing to conformational changes in the capsid, leading to the release of 
the viral RNA (Rossmann, 1994). Some compounds such as the Winthrop (WIN) compounds 
and their derivatives have a strong affinity for the same binding site in the hydrophobic pocket 
as the pocket factor. Therefore, after the displacement of the pocket factor, WIN compounds 
bind within the pocket, thereby stabilising the virus and preventing capsid uncoating 
(Rossmann, 1994) and (as reviewed in Smyth and Martin, 2002). 
For some enteroviruses such as PV and HRV3, receptor binding at physiological temperature is 
sufficient to trigger conformational changes in the capsid.  However, for other major group 
HRVs like HRV16, receptor binding and an acidic pH is required for capsid uncoating (Nurani et 
al., 2003; Racaniello, 1996). After binding to its receptor, exposure of HRV2 to acidic pH in the 
endosomal compartments is critical to induce conformational changes in the capsid which 
subsequently lead to virus uncoating (Prchla et al., 1994).  
In contrast to enteroviruses, aphthoviruses are acid labile. As a result of this, FMDV capsids 
dissociate upon encountering mildly acidic pH in the early endosome. FMDV has been shown 
to bind and infect cells using receptors other than integrins. Therefore, receptors appear to be 
required for FMDV binding at the cell surface which helps concentrate the virus, and the acidic 
pH serves as the trigger for capsid to dissociate, thereby releasing the viral RNA (Mason et al., 
1993).  
Upon receiving the appropriate trigger such as pH and/or receptor binding, picornaviruses 
undergo structural rearrangements in the capsid.  Enteroviruses such as PV and HRV follow a 
model of cell entry where the native particle (160S) is converted to an “A” particle (135S) from 
which RNA release takes place, leaving behind an intact empty capsid (80S) (Figure 1.15A). 
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However, other picornaviruses such as aphthoviruses do not appear to follow this model of 
uncoating where RNA release takes place through an intact particle. Instead, aphthoviruses 
such as FMDV appear to dissociate upon encountering low pH in the early endosome, thereby 
releasing the viral RNA (Figure 1.15B). In contrast to this existing dogma for aphthovirus 
uncoating, a recent study showed the detection of an intact but transient empty particle 
intermediate of the aphthovirus, equine rhinitis A virus (ERAV) (Tuthill et al., 2009). This finding 
suggested a common model of uncoating involving the formation of an intact intermediate 
particle by all picornaviruses.  
 
 
Figure 1.15 Models for picornavirus membrane permeabilisation. 
A. Upon receptor binding, PV capsid undergoes conformational changes, resulting in the 
exposure of capsid proteins which facilitate delivery of the viral genome through an intact 
particle. B. Upon encountering low pH, the FMDV capsid dissociates to release the viral 
genome.  
 
PV “A” particles can be formed by heating to 50°C (Curry et al., 1996). It is conceivable that the 
virus requires high activation energy for capsid conformational changes. The dependence on 
temperature and activation energy to convert native virus particles to “A” particles in the 
presence or absence of receptors is different. Studies by Tsang et al., showed that the receptor 
acts as a catalyst to lower the activation energy required for transition resulting in increased 
particle conversion from native to “A” particles (Tsang et al., 2001). The activation energy 
barriers can be lowered by other physiological factors in vivo including endosomal acidification 
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and binding and unbinding metal ions (Garriga et al., 2012; Hogle, 2002) and (as reviewed in 
Mateu, 2011).  
The trigger for conversion of “A” particles to empty particles is not known. The overall shape 
and dimensions of 135S and 80S are similar. Empty capsids are formed after the release of RNA 
from 135S particles. Therefore, RNA density observed in cryo-EM reconstructions of PV native 
(160S) and “A” particles (135S) particles was absent in the 80S particles (Belnap et al., 2000a).  
Comparison of cryo-EM reconstructions of PV “A” particles with “A” particles from which the 
first 31 amino acids at the N-terminus of VP1 were proteolytically removed, revealed the VP1 
N-terminus was present near the “propeller tip” around the threefold axis. The “ridge” of 
density connecting the fivefold mesa with the propeller tip was observed in the “A” particle 
but not in native particle (Figure 1.16). The “ridge”, was modelled as a potential amphipathic 
helix and N-terminal residues of VP1 have been attributed to the observed ridge density 
(Bubeck et al., 2005)  
 
Figure 1.16 The ridge in PV “A” particles comprised of VP1 N-terminus.  
A. Cryo-EM reconstruction of the PV “A” particle showed the linear “ridge” connecting a point 
on the fivefold mesa (blue dot) with the propeller tip (red dot). B. The “ridge” is not observed 
connecting a point on the fivefold mesa (blue dot) with the propeller tip (red dot) in the native 
PV particle. Figure reproduced from (Bubeck et al., 2005). 
 
Both native particles and “A” particles were found to be reactive with antibodies raised against 
peptide corresponding to the N-terminal residues of VP1 (Roivainen et al., 1993). These 
findings provided evidence for the externalisation of VP1 N-terminal residues in the “A” (135S) 
particles. The structural rearrangements in VP1 associated with cell entry were determined by 
3D reconstructions of cryo-EM images of PV “A” particles bound to antibodies raised against 
residues of the VP1 N-terminus. Analysis of the antibody binding position in PV native particle 
breathing state, showed VP1 N-terminal externalisation occurred near the twofold axis (Lin et 
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al., 2012), whereas in the PV “A” particles the VP1 N-terminus was externalised at the 
propeller tip. This observation suggested that the N-terminus of VP1 is directed to a different 
exit site during capsid “breathing” and when converted to the “A” particle.  
Therefore, there is evidence to show the site of externalisation of VP1 N-terminus, however, 
the site of release of VP4 is unknown. 
 
1.6.4.3 Site of RNA release 
Earlier X-ray crystallographic structures of PV and HRV revealed a solvent filled channel along 
the fivefold axis and the presence of VP4 and N-terminus of VP1, in close proximity to the 
fivefold axis, which became externalised during virus entry (Hogle et al., 1985; Rossmann et al., 
1985). Displacement of the pocket factor by ICAM-1 binding mediated stronger interactions 
between ICAM-1 and the binding site which caused structural rearrangements in the vicinity of 
the pocket, resulting in an opening at the fivefold axis (as reviewed in Rossmann et al., 2000). 
These observations led to the model of VP1 N-terminus and VP4 externalisation, and RNA 
egress via the channel present at the fivefold axis. The model proposed five copies of VP1 and 
VP4 would interact (in an experimentally undefined way) to permeabilise the membrane, 
possibly by pore formation, which would be contiguous with the solvent channel at the fivefold 
axis, thus facilitating the RNA egress from the fivefold axis of symmetry (Belnap et al., 2000a; 
Belnap et al., 2000b; Bubeck et al., 2005; Hadfield et al., 1997; Hewat and Blaas, 2004; Hogle, 
2002). However, the dimensions of the openings observed in previous studies (Hewat et al., 
2002; Levy et al., 2010; Rossmann et al., 2000), were insufficient to allow RNA egress. The 
model for picornavirus RNA release has been updated over the last few years.  
Comparison of HRV empty capsid and native virus revealed an expansion of the empty particle 
which involved hinge movements around VP1 pocket causing rearrangements of inter 
protomer and pentamer interactions which induced openings at the twofold axis (Figure 
1.17A, C and E). The dimensions of these observed openings were sufficient to allow RNA 
egress (Garriga et al., 2012).  
The twofold axis being a likely site for RNA exit was also supported by cryo-EM reconstructions 
of PV capsids caught in the act of releasing RNA from a site at the twofold axis (Figure 1.18). 
The RNA density footprint was observed at a distance of 20 Å from the twofold axis, 
immediately above the observed opening at the twofold axis (Figure 1.18C) (Bostina et al., 
2011). Also, X-ray crystallographic studies of empty particles of enterovirus 71 (EV71) revealed 
capsid expansion and openings (8×25 Å) at the twofold axis (Wang et al., 2012), expected to be 
sufficient to allow the release of viral RNA.  
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In the case of the openings observed at the twofold of HRV2, the overall negative charge of 
these openings would facilitate the expulsion of RNA which would be expected to be repulsed 
by the walls of the openings (Garriga et al., 2012). Therefore, the updated model suggests an 
opening at the twofold axis as the site for RNA egress. Similar findings of structural 
rearrangements in different enteroviruses, reinforces the hypothesis that members of the 
Enterovirus genus follow a common theme for capsid uncoating. Other picornaviruses, for 
example, apthoviruses such as FMDV, dissociate into pentameric capsid subunits as part of the 
uncoating process. However, there is increasing evidence that even for these viruses, the 
genome is released from an intact particle prior to the act of dissociation [(Tuthill et al., 2009) 
and unpublished work at The Pirbright Institute]. Therefore, it is possible that a common 
theme exists for genome delivery by all picornaviruses.  
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Figure 1.17 Openings at the twofold axis with dimensions consistent with that required for 
the release of viral RNA.  
A. Formation of pores in a pentamer of HRV2 empty particle. The residues forming the outer 
opening of the pore are highlighted in yellow. One pore is highlighted in a yellow box. B. Pore 
formation not observed in a pentamer of HRV2 native virus particle. The residues highlighted 
in yellow in panel A are also shown here. C. Inter-pentamer contacts of empty capsid depicted 
as ribbons. An opening in the interface of pentamers (highlighted by a black box) is observed. 
D. Inter-pentamer contacts of native virus capsid depicted as ribbons. The position of the 
symmetry axes is indicated. E. Close-up view of the opening observed at the twofold axis in the 
empty capsid in panel C. The lines crossing the cavity correspond to distances of (a) 10.2 Å and 
(b) 30.5 Å. The side chains of VP2 exposed at the pentamer-pentamer interface are labelled. In 
panels A-E, VP1 is shown in blue, VP2 in green and VP3 in red. Figure adapted from (Garriga et 
al., 2012).  
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Figure 1.18 Viral RNA exit site identified at the twofold axis.  
A. Surface representation of two virus particles caught in the act of genome release. Capsid 
shown in green and RNA density shown in red. B. Virus particles releasing their genomes (red) 
and the icosahedrally symmetrised average of the reconstructions is superimposed (in green). 
Twofold and fivefold axes of symmetry are indicated by black lines. C. Footprint of the putative 
RNA density (red), superimposed on a portion of the empty capsid. Axes of symmetry are 
numbered. At the chosen contour, holes near the twofold axis are evident and partly covered 
by the putative RNA footprint. Figure adapted from (Bostina et al., 2011). 
 
 
The formation of an “umbilicus” near the twofold axis of the virus was observed connecting 
virus particle to membrane, in cryo-electron tomography (cryo-ET) reconstructions of PV “A” 
particles interacting with liposomes. The umbilicus was formed close to the site of release of 
RNA and externalisation VP1 N-terminus. Virus particles did not appear to be in direct contact 
with the membrane but held ~50 Å away from the membrane surface (Strauss et al., 2013). 
This umbilicus may provide a conduit for the passage of RNA, protecting it from RNase in the 
endosomal environment. 
The viral RNA is densely packed inside the capsid and is expected to become unwound and 
lose some of its secondary structure during release. The loss of secondary structure required 
by RNA release was demonstrated by the studies showing loss of an intercalating dye upon 
RNA release from particles (Brandenburg et al., 2007). One possible explanation for the 
observation, in EM studies, of particles with varying RNA content (Bostina et al., 2011) may be 
the pausing of RNA release every time a region of more secondary structure is encountered. 
The potential factors initiating the release of RNA from the capsid are not known but the high 
concentration of RNA within the particle and low concentration in the cell may serve as a 
driving force for RNA release. A recent study of HRV2 showed that RNA exit begins with the 3’ 
end which is the less structured end and is followed by the 5’ end (Harutyunyan et al., 2013). 
 
Chapter 1 Introduction 
64 
 
1.6.4.4 Evidence for N-terminus of VP1 and VP4 in membrane permeabilisation 
At room temperature, both VP4 and the N-terminus of VP1 are enclosed within the virus 
capsid and become transiently externalised during capsid breathing. When the appropriate 
trigger is received, the capsid undergoes a conformational change involving the irreversible 
externalisation of N-terminus of VP1 and the loss of VP4. Both, VP4 and the N-terminus of VP1 
have been suggested to play a role in membrane permeabilisation, facilitating the transfer of 
RNA across the membrane.  However, the precise role played by each protein remains to be 
defined.  
Earlier studies showed that the externalised N-terminus of PV VP1 was responsible for binding 
liposome membranes (Fricks and Hogle, 1990). A synthetic peptide corresponding to the N-
terminus of HRV2 VP1 partitioned into and permeabilised membranes. The peptide mediated 
selective release of FITC labelled dextrans from isolated endosomes. This indicated the 
formation of size restrictive membrane pores rather than membrane disruption (Prchla et al., 
1995). The involvement of VP1 N-terminus in membrane anchoring was shown by the release 
of membrane associated PV “A” particles upon treatment with V8 protease which specifically 
cleaved VP1 to release the N-terminal 30 residues (Tuthill et al., 2006). As described previously 
(section 1.6.4.2), studies using antibodies raised against the N-terminus of PV VP1 showed that 
they reacted with PV native particles during capsid breathing and PV “A”  particles (Roivainen 
et al., 1993). Antibodies against the N-terminus of VP1 identified the exit site of VP1 N-
terminus in native PV particles at the twofold axis and at the propeller tip in the “A” particles. 
This may suggest that the N-terminus of VP1 is externalised at the twofold axis during capsid 
breathing and upon receptor binding is moved to the canyon, thereby enlarging the opening at 
the twofold axis. Either after or concurrent with RNA release from the twofold axis, the N-
termini of VP1 move back to the twofold axis (Lin et al., 2012). 
The findings demonstrating the membrane binding and permeabilising function of VP4 include 
the following: PV VP4 has been shown to partition into cellular and liposomal membranes. 
Mutations at the N-terminus of PV VP4 (threonine at position 28), either delayed or prevented 
delivery of RNA during infection and the same mutations also affected the electrophysiological 
properties of ion channels formed by the mutant viral particles in planar lipid membranes 
(Danthi et al., 2003; Tosteson et al., 2004), indicating VP4 plays a role in facilitating genome 
delivery across the membrane. VP4 released during conversion of PV 160S to 135S upon 
binding to receptor decorated liposomes was shown to be associated with membranes (Tuthill 
et al., 2006) and recombinant VP4 of HRV16 permeabilised membranes without membrane 
disruption (Davis et al., 2008), indicating the possibility of membrane pore formation. 
Dimerisation of VP4 at its N-terminus was observed during capsid breathing of HRV16 
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containing a serine to cysteine mutation in VP4 (Katpally et al., 2009). Also, VP4 is 
myristoylated at the N-terminus (Chow et al., 1987), and the myristate group is known to 
target proteins to membranes (described further in section 4.1). These observations suggest 
that membrane binding and insertion of VP4 may be by its N- terminus.  
Despite this information, the role of VP4 in the induction of membrane permeability remains 
poorly understood. The site of VP4 release from the capsid, demonstration of the terminus of 
VP4 that is externalised first and the terminus (or if both termini) responsible for membrane 
insertion to mediate RNA delivery and the mechanism for VP4-mediated membrane 
permeability are yet to be determined. 
 
1.7 Aims 
The capsid proteins, VP4 and N-terminus of VP1 have been suggested to contribute to 
membrane permeability, thereby facilitating the transfer of RNA across the membrane. The 
precise roles of the capsid proteins in cell entry and the mechanism of induction of membrane 
permeability are not known. In this thesis, I have investigated membrane permeability induced 
by capsid protein VP4 using HRV as a model virus and liposomes as model membranes. The 
overall aim is to further the understanding of the role of VP4 in picornavirus cell entry. To this 
end, the specific objectives of this project are as follows: 
 To develop a system for the expression and purification of recombinant VP4 
 To characterise conditions influencing VP4-induced membrane permeability 
 To determine the mechanism for induction of membrane permeability 
 To map the function of VP4 and investigate the role of VP1 in cell entry 
 To explore biophysical approaches for determining the structure of the VP4 membrane 
pore complex  
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2.1 General Materials 
2.1.1 Bacterial strains 
 
Escherichia coli (E. coli) DH5α (F-, Φ80dlacZΔM15, endA1, recA, hsdA1, (rk-, mk+), phoA, supE44 
λ-, thi-1, deoR, gyrA96, relA1, (ΔlacZYA-argF), U169, λ) were purchased as chemically 
competent cells from Invitrogen and used for cloning purposes. 
E.coli BL21(DE3) pLysS were purchased as chemically competent cells from Invitrogen, 
genotype F- ompT hsdSB (rB-mB-) gal dcm (DE3) pLysS (CamR) and used for protein expression 
purposes.  
E.coli Rosetta-gami B (DE3) pLacI were purchased from Novagen, genotype F-ompT hsdSB(rB- 
mB-) gal dcm lacY1 ahpC gor522::Tn10 trxB pRARE (CamR, KanR, TetR) and used to enhance the 
expression of proteins by supplying tRNAs for rarely used codons. The rare tRNA genes are 
present on the same plasmids that carry the lac repressor genes. 
2.1.2 Cell lines 
Original stock of Hela Ohio cells were obtained from the American Type Culture Collection 
(ATCC). Lab stocks maintained at a passage number of below 20.  
2.1.3 Expression vectors 
The commercial bacterial expression vectors pET-23a and pET-23d were purchased from 
Novagen. pET-23a was used to express PV and FMDV VP4 and VP4 fusion proteins and pET-23d 
was used to express HRV VP4 and VP4 fusion proteins. 
Plasmid encoding Hisx9 tag followed by trpLE in the pMM-LR6 vector (a kind gift from Dr. Fu, 
the Chou Lab) was used for the expression of His-trpLE-VP4 fusion protein.  
2.1.4 Antibodies 
Commercial antibodies used were monoclonal anti-polyhistidine peroxidase conjugate clone 
His-1 (Sigma Aldrich) (dilution 1:1000), polyclonal sheep anti-HRV VP4 C-terminus and VP4 N-
terminus (kind gift from Professor Rowlands, University of Leeds) (dilution 1:1000). The 
commercial secondary antibody donkey anti-sheep IgG-alkaline phosphatase (Molecular 
probes, Invitrogen) (dilution 1:2000).  
2.1.5 Detergents 
Sodium-n-dodecyl sulphate (SDS) was purchased from Sigma-Aldrich, 14:0 Lyso PG 1-myristoyl-
2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) sodium salt (LMPG), 3-[(3-
Cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonate (CHAPSO), N,N-
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dimethyldodecylamine N-oxide (LDAO), dodecylphosphocholine-12 (DPC), n-
Nonylphosphocholine (FOS-9), n-Tetradecylphosphocholine (FOS-14), n-octyl-β-D-
glucopyranoside (OG), 06:0 PC 1,2-dihexanoyl-sn-glycero-3-phosphocholine [DHPC (hexa)], 
07:0 PC 1,2-diheptanoyl-sn-glycero-3-phosphocholine [DHPC (hepta)] , n-dodecyl-ß-D-
maltoside (DDM), 3-Dodecylamido-N,N'-Dimethylpropyl Amine Oxide (LAPAO) were purchased 
from Affymetrix or Sigma Aldrich. 
2.1.6 Lipids 
The following phospholipids and cholesterol were purchased from Avanti Polar Lipids, as        
10 mg/ml solutions in chloroform. Stock solutions were aliquoted using Hamilton glass syringes 
into glass vials, sealed with parafilm and stored at -20°C. 
PA L-α-Phosphatidic acid (egg, monosodium salt) 
PC L-α-Phosphatidylcholine (egg) 
PE L-α-phosphatidylethanolamine (Brain, Porcine) 
Rhod PE L-α-Phosphatidylethanolamine with lissamine rhodamine B labelled head groups 
PI L-α-phosphatidylinositol (Soy, sodium salt) 
SM Sphingomyelin (Egg, Chicken) 
BMP bis(monooleoylglycero)phosphate (S,R Isomer) (ammonium salt) 
 
2.2 Manipulation of recombinant DNA 
2.2.1 DNA oligonucleotide primers 
Primers were supplied by Sigma-Aldrich as lyophilised powders and resuspended in deionised 
water to a stock concentration of 100 µM and stored at -20°C.  
2.2.2 Polymerase chain reaction (PCR) 
2.2.2.1 Preparative PCR 
The proof reading KOD hot start DNA polymerase kit (Novagen) was used to amplify the region 
of interest from HRV, PV or FMDV plasmids. Each PCR reaction contained 0.2 mM dNTPs,          
1 mM MgCl2, 10 % v/v DMSO, 1 x KOD buffer, 1 Unit (U) KOD polymerase, 2 mM forward 
primer, 2 mM reverse primer, ~50 ng template DNA and was made up to 50 μl with nuclease 
free water (Sigma-Aldrich). DNA was amplified in a thermal cycler (Eppendorf) and the 
reactions were heated to 96°C for 15 seconds, followed by 25 cycles of the following steps; 
denaturation at 95°C for 2 sec, primer extension at 54°C for 2 sec and annealing at 72°C for 2 
sec.  
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2.2.2.2 Colony screen PCR 
PCR was performed in a total volume of 100 µl in a 0.2 ml PCR tube. The reaction contained  
0.5 µM of appropriate forward and reverse primer, 1x PCR buffer (200 mM Tris-HCl -pH8.4, 
500 mM KCl , supplied as 10x concentrate), 0.2 mM of each  deoxyribonucleotide triphosphate 
(dNTPs), 1.5 nM MgCl2, 2.5 Units of Taq DNA polymerase (Life technologies Ltd.), nuclease-
free water (Millipore) and a single colony picked from a LB agar plate (with appropriate 
antibiotics). Tubes were incubated in a thermal cycler (Eppendorf) at 98°C for 10 minutes to 
completely denature the DNA. 25 cycles of the PCR amplification were carried out. Each cycle 
consisted of 30 sec at 98°C to completely denature template DNA, annealing at 60°C for 30 sec 
and extension at 72°C for 1 min. This was followed by cooling to and maintaining the reaction 
at 4°C.  
2.2.3 DNA sequencing 
Template DNA (500 ng) was heated to 96°C for 1 min to completely denature the DNA. PCR 
was performed in a total volume of 10 µl in a 0.2 ml PCR tube. A 10 µl reaction mixture 
typically contained 50 ng of denatured plasmid DNA template, 1.6 pM of forward or reverse 
primer, 2 µl of 5x Big Dye sequencing buffer, 0.25 µl of big dye terminator (Big Dye Terminator 
v3.1 cycle sequencing kit, Applied Biosystems). Typical reactions started with 1 min denaturing 
at 96°C followed by 25 amplification cycles. Each cycle consisted of 10 sec denaturing at 96°C, 
5 sec annealing at 50°C and 4 min extension at 60°C. This was followed by cooling to and 
maintaining the reaction at 4°C. DNA was sequenced to confirm the sequence and orientation 
of the insert in each clone. Sequencing was performed in-house with 3730 DNA Analyzer, 
Applied Biosystems. 
2.2.4 Restriction digestion of DNA 
All restriction enzymes were purchased from New England Biolabs (NEB). Restriction digests 
were performed under the optimal conditions using the manufacturer’s recommended buffer 
and incubation temperature. 10 µg/ml of BSA (supplied at 10 mg/ml) was added where 
recommended. Diagnostic digests were typically performed in a total volume of 25 µl. The 
reaction contained 0.5-1 µg DNA, restriction enzyme at 10 units/µg of DNA, 1x of appropriate 
supplied 10x reaction buffer and nuclease free water (Millipore). The reaction was mixed 
thoroughly and incubated for 2 hrs at 37°C. Preparative digests used for subsequent 
subcloning contained up to 10 µg DNA in a total reaction volume of 50-100 µl and incubated 
for 2-3 hrs at 37°C. 1x DNA loading buffer was added to the reaction and the digestion 
products analysed by agarose gel electrophoresis (section 2.2.5).  
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2.2.5 Agarose gel electrophoresis 
Agarose was dissolved in 1x TAE buffer [242 g Tris-base, 57.1 ml glacial acetic acid, 100 ml 0.5 
M EDTA, make up to 1 L with D2O (50x)] to 0.8 %-1.5 % (w/v) with careful heating in a 
microwave. When cooled, ethidium bromide was added to  approximately 0.3 µg/ml (using a 
10 mg/ml stock in water) and the molten agarose was poured into an electrophoresis gel cast 
and a comb inserted. The gel was allowed to set and then placed in an electrophoresis tank 
(Bio-Rad) containing 1x TAE buffer. Samples for electrophoresis were prepared by adding 
loading dye (NEB) to a final concentration of 1x. 1 Kb and 100 bp DNA markers (NEB) were 
electrophoresed alongside samples. Gels were subjected to 90 V for 1 hr. Fluorescent DNA 
bands were visualised on a UV transilluminator (Bio-Rad) and images captured using a Bio-Rad 
gel documentation system. 
2.2.6 Gel extraction of DNA  
DNA fragments were excised from agarose gel using a sterile scalpel, under preparative UV 
illumination on a transilluminator (FotoPrepI, Fotodyne). DNA was purified from the gel by 
following manufacturer’s instruction for QIAquick gel extraction microcentrifuge protocol 
(Qiagen). Briefly, agarose was solubilised, DNA absorbed onto the matrix, washed with high 
salt and eluted with nuclease free water (Sigma Aldrich). DNA was quantified using the 
spectrophotometry (Nanodrop 8000, Thermo Scientific) and stored at -20°C. 
2.2.7 DNA ligations 
All ligations were performed in a total reaction of 20 µl. Vector was dephosphorylated using 
rapid alkaline phosphastase (Roche Applied Science). Digested PCR product and 
dephosphorylated vector were added at a ratio of 5:1 and 3:1 to 1x T4 DNA ligase buffer, 5 U 
of T4 DNA ligase (NEB) and nuclease free water (Millipore). The reaction was mixed thoroughly 
and incubated at 16°C or o/n at room temperature. Some of the ligation reaction was used for 
transformation of DH5α E.coli cells (section 2.2.8).  
2.2.8 Transformation of chemically competent bacteria 
50 µl of chemically-competent DH5α E.coli cells were thawed on ice, followed by the addition 
of 10 µl of the DNA ligation mix (section 2.2.7) and swirled gently to mix. The cells were 
incubated on ice for 20 min, heat shocked in a 42°C water bath for 45 sec and then returned to 
ice for 2 min. 500 µl SOC medium (without antibiotics) was added and placed in a shaking 
incubator for 1 hr at 37°C. The cells were then plated out onto LB agar plates containing the 
appropriate antibiotic(s) (Kanamycin used at 50 µg/ml and ampicillin at 100 µg/ml). Plates 
were inverted and incubated o/n at 37°C.  
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For the transformation of DH5α, BL21 (DE3) pLysS or Rosetta-gami B (DE3) pLacI E.coli cells, 
with plasmid DNA, 20-50 ng of DNA was used. The transformed cells were recovered and 
plated as described above.   
2.2.9 Bacterial cultures 
A single bacterial colony was picked from an LB agar plate and added to 5 ml LB medium 
containing the appropriate antibiotic(s) (Kanamycin used at 50 µg/ml and ampicillin at           
100 µg/ml). This was carried out under aseptic conditions. The 5 ml culture was incubated o/n 
with continuous shaking (250 rpm) at 37°C. A sample of the small scale culture (~1 ml) was 
used to inoculate 250 ml of LB media containing the appropriate antibiotic(s). The large scale 
culture was incubated o/n with continuous shaking (250 rpm) at 37°C.  
2.2.10 Purification of bacterial DNA 
Small scale bacterial cultures (5 ml) grown o/n (section 2.2.9) were centrifuged at 4000 x g for 
20 min at 4°C and the medium thoroughly removed from the cell pellet. Plasmid DNA was 
isolated by following the manufacturer’s instructions for PureLink Quick Plasmid Miniprep 
protocol using centrifugation (Invitrogen). In brief, cells were resuspended in cell resuspension 
buffer (250 μl), lysed by addition of cell lysis buffer (250 μl) and incubated at room 
temperature for 5 min. Cells were then neutralised with neutralisation solution (350 μl) before 
centrifugation at 18, 000 x g for 10 min. The cleared bacterial lysate was then added to a 
miniprep column and centrifuged at 17900 x g for 1 min. Wash solution (800 μl) was applied 
twice to the column and centrifuged through the column at 18, 000 x g. The column was 
transferred to a sterile 1.5 ml tube and the DNA eluted with 30-50 μl of nuclease free water 
(Millipore) by centrifugation.  
Large scale bacterial cultures (250-500 ml) grown o/n (section 2.2.9) were centrifuged at        
6000 x g for 30 min at 4°C and cell pellet harvested. The plasmid DNA was then purified from 
the pelleted cells using a plasmid maxi kit (Qiagen) by following manufacturer’s instructions. In 
brief, the bacterial pellet was resuspended in buffer P1 (10 ml), lysed by addition of buffer P2 
(10 ml) and incubated at room temperature for 5 min. The cell lysate was neutralised with 
buffer P3 (10 ml), incubated on ice for 20 min and then centrifuged at 20000 x g for 30 min at 
4°C. A QIAGEN tip 500 maxiprep column was equilibrated with buffer QBT (10 ml) and the 
cleared bacterial lysate was allowed to flow through the column by gravity. The column was 
washed twice with buffer QC (30 ml) and the DNA eluted with elution buffer QF (15 ml). 
Isopropanol (10.5 ml) was added to the eluted DNA and centrifuged at 15000 x g for 30 min at 
4°C. The s/n was decanted from the DNA pellet, which was then washed with 70 % ethanol (5 
ml). After a final centrifugation step at 15000 x g for 10 min at 4°C, the ethanol was removed 
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and the DNA pellet air dried. The air dried pellet so obtained was resuspended in 0.5 ml of 
nuclease free water (Millipore).  
The DNA obtained from miniprep and maxiprep protocols was stored at -20°C. 
2.2.11 Quantification of DNA 
The concentration of DNA was determined by using spectrophotometry (Nanodrop 8000, 
Thermo Scientific). Plasmid DNA (1 µl) was loaded onto the pedestal of the spectrophotometer 
and absorbance measurements were taken at 260 nm and 280 nm. This was used to 
automatically determine DNA concentration (based on DNA concentration being proportional 
to absorbance at 260 nm for a given path length). The ratio of absorbance at 260 nm and      
280 nm was used to determine the purity of DNA (peak absorption by nucleic acid is at          
260 nm, while peak absorption for contaminating proteins is at 280 nm).   
2.2.12 Bacterial glycerol stocks 
Small scale bacterial cultures (1ml) were added to 225 µl of 80% glycerol in a sterile cryovial. 
The glycerol stock was mixed well and stored at -80°C. Viability of the cells was checked after 
one week by scraping off some of the frozen stock and streaking onto an LB agar plate 
containing the appropriate antibiotic(s).  
 
2.3 Protein biochemistry 
2.3.1 Sodium dodecyl sulphate -polyacrylamide gel electrophoresis (SDS-PAGE) 
For reducing SDS-PAGE, 10% resolving gel [2 ml glycerol, 5 ml Tricine gel buffer (3 M Tris, 3% 
(w/v) SDS, pH8.45), 3.8 ml 40% acrylamide (Sigma) and made up to 15 ml with D2O] and 5% 
stacking gel (1.5 ml Tricine gel buffer, 0.62 ml 40% acrylamide/bis-acrylamide and made up to 
4.1 ml with D2O) were prepared.  The amounts of 40% T acrylamide were adjusted to 4.7 ml or 
6.2 ml for 12% and 16.5% resolving gels, respectively. 0.1% ammonium persulphate (APS) and 
0.001% N,N,N',N'-Tetramethylethylenediamine (TEMED) were added to the resolving and 
stacking gel mix before pipetting into a gel cast. Gel comb of choice was inserted to make the 
wells. The gels were placed in a miniPROTEAN® Tetra Cell gel electrophoresis tank (Bio-Rad). 
1xTricine cathode buffer [1M Tris, 1M Tricine, 0.1% (w/v) SDS (10x)] was added to the inner 
chamber and Tricine anode buffer (0.2 M Tris, pH8.9) in the outer chamber. All protein 
samples were loaded with red loading buffer [10% glycerol, 2% (w/v) SDS, 0.01% (w/v) phenol 
red, 62.5 mM Tris-HCl pH6.8 (NEB) to give a 1x final concentration] and 10 mM Dithiothreitol 
(DTT). Samples were heated at 96°C for 10 min, loaded into the wells of the gel and subjected 
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to electrophoresis at room temperature at a constant voltage of 120 V for typically 1 hr. The 
migration of protein samples was compared with pre-stained molecular weight markers 
(Precision Plus Protein Dual colour standards, Bio-Rad).  
2.3.2 Native polyacrylamide gel electrophoresis (PAGE) 
Pre-cast 4-20% Mini-PROTEAN TGX native-PAGE gels (Bio-Rad) were used for the analysis of 
protein samples under non-reducing and non-denaturing conditions. Samples were mixed with 
an equal volume of native loading buffer (30% glycerol, 0.05% bromophenol blue, 150 mM 
Tris-HCl pH 7.0). Samples were not heated prior to loading onto native PAGE. The native gels 
were placed in a miniPROTEAN® Tetra Cell gel electrophoresis tank and proteins separated 
using Tris-glycine running buffer (0.025 M Tris base, 0.192 M Glycine, pH8.5) at 4°C at a 
constant voltage of 80 V for approximately 3 hrs.  
2.3.3 SDS-PAGE fixatives  
 Trichloroacetic acid fixation 
SDS-PAGE gels were submerged in 12% trichloroacetic acid for 1-3 hrs with gentle 
agitation at room temperature.  
 Formaldehyde fixation 
A solution of 25% ethanol, 15% formalin (formalin is 35% formaldehyde) was prepared. 
SDS-PAGE gels were submerged in the solution for 1 hr with gentle agitation at room 
temperature.  
 Glutaraldehyde fixation 
SDS-PAGE gels were submerged in 10% glutaraldehyde for 1 hr with gentle agitation at 
room temperature. Gels were washed twice with D20 for 20 min each before staining 
with Coomassie. 
2.3.4 Staining methods  
2.3.4.1 Coomassie brilliant blue staining 
Polyacrylamide gels (sections 2.3.1 and 2.3.2) were incubated in Coomassie Brilliant Blue stain 
(40 % v/v Methanol, 10 % v/v Acetic acid, 0.25 % w/v Coomassie Brilliant Blue R250) overnight 
at room temperature with continuous rocking. Gels were destained with destaining solution 
(40 % v/v methanol, 10 % v/v acetic acid) until protein bands became visible.  
2.3.4.2 Silver staining 
Polyacrylamide gels (sections 2.3.1 and 2.3.2) were stained with silver stain (Thermo Scientific) 
according to the manufacturer’s instructions.  
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2.3.4.3 Other stains 
Polyacrylamide gels (sections 2.3.1 and 2.3.2) were stained with other stains: 
 Copper chloride (CuCl2) negative stain: The gel was rinsed in D2O for 1 min. D2O was 
discarded and the gel immersed in 50 ml 0.3 M CuCl2 with gentle agitation at room 
temperature until the protein bands were stained to desired intensity.  The solution 
was discarded and the gel washed in D2O for 3 min. 
 Zinc imidazole negative stain: The gel was rinsed in D2O for 1 min. D2O was discarded 
and the gel immersed in 50 ml 0.2 M imidazole for 1 hr. The solution was discarded 
and gel immersed in 50 ml 0.3 M ZnCl2 with gentle agitation at room temperature until 
the background became dark blue and the transparent protein bands became visible.  
 Sypro orange stain: The gel was immersed in 50 ml of 1:5000 dilution of Sypro orange 
stain (Bio-Rad) in 7.5% (v/v) acetic acid. The tray was covered with foil for 1 hr with 
gentle agitation at room temperature. The gel was then rinsed with 7.5% (v/v) acetic 
acid for 30 sec. The gel was placed on a UV light box (BioRad) for imaging.  
2.3.5 Western blot 
After SDS-PAGE, proteins were transferred to polyvinyl difluoride (PVDF) membrane 
(Immobilon, Millipore) at 90 V for 1 hr in transfer buffer (0.2 M Tris, 20 % v/v methanol). 
Membranes were blocked for 1 hr at room temperature or o/n at 4oC in blocking buffer [0.1% 
(v/v) PBS-Tween 20 (PBS-T), 5% (w/v) dried Marvel milk] with continuous rocking.  The 
membrane was incubated with the primary antibody in blocking buffer at the relevant dilution 
for 1 hr at room temperature, with continuous rocking. The membrane was then washed three 
times in 0.1% PBS-T, changing the wash once every 20 min.  This was followed by incubating 
the membrane with the secondary antibody in blocking buffer at the relevant dilution for 1 hr 
at room temperature, with continuous rocking. For horseradish peroxidase (HRP) conjugated 
primary antibodies, a secondary antibody was not necessary. The membranes were washed as 
described previously. Excess of PBS-T was removed and the electrochemiluminescence (ECL) 
solution (Thermo Scientific) pipetted over the membrane. The membrane was transferred to a 
light-proof cassette and developed manually using CL-XPosure film (Thermo scientific).  
2.3.6 Densitometry analysis of western blots 
Kodak image station 4000r was used to analyse Western blots by densitometry. Rectangular 
boxes were drawn around the bands to be compared and control area. Densitometry values 
were generated using the Carestream Molecular Imaging software, Network edition (MI NE). 
Mean intensity values were used to generate the graphs.  
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2.3.7 Autoradiography 
Following SDS-PAGE, the gel was submerged in destain (40 % v/v methanol , 10 % v/v acetic 
acid) for 30 min with gentle agitation at room temperature. The destain solution was discarded 
and gel submerged in enlightening solution (PerkinElmer) for 30 min with gentle agitation at 
room temperature. The gel was dried using the vacuum at 80°C. The gel was exposed to CL-
XPosure film (Thermo Scientific) in a light-proof cassette at -80°C for up to 2 weeks and 
developed manually. 
2.3.8 Chemical crosslinking  
2.3.8.1 Chemical crosslinking with DSP 
Rehydrated samples of VP4His were treated with Dithiobis[succinimidyl propionate] (DSP) 
(Thermo scientific) to final concentration of 0.5 mM or 1 mM, in a  total reaction volume of     
25 µl. The reaction was incubated for 20 min at 25°C. The reaction was terminated by the 
addition of 1 M Tris-HCl, pH7.5 to a final concentration of 50 mM, for 15 min at 25°C. If 
required, cross-linking was reversed by the addition of 50 mM DTT and incubation at 37°C for 
30 min.   
2.3.8.2 Chemical crosslinking with glutaraldehyde 
Rehydrated samples of VP4His were mixed with 5 µl of 2.3% freshly prepared solution of 
glutaraldehyde, in a total volume of 25 µl. The reaction was incubated for 5 min at 37°C. The 
reaction was terminated by the addition of 1 M Tris-HCl, pH8.0, to a final concentration of 50 
mM.  
2.3.9 Acetone precipitation 
Four times the sample volume of acetone (pre-cooled to -20°C) was added, mixed thoroughly 
on a vortex and incubated for 60 min at -20°C. For smaller proteins, the acetone containing 
samples were incubated o/n at -20°C. The precipitated protein was collected by centrifugation 
at 21, 000 x g for 20 min. The precipitated protein was resuspended in the appropriate buffer.  
2.3.10 Measurement of total protein concentration 
2.3.10.1 Bicinchoninic acid protein assay 
Bicinchoninic acid (BCA) protein assay (Thermo scientific) was used to determine protein 
concentrations, according to manufacturer’s instructions. Briefly, 10 µl of the protein sample 
(in triplicate) was mixed with the BCA reagents A and B (50:1, reagent A:B), mixed thoroughly 
and incubated at 37°C for 30 min. The plate was cooled to room temperature before 
measuring the absorbance at 562 nm using a plate reader. A series of dilutions of known 
concentrations of BSA were prepared and assayed alongside the protein samples and a 
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standard curve plotted. The standard curve was used to determine the protein concentration 
of each unknown sample. 
2.3.10.2 Bradford assay 
Bradford assay (Thermo Scientific) was used to determine protein concentrations, according to 
manufacturer’s instructions. Briefly, 300 µl of Bradford reagent (coomassie blue G-250) was 
added to 10 µl of the protein sample (in triplicate), mixed thoroughly, incubated at room 
temperature for 10 min and absorbance measured at 595 nm using a plate reader. A series of 
dilutions of known concentrations of BSA were prepared and assayed alongside the protein 
samples and a standard curve plotted. The standard curve was used to determine the protein 
concentration of each unknown sample. 
2.3.10.3 Spectrophotometry 
The concentration of protein was determined by using spectrophotometry (Nanodrop 8000, 
Thermo Scientific). Protein sample (2 µl) was loaded onto the pedestal of the 
spectrophotometer and absorbance measurement taken at 280 nm.  
 
2.4 Expression of GST-tagged VP4 in inclusion bodies 
One colony of E.coli BL21 (DE3) pLysS cells transformed (section 2.2.8) with pETVP4PreGST or 
VP4ThGST was added to 10 ml of LB (100 µg ml of ampicillin) and grown o/n at 37°C with 
constant shaking at 250 rpm. Where E.coli cells were co-transformed with pET-NMT, 
kanamycin (50 µg/ ml) and ampicillin (100 µg/ml) were added to the media. 5 ml of the o/n 
culture was added to 500 ml LB (with appropriate antibodies) and grown at 37°C with constant 
shaking at 250 rpm to an OD600 0.4. Myristic acid was added to a final concentration of 5 µg/ml 
(using a stock solution in methanol) to E.coli cells co-transformed with pETNMT. The culture 
was induced with 1 mM IPTG for 4 hrs at 37°C. The culture was divided into 50 ml, pelleted and 
stored at -20°C.  
 
2.5 Isolation of GST-tagged VP4 inclusion bodies  
Bacterial cell pellets from 50 ml culture volumes (section 2.4) were lysed with 10 ml of cold 
lysis buffer (20 mM Na2HPO4, pH7.4, 150 mM NaCl, 1% Triton X-100, 500 µg/ml lysozyme and 
1x protease inhibitors (Fermentas), incubated at 4°C for 1 hr on a rotational wheel. The sample 
was sonicated (10 micron amplitude, Misonix Microson) on ice with 30 sec on and 30 sec off x 
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10 cycles. The lysate was pelleted at 4000 x g for 15 min to remove cell debris. The pellet was 
resuspended in 2 ml 100 mM ammonium acetate and inclusion bodies pelleted at 4000 x g for 
5 min. The inclusion bodies were resuspended and washed with 2 ml washing buffer (10 mM 
Tris, pH7.4, 100 mM NaCl, 1x protease inhibitors) and pelleted at 4000 x g for 5 min. The pellet 
was washed three times with 2 ml 0.1% sarkosyl followed by three washes with 2 ml wash 
buffer. At the final stage, the inclusion body pellet was resuspended in 1 ml wash buffer 
(without protease inhibitors).  
 
2.6 Expression of GST-tagged VP4 as soluble protein 
One colony of E.coli BL21 (DE3) pLysS cells transformed with pETVP4PreGST or VP4ThGST was 
added to 10 ml of LB (100 µg/ml of ampicillin) and grown o/n at 37°C with constant shaking at 
250 rpm. Where E.coli were co-transformed with pET-NMT, kanamycin (50 µg/ ml) and 
ampicillin (100 µg ml) were added to the media. Myristic acid was added to a final 
concentration of 5 µg/ml (using a stock solution in methanol) to E.coli cells co-transformed 
with pETNMT. 
 
2.7 Purification of GST-tagged soluble protein  
3 L of LB (containing appropriate antibiotics) was inoculated with o/n cultures (using a 1/100 
dilution) and grown with constant shaking at 250 rpm at 30°C. At OD600 0.7, the cultures were 
induced with 1 mM IPTG. Myristic acid was added to a final concentration of 5 µg/ml (using a 
stock solution in methanol) to pETNMT co-transformed bacterial cells. The bacterial cultures 
were induced for 4 hrs at 30°C. The induced bacterial cells were harvested by centrifugation at 
4000 x g for 30 min at 4°C. The cell pellet was divided into three and each pellet was 
resuspended in 15 ml bacterial lysis buffer [20 mM Na2HPO4, pH7.4, 150 mM NaCl, 1% Triton 
X-100, 500 µg/ml lysozyme and 1x protease inhibitors (Fermentas)]. The bacterial cells were 
lysed by sonication (10 micron amplitude, Misonix Microson) on ice with 30 sec on and 30 sec 
off x 10 cycles.  The soluble protein was obtained by centrifugation at 20 000 x g for 30 min at 
4°C. The supernatant (s/n) was applied to a pre-packed 1 ml glutathione agarose column (GE 
healthcare), according to manufacturer’s instructions. The column was equilibrated with 
binding buffer (1x PBS, pH7.3) and the protein containing sample applied onto the column. The 
column was washed with 15 ml of binding buffer and GST-tagged VP4 was eluted from the 
column as 1 ml fractions using elution buffer (50 mM Tris-HCl, 10 mM reduced glutathione, 
Chapter 2 Materials and Methods 
78 
 
pH8.0). All fractions were analysed by SDS-PAGE and Coomassie staining. After protein elution, 
the glutathione agarose column was washed with distilled water, followed by 20% ethanol 
wash. Fractions containing GST-tagged VP4 and minimum contaminants were pooled and 
dialysed (using a membrane with 10 kDa molecular weight cut off) against liposome buffer (10 
mM HEPES, 107 mM NaCl, pH7.4).  
 
2.8 Expression and purification of His-tagged 3C protease 
E.coli BL21 (DE3) cells were transformed (section 2.2.8) with the plasmid encoding His-3C 
protease (kind gift from Dr. Toshana Foster). A single colony was picked and inoculated into     
5 ml of LB broth containing kanamycin (50 µg/ml) and grown o/n with constant shaking at   
250 rpm at 37°C. 400 ml of LB was inoculated with o/n culture (1 in 100 dilution) and grown 
with constant shaking at 250 rpm at 37°C. At OD600 0.6, expression was induced with 1mM IPTG 
for 3 hrs at 37oC. The induced bacterial cells were harvested by centrifugation at 4000 x g for 
30 min at 4°C. The pellet was resuspended in 20 ml lysis buffer (500 µg/ml lysozyme, 1 % 
Triton X-100, 1x protease inhibitors, PBS) followed by sonication on ice with 30 sec on and 30 
sec off x 10 cycles. The clarified s/n was obtained by centrifugation at 20 000 x g for 15 min at 
4°C, and eluted using 1 ml pre-packed nickel affinity chromatography column (GE Healthcare), 
according to manufacturer’s instructions. Briefly, the column was washed with 5 ml of D2O, 
equilibrated with buffer 1 (20 mM Na2HPO4, 0.5 M NaCl, 10 mM imidazole), following which 3C 
protease containing s/n was applied to the column. The column was washed with 3 ml of 
buffer 1. 3C protease was eluted using an imidazole gradient of 0.01 M, 0.1 M followed by    
0.5 M. The eluted fractions were analysed by SDS-PAGE (section 2.3.1) and Coomassie staining 
(section 2.3.4.1). The fractions containing minimum contaminants were pooled and dialysed 
into storage buffer (50 mM Tris, pH8, 150 mM NaCl, 10 mM EDTA, 10 mM β-mercaptoethanol 
and 20 % glycerol), with two o/n buffer changes. 3C protease was stored at -20°C. 
 
2.9 Preparative electrophoresis for isolation of VP4 
VP4 excised from the gel was put into dialysis tubing (Spectrum Laboratories, Inc.) with 500 µl 
of elution buffer (150 mM glycine, 20 mM Tris-base, 0.1% sarkosyl), placed in a gel 
electrophoresis tank containing elution buffer and subjected to electrophoresis at 100 V for     
1 hr. The polarity was then reversed for 1 min. The elution buffer containing VP4 was 
recovered from the dialysis tubing and precipitated using acetone (section 2.3.9).  
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2.10 Preparative SDS-PAGE using the prep cell  
SDS-PAGE using prep cell (model 491, Bio-Rad) was used to purify proteins by continuous 
elution electrophoresis, according to manufacturer’s instructions. Briefly, samples were 
subjected to electrophoresis through a cylindrical gel matrix comprised of 16.5% tris-tricine 
resolving gel and 5% stacking gel, using tris-tricine gel anode and cathode buffers (section 
2.3.1). Electrophoresis was carried out at 40 mA, o/n at 4°C, using an elution rate of 1 ml/min. 
A fraction collector (Amersham Pharmacia Biotech) was used to collect protein fractions 
immediately after the dye front eluted from the gel. Proteins eluted based on their molecular 
weights, with proteins of the lowest molecular weight eluting first followed by proteins of 
higher molecular weight. Fractions were analysed by SDS-PAGE (section 2.3.1), Coomassie 
staining (section 2.3.4.1), silver staining (section 2.3.4.2) and western blot (section 2.3.5). 
 
2.11 Expression of VP4 and VP4His 
One colony of E.coli BL21 (DE3) pLysS cells transformed with pETVP4His or pETVP4 was added 
to 100 ml of LB (100 µg/ml of ampicillin) and grown o/n at 37°C with constant shaking at 250 
rpm. Where E.coli cells were co-transformed with pETNMT, kanamycin (50 µg/ ml) and 
ampicillin (100 µg ml) were added to the media. Myristic acid was added to a final 
concentration of 5 µg/ml (using a stock solution in methanol) to E.coli cells co-transformed 
with pETNMT. 
 
2.12 Purification of VP4His under non-denaturing conditions 
3 L of LB (containing appropriate antibiotics) was inoculated with o/n cultures (using a 1/100 
dilution of cultures described in section 2.11) and grown with constant shaking at 250 rpm at 
30°C. At OD600 0.7, VP4 His or VP4 expression was induced by the addition of 0.2 mM IPTG for 3 
hrs at 30°C. Myristic acid was added to a final concentration of 5 µg/ml (using a stock solution 
in methanol) to E.coli cells co-transformed with pETNMT. The induced bacterial cell pellet was 
divided into three and each pellet resuspended in 15 ml lysis buffer (20 mM Na2HPO4, 150 mM 
NaCl, 500 µg/ml lysozyme, 1% Triton X-100, 1x protease inhibitors). The bacterial cells were 
lysed by sonication (10 micron amplitude, Misonix Microson) on ice with 30 sec on and 30 sec 
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off x 10 cycles. The s/n was collected by centrifugation at 1500 x g for 1 hr at 4°C. The s/n was 
applied to a pre-packed 1 ml nickel affinity chromatography column (GE Healthcare), according 
to manufacturer’s instructions. Briefly, the column was washed with 50 ml of D2O and 
equilibrated with binding buffer (20 mM Na2HPO4, 150 mM NaCl, 1% Triton X-100, 30 mM 
imidazole). 30 mM imidazole was added to the VP4His containing sample and applied onto the 
column. The column was washed with 50 ml of buffer (20 mM Na2HPO4, 150 mM NaCl, 1% 
Triton X-100, 30 mM imidazole) and VP4His eluted as 3 ml fractions using an imidazole 
gradient (150 mM, 250 mM and 0.5 M). The fractions were analysed by SDS-PAGE (section 
2.3.1) and Coomassie staining (section 2.3.4.1) and western blot (section 2.3.5). 
 
2.13 Purification of VP4His under denaturing conditions 
3 L of LB (containing appropriate antibiotics) was inoculated with o/n cultures (using a 1/100 
dilution of cultures described in section 2.11) and grown with constant shaking at 250 rpm at 
30°C. At OD600 0.7, VP4 His or VP4 expression was induced by the addition of 0.2 mM IPTG for 3 
hrs at 30°C. Myristic acid was added to a final concentration of 5 µg/ml (using a stock solution 
in methanol) to E.coli cells co-transformed with pETNMT. Bacteria were lysed in denaturing 
lysis buffer (20 mM Na2HPO4, 150 mM NaCl, 1% Triton X-100, 7M urea, pH7.5) and sonicated 
(10 micron amplitude, Misonix Microson) on ice with 30 sec on and 30 sec off x 10 cycles. The 
clarified supernatant was collected by centrifugation at 1500 x g for 1 hr at 4°C and applied to 
a pre-packed 1 ml nickel affinity column (GE Healthcare), according to manufacturer’s 
instructions. Briefly, column was washed with 50 ml of D2O and equilibrated with binding 
buffer (20 mM Na2HPO4, 150 mM NaCl, 1% Triton X-100, 7M urea, 30 mM imidazole, pH7.5). 
30 mM imidazole was added to the sample containing VP4His and applied to the column. The 
column was washed with 50 ml of buffer (20 mM Na2HPO4, 150 mM NaCl, 1% Triton X-100, 7M 
urea, 30 mM imidazole, pH7.5) and VP4His eluted as 3 ml fractions using an imidazole gradient 
(150 mM, 250 mM and 0.5 M). The fractions were analysed by SDS-PAGE (section 2.3.1) and 
Coomassie staining (section 2.3.4.1) and western blot (section 2.3.5). Fractions containing 
VP4His with minimal contaminants were pooled and dialysed (using a membrane with 3.5 kDa 
molecular weight cut off) against  a urea gradient of 7 M, 3 M, 1 M urea (in PBS) for 4hrs each 
at 4°C. This was followed by dialysis against PBS for 4 hrs or o/n at 4°C. The visibly precipitated 
VP4His was collected by centrifugation  at 21, 000 x g, resuspended in DMSO and stored at       
-20°C. 
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2.14 Purification of VP4PreGST under denaturing conditions 
VP4PreGST was purified under denaturing conditions as described for VP4His in section 2.13. 
 
2.15 Expression and purification of His-trpLE-VP4  
M9 minimal media was used for the expression of isotopically labelled proteins for NMR 
spectroscopy. 1 L of M9 minimal media (6 g  Na2HPO4, 3 g KH2PO4, 0.5 g NaCl, 1 g 
15N-labelled 
NH4Cl) was sterilised by autoclaving. 2 ml 1M MgSO4, 3 g D-glucose and 100 µl 1M CaCl2 and 
kanamycin (50 µg/ml) added to the sterilised media.  
VP4 (with serine replacing methionine at position 17) was expressed as a C-terminal fusion to 
trpLE with an N-terminal 9-His-tag in the pMM-LR6 vector (His-trpLE-VP4). VP4 was purified as  
using the method previously described for M2 of influenza virus (Schnell and Chou, 2008). 
E.coli BL21 (DE3) cells were transformed (section 2.2.8) with the plasmid encoding His-trpLE-
VP4 and grown in 1 L M9 minimal media with constant shaking at 250 rpm at 37°C. At OD600 
0.7, expression was induced with 0.5 mM IPTG for 18 hrs with constant shaking at 250 rpm at 
37°C. His-trpLE-VP4 expressed into inclusion bodies. Bacterial cells were lysed using 30 ml 
buffer [50 mM Tris-HCl (pH8.0), 200 mM NaCl] followed by sonication (Branson Sonifier 450) 
on ice for 5 min with 2 min recovery time x 2 cycles. Inclusion bodies were pelleted by 
centrifugation at 38, 000 x g for 30 min at 4°C.  The inclusion body pellet was lysed using 30 ml 
of inclusion body lysis buffer (6M guanidine chloride, 50 mM Tris-HCl (pH8.0), 200 mM NaCl, 
1% Triton X-100) and homogenised using a glass rod. The soluble material was clarified by 
centrifugation at 38, 000 x g (sorvall SS34) for 30 min at 4°C.   
Nickel immobilised metal ion affinity chromatography (IMAC) resin (Thermo Scientific) were 
used to prepare the column for His-tagged protein purification. The column was washed with 
D2O and sample containing His-trpLE-VP4 applied to the column. 50 ml of 8 M urea was 
applied to the column and followed by 10 ml x 3 column washes with D2O. His-tagged protein 
eluted was with 70 % formic acid (4 ml x 3).  
VP4 was released from the fusion protein by CNBr cleavage by the addition of 2 g CNBr in 70% 
formic acid for 1 hr at room temperature. The cleavage reaction was dialysed using a 
membrane with 3.5 kDa molecular weight cut off, against 4 L water for 40 min x 2, at room 
temperature. The dialysed material (approximately 12 ml) was collected and divided into two. 
10 ml of acetonitirile was added to 7.5 ml of dialysed material and lyophilized o/n. The 
lyophilised material was dissolved in 4 ml 70 % formic acid and applied onto a C18 column 
(Higgins Analytical Inc.). VP4 separated from His-trpLE-VP4 by reverse phase-high pressure 
Chapter 2 Materials and Methods 
82 
 
liquid chromatography (RP-HPLC) (BioRad), using a 0-100 % linear gradient of buffer (buffer A: 
25 % acetonitrile, 0.1 % trifluoroacetic acid to buffer B: 25 % isopropanol, 25 % acetonitrile, 0.1 
% trifluoroacetic acid). 5 ml x 56 fractions were collected and the peak fractions containing 
protein identified by Biologic DuoFlow (BioRad) programme were analysed by SDS-PAGE 
(section 2.3.1), Coomassie staining (section 2.3.4.1) and silver staining (section 2.3.4.2).  
 
2.16 Reconstitution of VP4 and GST-tagged VP4 in detergent 
micelles 
Purified VP4 (0.1 mg) (section 2.14) was lyophilised and used for the studies to optimise VP4 
reconstitution in detergent micelles. The process of refolding lyophilised VP4 involved  
dissolving in 6 M guanidine hydrochloride (GnHCl) and the appropriate detergent at 
approximately 100 mM, in sodium acetate (pH5.5), sodium phosphate (pH7.0, pH7.5) or HEPES 
(pH8.0) buffer. This was followed by dialysis using a membrane with 3.5 kDa molecular weight 
cut off (Thermo scientific), to remove GnHCl. The reconstitution of VP4 in detergent micelles 
was confirmed by size exclusion chromatography (AKTA purifier, Unicorn manager software) 
using a Superose 6 10/300 column (GE Healthcare).  
VP4PreGST purified as described in section 2.13 was vacuum dried o/n and similarly 
reconstituted in a range of detergents.  The reconstitution of VP4PreGST in detergent micelles 
was confirmed by size exclusion chromatography using a Superdex, 200 10/300 column (GE 
Healthcare).  
 
2.17 Nuclear magnetic resonance (NMR)  
10 % deuterated water  was added to the reconstituted VP4 (section 2.15) and the sample 
transferred to an NMR tube. The sample was centrifuged gently at the experimental 
temperature to remove any trapped air. The sample was placed in Agilent 600 MHz or 700 
MHz prior to initiating the 1D or 2D heteronuclear single quantum coherence spectroscopy 
(HSQC) NMR experiment. Data acquisition, processing and analysis was carried out using 
NMRPipe and NMRDraw by Dr Fu and Dr Brüeschweiler. 
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2.18 Circular dichroism spectroscopy 
VP4 reconstituted in detergent micelles (section 2.15) was subjected to circular dichroism 
using a circular dichroism spectrophotometer (JASCO J-815) and a 1 cm path length cuvette. 
Samples were scanned from 260 nm to 190 nm with 1 nm band width in a sample chamber, at 
25°C. Continuous scanning mode at a scanning speed of 50 nm/min was used. Spectra were 
background-corrected for light scattering. Five scans were averaged to generate the final CD 
spectra. CD spectra were plotted using ProFit (Quantum Soft). CD spectra (ellipticity) were 
converted to mean residue ellipticity according to the formula:  
[ϴ]M= M*ϴ *0.001 / {(10)*(l)*(c)*(n)*(0.001)} 
Where [ϴ]M is degcm
2 dmol-1, M is the molecular weight of VP4 (7400 g/mol), ϴ is the 
measured ellipticity in degrees, l is the path length of the cuvette in centimeters (0.1), c is the 
protein concentration (mg/ml) and n is the number of amino acids in VP4. 
Far UV spectra were deconvoluted with CDSSTR algorithm in the DichroWeb package 
(dichroweb.cryst.bbk.ac.uk/html userguide.shtml ) to estimate protein secondary structure 
content. This was kindly carried out by Dr. Franz Hagn (Harvard Medical School).  
 
2.19 Transmission electron microscopy 
EM grids bearing a carbon support were glow discharged for 15 sec (EMS 100 glow discharge 
unit). VP4GST reconstituted in DPC and purified by size exclusion chromatography (section 
2.15) was adsorbed onto grids and stained with 0.75 % uranyl formate (pH4.5). Images were 
collected on a JEOL 1200EX operating at 80kV.  
 
 
2.20 Purification of HRV16 
HRV16 was propagated in HeLa Ohio cells in roller bottles (2125 cm2, Greiner Bio One) x 20 in 
the presence of growth media [Dulbecco’s modified eagle medium (DMEM)( Invitrogen), 10% 
foetal calf serum, 2 mM L- glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin. Cells 
were infected at a multiplicity of infection (MOI) of 0.1 at 37°C and complete cytopathic effect 
(CPE) was observed at 48 hrs. Infected Hela Ohio cells were lysed by three freeze/thaw cycles 
and clarified supernatants concentrated by precipitation o/n with saturated ammonium 
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sulphate solution (50 % final concentration). The precipitate was harvested by centrifugation 
at 4000 x g for 1 hr at 4°C. The precipitate was resuspended in 20 ml PBS and 0.1 % NP-40 
(Thermo Scientific) and pelleted through a 2 ml cushion of 30% (w/v) sucrose by centrifugation 
at 140, 000 x g for 2 hrs at 25°C. The pellet was resuspended in 0.5 ml cold PBS, 0.1 % SDS 
added to it and centrifuged at 4000 x g for 10 min at 12°C. The s/n was loaded onto a sucrose 
density gradient comprising 15-45 % (w/v) sucrose which was centrifuged at 140, 000 x g for 2 
hrs at 12°C. The gradient was fractionated from bottom to top and absorbance at 260 nm 
(A260) was measured to determine the fractions containing HRV16. The purity of HRV16 
fractions was determined by SDS-PAGE (section 2.3.1), Coomassie staining (section 2.3.4.1) 
and silver staining (section 2.3.4.2).  The fractions containing sufficient HRV16 and least 
contaminants were pooled, divided into 100 µl aliquots and stored at -80°C. 
 
2.21 35S-HRV16 labelling and purification  
2 x 107 HeLa Ohio cells were infected with HRV16 at an MOI of 5 in the presence of growth 
media [Dulbecco’s modified eagle medium (DMEM)( Invitrogen)], 10%  foetal calf serum, 2 mM 
L- glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin. After attachment of HRV16 for 
30 min at room temperature, cells were incubated at 37°C for 1 hr. The media was discarded 
and replaced with methionine-free media, supplemented with 5% dialysed foetal calf serum 
(Gibco, life technologies), 2 mM L-glutamine, 20 mM sterile HEPES, for 3 hrs at 37°C.  The 
infected cells were labelled at 3 hrs post infection by the addition of 1 mCi of 35S- methionine 
(Perkin Elmer). Cells were harvested at 11 hrs post-infection and purified as described in 
section 2.20. 
2.22 Preparation of liposomes 
Liposomes were prepared as previously described (Tuthill et al., 2006) and as follows. 
Phosphatidic acid, phospatidylcholine, cholesterol and rhodamine-labelled 
phosphatidylethanolamine (Avanti Polar Lipids) (molar ratios 44.5:44.5:10:1 respectively) were 
mixed and dried under a steady stream of argon to form a film. Liposomes were rehydrated in 
liposome buffer (107 mM NaCl, 10mM HEPES, pH7.5) containing 50 mM carboxyfluorescein 
(CF), o/n with constant agitation at room temperature. The mini-extruder (Avanti Polar Lipids, 
Inc.) was assembled, according to manufacturer’s instructions and the rehydrated lipid 
extruded 13 times through the 400 nm-pore-size filter (Avanti Polar Lipids, Inc.). The liposomes 
were washed three times by centrifugation at 100, 000 x g to remove external CF from 
liposomes and finally resuspended in 100 µl of liposome buffer. The lipid concentration of 
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liposome preparations was estimated by comparing the level of rhodamine fluorescence in the 
liposome sample relative to samples of rehydrated lipids of known concentration. Dynamic 
light scattering (Malvern Zetasizer µV) was used to confirm the average diameter (400 nm) and 
size distribution of the liposomes. Liposomes were also visualised by negative stain (uranyl 
acetate, pH4.5) TEM (FEI Tecnai, Philips) (section 2.17). 
Similarly, liposomes mimicking the composition of early endosomes or late endosomes were 
prepared. Liposomes mimicking early endosomes were composed of PC, PE, SM and 
cholesterol (Avanti polar lipids) (molar ratios 40:10:5:45). Liposomes mimicking late 
endosomes were composed of PC, PE, PI, BMP and cholesterol (Avanti polar lipids) (molar 
ratios 40:10:10:20:20).  
Liposomes containing Fluorescein isothiocyanate (FITC) conjugated dextrans (FD) (Sigma) were 
prepared in the same way as CF containing liposomes. Except, the lipid film was rehydrated in 
the presence of 25 mg/ml FD, 107 mM NaCl, 10 mM HEPES, pH 7.5. 
 
2.23 Membrane permeability assay 
Purified liposomes containing CF or FD (section 2.22) were diluted in liposome buffer (107 mM 
NaCl, 10mM HEPES, pH7.5) so that the final lipid content was 50 µM. A typical volume of 5 µl 
of the test samples and controls were placed into the wells of a black, clear bottomed, 96 well 
plate (Greiner) and liposomes (95µl) added to each well. Membrane permeability was 
detected in real time by the release, unquenching and increase in CF fluorescence. 
Measurements were taken every 30 sec for 1 hr at ʎex 485 nm/ʎem 520 nm (Plate 
CHAMELEON V, Hidex). All reagents and plasticware were pre-equilibrated to the reaction 
temperatures of 25°C or 37°C. Initial rates were calculated from the linear slope of lines 
generated from the initial four data points.  
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Figure 2.1 Membrane permeability assay.  
Membrane permeabilisation of carboxyfluorescein containing liposomes results in the release 
of the dye which becomes unquenched and is read as a signal at ʎex 485 nm/ʎem 520 nm. 
 
2.24 FD release assay  
Liposomes containing FD were purified as described in section 2.22. Experiments determining 
real time release of FD could not be carried out due to the low, non-self quenching 
concentrations of FD used. Therefore, end point fluorescence measurements of liposome free 
s/n were taken to determine extent of FD release. FD containing liposomes were added to 
VP4His and control samples, incubated for 30 min at room temperature and centrifuged at 
162, 000 x g for 30 min at 20°C. The liposome free s/n were collected and transferred to a 
black, clear bottomed, 96 well plate (Greiner) and readings taken at ʎex 485 nm/ʎem 520 nm. 
The signal released by the addition of 0.5 % (v/v) Triton X-100 was taken as 100 % and all s/n 
adjusted to 0.5 % (v/v) Triton X-100 prior to recording fluorescent measurements, to normalise 
for fluorescence quenching by presence of detergent. 
 
2.25 Liposome floatation assay 
Purified VP4His (5 μM) was added to liposomes (50 μM lipid content) in a total volume of      
100 µl and incubated for 30 min at room temperature. An equal volume of 100 μl 40 % w v 
ficoll in HEPES, pH7.4 was mixed with the VP4His-liposome reaction so that the final 
concentration of ficoll was 20 % w/v. The sample was mixed carefully and placed at the bottom 
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of a 2.2 ml mini-ultracentifuge tube. This was followed by a layer comprising 1.6 ml of 10 % 
ficoll w/v followed by a layer of 0.4 ml liposome buffer, pH7.4. This discontinuous gradient was 
subjected to centrifugation at 33, 000 x g for 1 hr at 25°C. The gradient was fractionated from 
top to bottom. The pellet was resuspended in 0.1 % SDS. 10 µl of each fraction (and the 
resuspended pellet) was analysed by SDS-PAGE (section 2.3.1) and anti-His western blot 
(section 2.3.5). Rhodamine measurements of the fractions were taken at ʎex 520 nm/ʎem    
570 nm (Plate CHAMELEON V, Hidex) and used to assess liposome migration in the gradient.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3 Expression and purification of recombinant VP4 
88 
 
 
 
 
 
 
 
3 Chapter 3 
Expression and 
purification of 
recombinant VP4 
 
 
 
  
Chapter 3 Expression and purification of recombinant VP4 
89 
 
3.1 Introduction 
This chapter introduces the rationale for working with recombinant VP4, describes the design 
and cloning of expression plasmids, strategies devised for expression and purification of 
recombinant VP4 proteins. In addition, strategies for the purification of native VP4 from virus 
are described.  
VP4 has two functions: as a capsid protein and as a protein which interacts with membranes 
upon its release from the capsid. VP4 is released from the virus particles during conformational 
changes which may be triggered by binding to receptors, low pH or elevated temperature 
(56°C). Released VP4 has been shown to aggregate and deposit as a pellet when dissociated 
virus was subjected to centrifugation in sucrose gradients (Talbot et al., 1973), VP4 released 
from the virus particle partitioned into membranes (Danthi et al., 2003; Tuthill et al., 2006), 
VP4 is myristoylated at its N-terminus and myristoylation is known to target proteins to 
membranes (section 4.1). Therefore, from the perspective of producing recombinant protein, 
VP4 was considered as a membrane protein.  
Membrane proteins have been purified from natural sources, generated as recombinant 
proteins or synthesised chemically as short peptides. A range of different expression systems 
such as the bacteria E.coli, yeast Pichia pastoris or mammalian and insect cell lines have been 
used for the generation of recombinant proteins. VP4 constitutes approximately 8 % of the 
capsid protein (P1) and the limited amounts of native VP4 expected to be purified from virus 
would be insufficient for the intended functional and structural studies on VP4. Production of 
recombinant proteins in E.coli is quick, relatively inexpensive and facilitates characterisation of 
the protein in a defined system. Although the use of mammalian cell lines for the expression 
and purification of VP4 was more relevant, it presented disadvantages of lower production 
yield and high cost due to complex growth requirements. Therefore, E.coli was used for the 
generation of recombinant VP4 to meet the objectives stated in section 1.7. 
Functional and structural studies of recombinant membrane proteins are associated with 
technical challenges in protein expression, purification and reconstitution due to their 
hydrophobicity and insolubility (Lin and Guidotti, 2009). 
Native VP4 is myristoylated at the N-terminus. Myristoylation is a co-translational modification 
catalysed by the enzyme N-myristoyltransferase (NMT) involving the covalent attachment of 
myristic acid to the amino terminal glycine residue of the protein via an amide bond. 
Myristoylation occurs in numerous eukaryotic cells which express NMT but E.coli cells lack 
endogenous NMT (Farazi et al., 2001; Resh, 1999). Therefore, E.coli cells were co-transformed 
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with a plasmid encoding VP4 and plasmid encoding NMT, to facilitate myristoylation of 
recombinant VP4 protein. 
Studies on VP4 of HRV, PV and FMDV were carried out for reasons including the overall 
economic significance of all three viruses (section 1.1.1) and the differences in their uncoating 
mechanisms. Further, PV is the prototype for picornaviruses, genetically and biochemically 
well studied and was also chosen as one of the viruses in this project due to previous studies 
on PV VP4 mutations (Threonine at position 28) which were shown to affect RNA delivery into 
the cytoplasm during infection (Danthi et al., 2003). We wanted to determine if equivalent 
mutations in HRV and FMDV VP4 had a similar effect on RNA delivery. HRV was chosen for this 
study due to the availability of an existing system for the expression and purification of GST-
tagged HRV VP4 and studies showing VP4-mediated membrane interactions (Davis et al., 
2008). FMDV was chosen for this study because FMDV VP4 differs from enterovirus VP4 in size 
and amino acid composition. Also, FMDV is the subject of extensive research at the Pirbright 
Institute. 
 
Strategies for the expression and purification of recombinant VP4 
Several approaches were tried for the expression and purification of recombinant VP4 to 
produce material suitable for use in membrane permeability assays, biochemical studies such 
as VP4 multimerisation and structural studies including circular dichroism (CD) spectroscopy, 
transmission electron microscopy (TEM) and nuclear magnetic resonance (NMR) spectroscopy.  
VP4 was produced without a tag, with a glutathione S-transferase (GST) or a hexahistidine (His) 
tag at its C-terminus; or as a His-trpLE fusion at its N-terminus. These constructs are shown in 
Figure 3.1.  
Due to the presence of the myristate group at the N-terminus, myristoylated VP4 could only be 
produced with tags fused at the C-terminus of VP4. VP4 was therefore expressed with a GST-
tag at its C-terminus. The GST-tag offered the advantages of rapidly folding into a stable and 
soluble form thereby aiding solubility of the fusion protein, and its size (26 kDa) facilitating 
TEM studies. However, there was concern that the large size of the GST-tag (26 kDa) may 
influence the activity of VP4 (~8 kDa). Therefore, VP4 with a hexahisitdine-tag at its C-terminus 
was also generated. This protein had the advantage of having a minimal tag but would be 
more difficult to resolve by TEM due to its small size. The use of fusion tags improves specific 
binding to matrices and facilitates protein purification but untagged VP4 was desirable for 
structural studies such as CD and NMR. For the production of untagged protein, VP4 was 
expressed either directly without a tag or as a fusion to His-trpLE at its N-terminus; in the latter 
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strategy although VP4 could not be myristoylated, this system provided an established 
approach for producing high yields of small insoluble proteins. Myristoylated and 
unmyristoylated forms of recombinant VP4 were expressed and purified for use in functional 
assays to investigate the influence of myristoylation on the induction of membrane 
permeability mediated by VP4. The general strategies used for obtaining recombinant VP4 
were cleavage of GST-tagged VP4 expressed as soluble protein or in inclusion bodies to release 
VP4 with a hexahistidine tag; cleavage of His-trpLE-VP4 expressed in inclusion bodies to 
release untagged VP4; direct expression and purification of His-tagged or untagged VP4. The 
details of these recombinant VP4 proteins and purification strategies used are summarised in 
Table (3.1) and will be described in the following sections of this chapter.  
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Figure 3.1 Schematic of expression constructs used for the generation of recombinant VP4. 
VP4 constructs were designed to express VP4 protein with a GST or His-tag at its C-terminus or 
His-trpLE at its N-terminus. VP4 was also directly expressed with a His-tag or as untagged VP4.  
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Table 3.1 VP4 constructs designed for expression of recombinant HRV, PV and FMDV VP4; and the purifications strategies used to purify VP4. 
 Name of construct Cleavage site Description Purification procedure 
HRV VP4 
constructs 
HRV VP4 Absent Direct expression of HRV VP4 as an 
insoluble protein.   
Denaturing conditions, nickel affinity chromatography 
HRV VP4His Absent Direct expression of His-tagged 
HRV VP4 as an insoluble protein.   
Denaturing conditions, nickel affinity chromatography 
HRV VP4HisPreGST 3C protease Expression of GST-tagged HRV VP4 
in inclusion bodies or as a soluble 
protein 
Isolation of inclusion bodies, glutathione affinity chromatography. Cleavage of 
VP4PreGST with 3C protease to release VP4His. VP4His isolated by gel 
electroelution or prep cell.  
HRV VP4HisThGST Thrombin protease Expression of GST-tagged HRV VP4 
in inclusion bodies  
Purification of inclusion bodies. Cleavage of VP4ThGST with thrombin protease. 
VP4 isolated by gel electroelution. 
His-trpLE-VP4 Absent Expression of VP4 as a C-terminal 
fusion to His-trpLE 
Isolation of inclusion bodies, nickel affinity chromatography, CNBr cleavage to 
release VP4, HPLC 
PV VP4 
constructs 
PV VP4 Absent Direct expression of PV VP4 as an 
insoluble protein.   
Denaturing conditions, nickel affinity chromatography 
PV VP4His Absent Direct expression of His-tagged PV 
VP4 as an insoluble protein.   
Denaturing conditions, nickel affinity chromatography 
PV VP4PreGST 3C protease Expression of GST-tagged PV VP4 
in inclusion bodies or as a soluble 
protein 
Isolation of inclusion bodies, glutathione affinity chromatography. Cleavage of 
VP4PreGST with 3C protease to release VP4His. VP4His isolated by gel 
electroelution or prep cell.  
PV VP4ThGST Thrombin protease Expression of GST-tagged PV VP4 
in inclusion bodies  
Purification of inclusion bodies. Cleavage of VP4ThGST with thrombin protease. 
VP4 isolated by gel electroelution. 
FMDV VP4 
constructs 
FMDV VP4 Absent Direct expression of FMDV VP4 as 
an insoluble protein.   
Denaturing conditions, nickel affinity chromatography 
FMDV VP4His Absent Direct expression of His-tagged 
FMDV VP4 as an insoluble protein.   
Denaturing conditions, nickel affinity chromatography 
FMDV VP4PreGST 3C protease Expression of GST-tagged FMDV 
VP4 in inclusion bodies or as a 
soluble protein 
Isolation of inclusion bodies, glutathione affinity chromatography. Cleavage of 
VP4PreGST with 3C protease to release VP4His. VP4His isolated by gel 
electroelution or prep cell.  
FMDV VP4ThGST Thrombin protease Expression of GST-tagged FMDV 
VP4 in inclusion bodies  
Purification of inclusion bodies. Cleavage of VP4ThGST with thrombin protease. 
VP4 isolated by gel electroelution. 
Codon 
optimised 
FMDV VP4 
constructs 
Opt FMDV VP4 Absent Direct expression of codon 
optimised FMDV VP4 as an 
insoluble protein.   
Denaturing conditions, nickel affinity chromatography 
Opt FMDV VP4His Absent Direct expression of codon 
optimised His-tagged FMDV VP4 as 
an insoluble protein.   
Denaturing conditions, nickel affinity chromatography 
Opt FMDV VP4PreGST 3C protease Expression of codon optimised 
GST-tagged FMDV VP4 in inclusion 
bodies or as a soluble protein 
Isolation of inclusion bodies, glutathione affinity chromatography. Cleavage of 
VP4PreGST with 3C protease to release VP4His. VP4His isolated by gel 
electroelution or prep cell.  
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3.2 Purification of recombinant VP4His from GST-tagged VP4 
3.2.1 Cloning of GST-tagged VP4 from HRV, PV and FMDV 
An existing plasmid expressing HRV16 VP4 with a hexahistidine tag, a thrombin protease 
cleavage site and a GST-tag fused to its C-terminus (pET23d VP4ThGST) was available from a  
previous study in the lab (Davis et al., 2008).  
In order to generate a plasmid for the expression of GST-tagged PV VP4, nucleotide sequence 
for VP4 from PV1 Mahoney (pET PV-M) was amplified by PCR (section 2.2.2.1) to produce VP4 
with the restriction site NdeI, the initiator codon, His-tag and 3C protease sequence, using the 
appropriate primers (PV VP4_F and PV VP4/His/Pre_R, Table 3.2). The GST nucleotide 
sequence was amplified from the pET23d VP4ThGST construct to produce GST with 3C 
protease sequence, His-tag, stop codon and the restriction site XhoI, using the appropriate 
primers (His/Pre/GST_F and GST_R, Table 3.2). The molecular weight of the amplified PCR 
products was confirmed by gel electrophoresis using a 1.5 % agarose gel (section 2.2.5). The 
above obtained PCR products containing the VP4 nucleotide sequence was designed to overlap 
with the PCR product containing the GST nucleotide sequence to produce the final VP4PreGST 
product, using the appropriate primers for overlapping PCR (PV VP4_F and GST_R). The 
schematic of this PCR strategy used for the generation of VP4GST is shown in Figure 3.2. FMDV 
VP4PreGST was generated similarly. HRV VP4PreGST was produced similarly to PV and FMDV 
constructs except, pET23d was used as the expression vector and NcoI was introduced as the 
restriction site at the N-terminus of VP4. pET23d could not be used for PV and FMDV GST-
tagged VP4 constructs due to the presence of NcoI restriction site in the sequence, therefore 
pET23a containing NdeI in place of NcoI restriction site was used.  
Using the same overlapping PCR strategy, constructs encoding PV or FMDV VP4, His-tag, a 
thrombin cleavage site and flanked by restriction sites NdeI and XhoI were generated using the 
appropriate primers. Nucleotide sequences encoding VP4 from PV1 Mahoney (pET PV-M) and 
FMDV VP4 from FMDV O1K (pT7S3 O1K) were amplified by PCR using appropriate primers (PV 
VP4_F and PV VP4/His/Th_R or FMDV VP4_F and FMDV VP4/His/Th_R, Table 3.2). GST was 
amplified as described above using appropriate primers (His/Th/GST_F and GST_R, Table 3.2). 
Overlapping PCR of the above obtained amplified products was carried out to produce the final 
VP4ThGST, as described above.  
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Table 3.2 Table of primers used for the generation of recombinant VP4 constructs for HRV, PV and FMDV 
Name Sequence 5’ to 3’ Description of primer 
HRV VP4_F TATACCATGGGCGCTCAAGTATCTAGACAGAATG Forward primer for amplifying HRV VP4, introducing NcoI and start codon 
HRV VP4_R TATACTCGAGTCATTGCAGAGTGGGTATGCCTTTCTCCAAC Reverse primer for amplifying HRV VP4, introducing stop codon and XhoI  
HRV VP4His_R TATACTCGAGTCAATGGTGATGGTGATGGTGTTGCAGAGTG Reverse primer for amplifying HRV VP4, introducing His-tag , stop codon and  XhoI  
HRV VP4/His/Pre_R GGGCCCCTGGAACAGAACTTCCAGATGGTGATGGTGATGGTGTTGCAGAG Reverse primer for amplifying HRV VP4 with His-tag and introducing 3C protease  
His/Pre/GST_F CATCACCATCACCATCTGGAAGTTCTGTTCCAGGGGCCCATGTCCCCTATACTAG
GTTATTGGAAAATTAAGGG 
Forward primer for amplifying His-tag and 3C protease, introducing start codon 
and GST-tag 
GST_R TATACTCGAGTCAATCCGATTTTGGAGG Reverse primer for amplifying GST-tag, introducing stop codon and XhoI 
PV VP4_F TAGTATACATATGGGTGCTCAGGTTTCATCACAG  Forward primer for amplifying PV VP4, introducing NdeI and start codon 
PV VP4_R  TATACTCGAGTCAGTTTAGCATTGGGGCTGTTTTTATCAGG     Reverse primer for amplifying PV VP4 and introducing stop codon and XhoI 
PV VP4His_R TATACTCGAGTCAATGGTGATGGTGATGGTGGTTTAGCATTGGGGCTGTTTTTA
TCAGG 
Reverse primer for amplifying PV VP4, introducing His-tag, stop codon and  XhoI 
PV VP4/His/Pre_R CCCCTGGAACAGAACTTCCAGATGGTGATGGTGATGGTGGTTTAGCATTGGGG
CTGTTTTTATCAGG 
Reverse primer for amplifying PV VP4 with His-tag and introducing 3C protease 
sequence 
FMDV VP4_F TAGTATACATATGGGGGCTGGACAATCCAGTCC Forward primer for amplifying FMDV VP4,  introducing NdeI and start codon 
FMDV VP4_R TATACTCGAGTCAGGCGAGAAGAGCGCCGAAAAG Reverse primer for amplifying FMDV VP4, introducing stop codon and XhoI 
FMDV VP4His_R TATACTCGAGTCAATGGTGATGGTGATGGTGGGCGAGAAGAGCGCCGAAAAG Reverse primer for amplifying FMDV VP4, introducing His-tag, stop codon and  XhoI 
FMDV 
VP4/His/Pre_R 
CCCCTGGAACAGAACTTCCAGATGGTGATGGTGATGGTGGGCGAGAAGAGCG
CCGAAAAG 
Reverse primer for amplifying FMDV VP4 with His-tag and introducing 3C protease 
sequence 
PV VP4His/Th_R GGATCCACGCGGAACCAGATGGTGATGGTGATGGTGGTTTAGCATTGGGGCTG
TTTTTATCAGG 
Reverse primer for amplifying FMDV VP4 with His-tag and introducing thrombin 
protease sequence 
His/Th/GST_F CATCACCATCACCATCTGGTTCCGCGTGGATCCATGTCCCCTATACTAGGTTATT
GGAAAATTAAGGG 
Forward primer for amplifying His-tag and thrombin protease sequences, 
introducing start codon and GST-tag 
FMDV 
VP4/His/Th_R 
GGATCCACGCGGAACCAGATGGTGATGGTGATGGTGGGCGAGAAGAGCGCCG
AAAAG 
Reverse primer for amplifying FMDV VP4 with His-tag and introducing thrombin 
protease sequence 
OptFMDV VP4_F TAGTATACATATGGGTGCAGGCCAAAGCTCTCC Forward primer for amplifying codon optimised FMDV VP4 and introducing NdeI 
and start codon 
OptFMDV VP4_R TATACTCGAGTCATGCCAGCAGTGCACCAAACAG  Reverse primer for amplifying codon optimised FMDV VP4, introducing stop codon 
and XhoI 
OptFMDV VP4His_R TATACTCGAGTCAGTGATGGTGATGATGATGTGCCAGCAGTG Reverse primer for amplifying codon optimised FMDV VP4, introducing His-tag, 
stop codon and  XhoI 
HindIII VP4_F GCG CCG AAA GTA CGC GCT AAG CTT GGT ATG GGC GCT CAA GTA TCT 
AGA CAG AAT 
Forward primer for amplifying VP4,  introducing MΔS in VP4, HindIII and first few 
nucleotides of trpLE 
VP4 (MΔS)_F CAC TCA ACA CAA AAT TCT GTG TCA AAT GGA TCC AGC CTC AAT Forward primer for amplifying VP4 with MΔS 
VP4(MΔS)_R GGA TCC ATT TGA CAC AGA ATT TTG TGT TGA GTG Reverse primer for amplifying VP4 and introducing MΔS in VP4 
BamHI VP4_R ATATTA GGATCC TCA TTG CAG AGT GGG TAT GCC TTT CTC CAA Reverse primer for amplifying VP4, introducing stop codon and BamHI 
Chapter 3 Expression and purification of recombinant VP4 
96 
 
 
 
Figure 3.2 Schematic of PCR strategy used to generate plasmids encoding GST-tagged VP4.  
GST-tagged VP4 plasmid constructs containing either 3C protease (pETVP4PreGST) or thrombin 
protease coding sequences (pETVP4PreGST) were generated for HRV, PV and FMDV. NcoI 
restriction site was replaced by NdeI restriction site in PV and FMDV VP4 constructs. Pro: 3C 
protease or thrombin protease encoding sequences. 
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The PCR amplified PV VP4PreGST product was digested with NdeI and XhoI (section 2.2.4) 
(Figure 3.3). The digestion product VP4PreGST was gel purified and ligated into NdeI and XhoI 
digested pET23a (section 2.2.7). E.coli DH5 α cells were transformed with the ligation reaction 
(section 2.2.8). Colonies were picked, grown in LB media and plasmid DNA purified by miniprep 
(section 2.2.10). Diagnostic digestion on the miniprep material was carried out with NdeI and 
XhoI and positive clones identified by the release of VP4PreGST (920 bp) (Figure 3.4). PCR 
colony screen (section 2.2.2.2) and sequencing (section 2.2.3) were used to confirm the 
sequence of the insert. Similarly, PV VP4ThGST, FMDV VP4PreGST, FMDV VP4ThGST DNA 
clones were generated and sequences confirmed. HRV VP4PreGST was also generated in the 
same way as explained above, except pET23d vector was used and NdeI restrictions site was 
replaced with the NcoI restriction site.  
 
 
 
Figure 3.3 Restriction digestion products of PCR amplified PV VP4PreGST.  
An image of a 1.5 % agarose gel showing PCR amplified PV VP4PreGST digested with the 
restriction enzymes, NdeI and XhoI. The digested products were obtained at the expected size 
of ~1 kb. Uncut PVVP4PreGST was used as a control. The size of molecular weight markers 
(1Kb ladder) is indicated to the left of the image and was used to confirm the size of the 
digested product (920 bp).  
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Figure 3.4 Identification of positive clones for pETPVVP4PreGST.  
An image of a 1.5 % agarose gel showing the products of pETPV VP4PreGST diagnostic 
digestion with the restriction enzymes, NdeI and XhoI. Lanes 1-5 show the release of 
VP4PreGST at the expected size of ~1 kb from pETPVVP4PreGST (~3.5 kb). The size of 
molecular weight markers (1 Kb ladder) is indicated to the left of the image and was used to 
confirm the size of the released product (920 bp). 
 
3.2.2 Expression of GST-tagged VP4 
Myristoylated GST-tagged VP4 was expressed by co-transformation of E.coli BL21 (DE3) pLysS 
cells with plasmids encoding GST-tagged VP4 (VP4ThGST or VP4PreGST) and with a plasmid 
encoding NMT (section 2.2.8). Cultures (in LB media containing 100 µg/ml ampicillin and 50 
µg/ml kanamycin) were grown to OD600 0.7 and induced with IPTG. Optimal IPTG concentration 
used to induce expression and the duration of expression of HRV VP4ThGST had previously 
been determined in the lab to be 4 hrs post induction of expression with 1 mM IPTG. When 
expressed at 37°C, expression of GST-tagged VP4 proteins was directed to inclusion bodies 
whereas expression at 30°C yielded more soluble protein, though a significant proportion was 
still expressed as insoluble protein.  
GST-tagged VP4 proteins contained a His-tag followed by a thrombin protease or HRV14 3C 
protease cleavage site, followed by the GST-tag (Figure 3.1). VP4His was, therefore, released 
from the GST-tagged protein by cleavage with thrombin protease or 3C protease. 3C protease 
was expressed and purified in-house, using established protocols (section 2.8). The use of 3C 
protease was more economically viable than thrombin protease which was purchased.  
HRV VP4PreGST protein expression was induced at 37°C for 4 hrs (section 2.4). Cells were 
harvested, lysed (section 2.5), proteins separated by SDS-PAGE (section 2.3.1) and stained with 
Coomassie blue (section 2.3.4.1). High-level expression of HRV VP4GST was demonstrated by 
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the presence of protein of expected size (approximately 37 kDa) in the induced sample for 
VP4PreGST but not in the uninduced sample (Figure 3.5).  
 
 
Figure 3.5 Induction of expression of HRV VP4PreGST.  
Coomassie stained 12 % tris-tricine SDS-PAGE of induced E.coli BL21 (DE3) pLysS cells 
transformed with pETHRV VP4PreGST. Expression of VP4PreGST was observed at ~37 kDa (as 
indicated by the black arrow). The size of molecular weight markers (kDa) is indicated to the 
left of the image. 
 
Expression trials for PV and FMDV VP4PreGST and VP4ThGST proteins were carried out at 30°C 
and 37°C. In contrast to the high-level expression for HRV GST-tagged VP4 proteins detected 
by SDS-PAGE and Coomassie staining, expression levels at both temperatures tested for PV 
VP4PreGST and VP4ThGST  were very similar and easily observed by anti-His western blot but 
not by Coomassie staining. The expression levels obtained for FMDV VP4ThGST and VP4PreGST 
were very low and barely or not detected by anti-His western blot.  
Analysis of the expression levels with GST-tagged VP4 from HRV, PV and FMDV showed that 
HRV had the highest level of expression followed by PV which was followed by very low levels 
of expression for FMDV. 
3.2.2.1 Strategies to improve expression levels of GST-tagged fusion proteins 
In genomes most amino acids are encoded by two or more synonymous codons. The 
frequency at which each codon is used differs among genomes. Abundance of transfer RNA 
(tRNA) in cells reflects the codon bias of its mRNA. Therefore, the abundance of cellular tRNAs 
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that can read codons determines the translation efficiency of different codons. Codons 
referred to as “rare” codons are usually translated to a low rate due to low abundance of their 
cognate tRNAs. “Preferred” codons have high translation efficiency due to the high abundance 
of their cognate tRNAs. Codon bias implies that genes with abundant codons that are rarely 
used in E.coli are likely to be expressed with low efficiency (Ikemura, 1985; Sharp et al., 1988). 
Codon optimisation is the exchange of rare codons in an extrinsic gene for more abundant 
codons without affecting the amino acid sequence of the encoded protein (Chen and Texada, 
2006). In order to improve the low or very low levels of expression obtained for PV and FMDV 
GST-tagged VP4, respectively, the fusion proteins were expressed in E.coli Rosetta-gami B 
(DE3) pLacI cells (section 2.2.8). This strain of E.coli has been engineered to supply tRNAs for 
codons that are “rare” in E.coli.  These codons are arginine codons AGA, AGG, and CGA, glycine 
codon GGA, isoleucine codon AUA, leucine codon CUA, and proline codon CCC. E.coli Rosetta-
gami B (DE3) pLacI cells were transformed with plasmids encoding PV and FMDV GST-tagged 
VP4 (section 2.2.8) and induced protein expression levels compared with E.coli BL21 (DE3) 
pLysS cells (Figure 3.6). 
There was an improved level of expression of PV VP4PreGST in the E.coli Rosetta -gami B (DE3) 
pLacI cells compared to E.coli BL21 (DE3) pLysS cells. Levels of PV VP4ThGST protein expression 
were similar in both strains of E.coli as detected by anti-His western blot (Figure 3.6A). In 
contrast, the levels of FMDV VP4PreGST and VP4THGST expression levels were very low in 
both strains of E.coli, as detected by anti-His western blot (Figure 3.6B). Unsatisfactory yields 
of VP4 would be expected to be purified with these levels of protein expression.  
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Figure 3.6 Comparison of expression levels for GST-tagged VP4 in E.coli pLysS with E.coli 
rosetta cells.  
Detection of GST-tagged VP4 expression levels by 12 % tris-tricine SDS-PAGE and anti-His 
western blot. A. PV VP4PreGST and VP4ThGST expression levels in E.coli pLysS and rosetta 
cells. B. FMDV VP4PreGST and VP4ThGST expression levels in E.coli pLysS and rosetta cells. 
Black arrows in panels A and B indicate expression levels of VP4PreGST and VP4ThGST 
detected at ~37 kDa. The size of molecular weight markers (kDa) is indicated to the left of the 
image. 
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The reasons for very low or undetectable expression levels of GST-tagged FMDV VP4 in E.coli 
Rosetta-gami B (DE3) pLacI cells are not clear. An alternative way to circumvent the problems 
with rare tRNAs in E.coli was to optimise codons from “rare” to “preferred” codons, thereby 
ensuring a sufficient supply of their cognate tRNAs. A codon optimised sequence encoding 
FMDV VP4PreGST was commercially synthesised (DNA2.0).  
E.coli BL21 (DE3) pLysS cells were transformed with the plasmid encoding a codon optimised 
sequence for FMDV VP4PreGST (optFMDV VP4GST) (section 2.2.8) and expression induced at 
30°C and 37°C. Induced cells were harvested 4 hrs post induction, lysed under non-denaturing 
conditions (section 2.12) and expression levels and solubility of optFMDV VP4GST was 
analysed by SDS-PAGE (section 2.3.1) and anti-His western blot (section 2.3.5) (Figure 3.7). The 
level of expression of non-codon optimised HRV VP4His, induced at 30°C was used as a control 
for comparison with expression levels induced for optFMDV VP4PreGST at 30°C and 37°C 
(Figure 3.7). Following lysis, optFMDV VP4PreGST was only detected in the total lysate when 
expressed at 30°C and as insoluble protein when expressed at 37°C. optFMDV VP4PreGST was 
not detected as soluble protein by anti-His western blot (Figure 3.7). Despite the codon 
optimisation of FMDV VP4PreGST, the observed expression levels were still low and therefore, 
not expected to give a sufficient yield of VP4PreGST. 
 
Figure 3.7 Expression and solubility of optFMDV VP4PreGST.  
Expression and solubility of optFMDVVP4PreGST at 30°C and 37°C, as detected by 16.5 % tris-
tricine SDS-PAGE and anti-His western blot. Expression level of HRV VP4His induced at 30°C 
was used as a control. Black arrow indicates expression levels and solubility of optFMDV 
VP4PreGST detected at ~37 kDa and expression levels for HRV VP4His detected at ~8 kDa. The 
size of molecular weight markers (kDa) is indicated to the left of the image. 
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FMDV VP4 and VP4His were amplified from a sequence encoding FMDV VP4PreGST using 
appropriate primers (optFMDV VP4_F and optFMDV VP4_R ; opt FMDV VP4_F and optFMDV 
VP4His_R, respectively, Table 3.2). However, similar to the observations made before codon 
optimisation (Figure 3.6B), FMDV VP4 expression levels were very low and not detected by 
anti-His western blot. Hence, this approach of using codon optimised DNA was not taken 
further to produce FMDV VP4.  
The analysis of expression levels, led to the decision of using GST-tagged HRV VP4 to obtain 
recombinant VP4 for the intended studies. The following sections discuss the various 
approaches used to obtain recombinant HRV VP4.  
3.2.3 Isolation of VP4His from GST-tagged VP4 fusion protein inclusion bodies 
It is well established that high level expression of recombinant proteins in E.coli often results in 
the formation of insoluble aggregates known as inclusion bodies (IB). Previous studies in the 
lab had shown that expression of VP4ThGST at 37°C yielded protein in IB (section 3.2.2). Small 
scale studies of VP4PreGST and VP4ThGST expression in E.coli BL21 (DE3) pLysS at 37°C and 
solubility showed the formation of IB. Therefore, large scale cultures expressing VP4PreGST 
were set up, cell pellets lysed and IB isolated. The purified IB were resuspended in buffer (free 
of protease inhibitors), aliquoted and stored at -20°C (section 2.5) (Figure 3.8, steps 1-12). A 
sample of IB (HRV VP4ThGST or HRV VP4PreGST) was analysed by SDS-PAGE (section 2.3.1) 
and Coomassie staining (section 2.3.4.1).  
For the release of VP4His from VP4ThGST IB, cleavage of VP4ThGST with thrombin protease 
was carried out o/n at 4°C. The cleavage reactions were separated by SDS-PAGE. The gel area 
in which released VP4 was expected to migrate was excised and protein electroeluted from the 
gel slice (section 2.9) (Figure 3.8, steps 13-15). Electroeluted VP4His was not detected by 
Coomassie staining (section 2.3.4.1), silver staining (section 2.3.4.2) or anti-His western blot 
(section 2.3.5).  
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Figure 3.8 Schematic of purification of VP4His from GST-tagged HRV VP4.  
An overview of the method used for the purification of VP4His from GST-tagged HRV VP4 
inclusion bodies is shown in steps 1-15. Briefly, E.coli pLysS cells transformed with plasmids 
encoding GST-tagged VP4. GST-tagged VP4 was expressed in inclusion bodies which were 
isolated and resuspended in wash buffer (without protease inhibitors). The inclusion bodies 
were cleaved with 3C protease or thrombin protease for the release of VP4His. The cleavage 
products were separated by SDS-PAGE, the area where VP4His was expected to migrate to, 
was excised and VP4His gel electroeluted. Pro: 3C protease or thrombin protease coding 
sequences, IB: inclusion bodies. 
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For the release of VP4His from VP4PreGST IB, cleavage of VP4PreGST with 3C protease was 
carried out. In order to generate 3C protease, E.coli BL21 (DE3) pLysS cells were transformed 
with a plasmid encoding His-tagged 3C protease (pET28b His-3C) (a kind gift from Dr Toshana 
Foster, University of Leeds). His-3C-protease expression was induced with 1 mM IPTG and cell 
pellets harvested 3 hrs post induction. His-3C protease was purified by nickel affinity 
chromatography. The eluted fractions containing 3C protease were resolved by SDS-PAGE 
(section 2.3.1) and purity determined by Coomassie staining (section 2.3.4.1) (Figure 3.9). The 
fractions with minimum contaminants were pooled and dialysed into storage buffer and stored 
at -20°C (section 2.8). 
 
Figure 3.9 His-3C protease elution fractions from nickel affinity chromatography.  
Fractions containing 3C protease eluted using an increasing imidazole gradient were analysed 
by 12 % tris-glycine SDS-PAGE and Coomassie staining. Elution fractions were analysed over 
two separate SDS-PAGE gels. Black arrow indicates observed His-3C protease at 22 kDa. The 
size of molecular weight markers (kDa) is indicated to the left of the image. 
        
For the release of VP4His from VP4ThGST IB, cleavage of VP4ThGST IB was carried out with 
thrombin protease (Amersham Biosciences). Twenty units of thrombin protease was added to 
a standard volume (4 µl) of a standard IB prep or 10 µg of purified 3C protease was added to 
an excess of IB (50 µl). The cleavage reaction was incubated o/n at 4°C. Cleavage products 
were separated by SDS-PAGE (section 2.3.1) and analysed by Coomassie staining (section 
2.3.4.1) and anti-His western blot (section 2.3.5). Upon cleavage of VP4PreGST or VP4ThGST 
with 3C or thrombin protease, respectively, the release of VP4His was observed (Figure 3.10). 
The intensity of appearance of the released GST-tag was directly related to that of VP4His. 
However, the appearance of the IB, suggested that the cleavage reaction was not going to 
completion. The small size of VP4His and the poor efficiency of Coomassie stain binding to VP4 
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possibly contributed to the appearance of VP4 as a protein band of low intensity. Attempts at 
improving the visualisation of VP4 are discussed in section 3.6. 
 
 
 
Figure 3.10 Cleavage of GST-tagged HRV VP4 inclusion bodies with 3C or thrombin proteases.  
Release of VP4His by cleavage of HRV VP4PreGST and HRV VP4ThGST inclusion bodies (IB) with 
3C protease (3C) or thrombin protease (Th). Cleavage products were analysed by 16.5 % tris-
tricine SDS-PAGE and Coomassie staining (top panel) and anti-His western blot (bottom panel). 
Black arrow indicates released VP4His with expected apparent molecular weight of 
approximately 8 kDa. The size of molecular weight markers (kDa) is indicated to the left of the 
image.  * indicates the band detected in HRV VP4PreGST inclusion body (IB) before cleavage.   
 
To attempt purification of VP4His, large scale cleavage reactions were separated by SDS-PAGE 
(section 2.3.1) and the gel area where VP4His was expected to migrate (~8 kDa) was excised 
and the protein electroeluted (section 2.9). The electroeluted material was analysed by SDS-
PAGE (section 2.3.1) followed by anti-His western blot (section 2.3.5). However, HRV VP4His 
was not detected.  
In order to confirm that the method used to electroelute protein from the gel slice was 
functional, gel electroelution using a control protein, aprotinin (6.5 kDa) which was of similar 
size to VP4His, was carried out.  
The amount of aprotinin obtained (approximately 1 %) was similar if gel containing aprotinin 
was excised and aprotinin immediately electroeluted, gel that had been excised, frozen and 
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then aprotinin electroeluted or gel that had been excised, cut into smaller pieces and then 
aprotinin electroeluted (section 2.9). The electroeluted material was acetone precipitated 
(section 2.3.9) and analysed by SDS-PAGE (section 2.3.1) and Coomassie staining (section 
2.3.4.1). Majority of the aprotinin was detected by Coomassie staining in the excised gel slice 
and had not electroeluted. Therefore, electroelution of aprotinin was inefficient. The use of 
200 V (84 mA) instead of 100 V for 1 hr, followed by acetone precipitation was found to 
marginally improve the recovery of aprotinin. The recovered aprotinin was only approximately 
5 % of the total input aprotinin. Therefore, suboptimal electroelution and incomplete acetone 
precipitation contributed to the poor recovery of aprotinin.  
The conditions that favoured improved aprotinin recovery were applied to the electroelution 
of VP4. However, detectable amounts of VP4His were not recovered. This was possibly due to 
the differences in amino acid composition between aprotinin and VP4, loss of VP4 that 
occurred during electroelution because of VP4 sticking to the tubing and incomplete acetone 
precipitation of electroeluted VP4.  
A variation on the use of SDS-PAGE to purify VP4His was attempted by using a preparative 
SDS-PAGE apparatus (Bio-Rad Prep Cell 491). This uses a column of polyacrylamide gel through 
which proteins are electrophoresed until eluting directly out of the column and into a series of 
fractions (section 2.10). The high sample capacity enabled multiple cleavage reactions to be 
loaded and separated by SDS-PAGE. The control protein, aprotinin (1 mg), was first purified to 
confirm that the prep cell could be used for the purification of small proteins. Following the 
confirmation of use of the prep cell to purify aprotinin, large scale o/n cleavage reactions of 
VP4PreGST with 3C protease (25 µl IB cleaved with 50 µl 3C protease x 10 reactions), were 
acetone precipitated (section 2.3.9) and loaded onto the prep cell SDS-PAGE column. The use 
of 3C protease generated in-house was more economically viable than purchased thrombin 
protease. Hence, 3C protease (instead of thrombin protease) was used for large scale cleavage 
reactions. The products resulting from 3C protease cleavage of VP4PreGST IB were eluted as    
5 ml x 50 fractions. Fractions were acetone precipitated (section 2.3.9) and analysed by SDS-
PAGE (section 2.3.1) and anti-His western blot (section 2.3.5). VP4His was not detected in any 
of the eluted fractions.  Possible explanations for the absence of detectable amounts of VP4His 
included sub-optimal cleavage of VP4PreGST with 3C protease and incomplete acetone 
precipitation of VP4His present in the prep cell eluted fractions. Furthermore, 1 mg of 
aprotinin was used as input on the SDS-PAGE column and purification by prep cell recovered 
approximately 10 % of the total input aprotinin. Therefore, the proof of concept that prep cell 
could be used for the purification of small proteins was demonstrated with the purification of 
Chapter 3 Expression and purification of recombinant VP4 
108 
 
aprotinin. This technique could potentially be used for the purification of VP4His but would 
necessitate a much larger scale IB cleavage prep and high cleavage efficiency with 3C protease. 
Despite the above described optimisation steps, insufficient amounts of VP4His were obtained 
by cleavage of VP4PreGST IB to enable carrying out the intended functional and biochemical 
assays with VP4His.  
 
3.2.4 Isolation of VP4His from soluble GST-tagged VP4  
GST-tagged HRV VP4 proteins could be expressed as insoluble protein in IBs (37°C) or as a 
partially soluble protein (30°C) (section 3.2.2). Expression levels of PV VP4PreGST at 30°C were 
similar to that observed at 37°C (Figure 3.11).   
The approach involving 3C or thrombin protease cleavage of GST-tagged VP4 IB gave limited 
yields of VP4His (section 3.2.3). Therefore, a different approach using cleavage of soluble 
VP4PreGST was carried out. Preliminary studies to attempt this used 3C cleavage of soluble PV 
VP4PreGST. To achieve this, PV VP4PreGST was expressed in E.coli BL21 (DE3) pLysS cells at 
30°C and the bacterial cell pellet harvested at 4 hrs post induction with 1 mM IPTG. The pellet 
was lysed by using 1 % Triton X-100 and separated into soluble and insoluble fractions (section 
2.7). Analysis of the resulting solubility test fractions (total lysate, insoluble fraction and 
soluble fraction) by SDS-PAGE (section 2.3.1) and anti-His western blot (section 2.3.5) showed 
that majority of PV VP4PreGST expressed at 30°C was obtained as soluble protein whereas as 
at 37°C the majority was insoluble protein (Figure 3.11).  
 
Figure 3.11 Expression and solubility of PV VP4PreGST.  
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PV VP4PreGST expression and solubility at 30°C and 37°C, as detected by 12 % tris-tricine SDS-
PAGE and anti-His western blot. Black arrow indicates PV VP4PreGST detected at ~37 kDa. The 
size of molecular weight markers (kDa) is indicated to the left of the image. 
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Soluble PV VP4PreGST was purified using affinity chromatography on an immobilised 
glutathione agarose column (section 2.7).  The eluted fractions were analysed by SDS-PAGE 
(section 2.3.1) and Coomassie staining (section 2.3.4.1) (Figure 3.12).        
 
Figure 3.12 Purification of PV VP4PreGST by glutathione affinity chromatography.  
Fractions containing PV VP4PreGST eluted from a glutathione agarose column analysed by      
12 % tris-tricine SDS-PAGE and Coomassie staining. Black arrow indicates PV VP4PReGST 
visualised at ~37 kDa. The size of molecular weight markers (kDa) is indicated to the left of the 
image. 
 
 
Fractions containing VP4PreGST with minimum contaminants were pooled and dialysed 
against 3C protease storage buffer, followed by o/n cleavage with 3C protease in a fivefold 
dilution series (1 µg- 0.0016 µg) added to a standard amount of VP4PreGST (0.4 µg) 
(concentrations of 3C and VP4PreGST determined by BCA assay). Cleavage products were 
acetone precipitated and separated by SDS-PAGE (section 2.3.1) and visualised by Coomassie 
staining (section 2.3.4.1). VP4His released from VP4PreGST was observed after cleavage with  
1 µg, 0.2 µg, 0.04 µg 3C protease. Released VP4His was not detected when 3C protease was 
used at a concentration below 0.04 µg (Figure 3.13). The intensity of appearance of released 
GST-tag was directly related to that of VP4His. The appearance of GST-tag released from 
VP4PreGST suggested that the cleavage was working better than that inferred from the 
appearance of the released VP4His. This could possibly be due to the detection problems of 
VP4 with Coomassie stain (discussed in section 3.6).  
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Figure 3.13 Release of VP4His from PV VP4PreGST by cleavage with 3C protease.  
Soluble PV VP4PreGST cleaved with a dilution series of 3C protease (1 µg - 0.0016 µg). 
Cleavage products analysed by 16.5 % tris-tricine SDS-PAGE and Coomassie staining. Black 
arrows indicate VP4PreGST, GST, 3C protease and VP4His visualised at ~37 kDa, 26 kDa, 22 kDa 
and ~8 kDa, respectively. The size of molecular weight markers (kDa) is indicated to the left of 
the image. 
 
A large scale cleavage reaction (10 µg VP4PreGST and 25 µg of 3C protease) was carried out, 
acetone precipitated, separated by SDS-PAGE (section 2.3.1), the gel area where VP4His was 
expected to migrate was excised and gel electroeluted (section 2.9). The electroeluted 
material was acetone precipitated (section 2.3.9), analysed by SDS-PAGE (section 2.3.1) and 
anti-His western blot (section 2.3.5). VP4His was not detected.  
An alternative method had to be developed due to the limited yields of VP4His obtained using 
cleavage of VP4GST constructs with 3C or thrombin protease.  
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3.3 Purification of recombinant VP4 and VP4His  
3.3.1 Construction of expression plasmids for VP4 and VP4His  
Given the limited success of obtaining VP4His from cleavage of GST-tagged VP4 (sections 3.2.3 
and 3.2.4), a different strategy of directly expressing and purifying VP4 and VP4His was 
developed. VP4 had the advantage of being untagged and therefore most similar to native VP4 
while the minimal hexahistidine tag present in VP4His facilitated protein purification and 
detection.  
pET23d HRV VP4ThGST was used as template DNA for the PCR amplification of the sequence 
encoding  HRV VP4 and HRV VP4His using the appropriate primers (HRV VP4_F and HRV VP4_R 
or HRV VP4_F and HRV VP4His_R, Table 3.2). The schematic of the PCR strategy and the 
generated PCR products for HRV VP4 and HRV VP4His are shown in Figure 3.14. Similarly, 
constructs were designed to express VP4 and VP4His from PV and FMDV using the appropriate 
primers (PV VP4_F and PV VP4_R or PV VP4_F and PV VP4His_R; FMDV VP4_F and FMDV 
VP4_R or FMDV VP4_F and FMDV VP4His_R, Table 3.2), pET23a vector was used instead of 
pET23d and NcoI restriction site was replaced by NdeI restriction site. 
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Figure 3.14 Schematic of PCR strategy used for the generation of plasmids encoding VP4 and 
VP4His.  
PCR products A. VP4His and B. VP4 were generated for HRV, PV and FMDV. NcoI cleavage site 
for HRV was replaced by NdeI cleavage site in PV and FMDV VP4 plasmid constructs. Pro: 3C 
protease or thrombin protease encoding sequences. 
 
The sizes of PCR products for HRV VP4 and VP4His were confirmed by 1.5 % agarose gel 
electrophoresis (section 2.2.5) and products digested with NcoI and XhoI (section 2.2.4) (Figure 
3.15). Digestion products were gel purified and ligated into the backbone obtained from NcoI 
and XhoI restriction digestion of pETHRV VP4ThGST (sections 2.2.4-2.2.7).  
E.coli DH5α cells were transformed with the ligation reactions and positive clones for pETHRV 
VP4 and pETHRV VP4His identified by colony screen PCR (section 2.2.2.2) using appropriate 
primers (T7_P and T7_T) (Figure 3.16). The sequence of the insert was confirmed by 
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sequencing (section 2.2.3). Similarly, PV and FMDV VP4 and VP4His constructs were generated 
and sequences confirmed.  
 
Figure 3.15 PCR amplified VP4 and VP4His digested with NcoI and XhoI.  
An image of a preparative 1.5 % agarose gel showing the products of VP4 and VP4His digested 
with NcoI and XhoI and observed at ~ 200 bp. The size of molecular weight markers (100 bp 
ladder) is indicated to the left of the image and was used to confirm the size of the digested 
products (~200 bp). 
 
 
Figure 3.16 Identification of positive pETHRV VP4 and pETHRV VP4His clones by colony 
screen PCR.   
An image of a 1.5 % agarose gel showing the identification of positive clones for pETHRV VP4 
and pETHRV VP4His by colony screen PCR using T7_P and T7_T as primers. Black arrow 
indicates PCR amplified HRV VP4 or HRV VP4His. The size of molecular weight markers (1Kb 
ladder) is indicated to the left of the image and was used to confirm the size of the product 
(~300 bp).  
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3.3.2 Expression of VP4 and VP4His 
Expression plasmids generated for VP4 and VP4His, corresponding to VP4 from HRV, PV or 
FMDV (section 3.3.1) were used to investigate expression levels of VP4 and VP4His. 
Myristoylated VP4 and VP4His were expressed by co-transformation of E.coli pLysS BL21 (DE3) 
cells with plasmids encoding VP4 (or VP4His) with plasmid encoding NMT (section 2.2.8).  
Small scale cultures of transformed E.coli BL21 (DE3) pLysS cells were grown at 30°C or 37°C to 
an OD600 of 0.7 then induced with IPTG. A range of IPTG concentrations (0.2 mM, 0.5 mM or    
1 mM) were tested to induce protein expression and no significant differences were observed. 
IPTG was used at 0.2 mM for the induction of expression in all future experiments. Samples 
were collected at 3 hrs post induction and analysed by SDS-PAGE (section 2.3.1), Coomassie 
staining (section 2.3.4.1) and anti-His western blot (section 2.3.5).  Expression levels for HRV 
VP4His were similar at 30°C and 37°C, detected by Coomassie staining and anti-His western 
blot. Expression levels for PV VP4His were below the detection limit of Coomassie stain but 
were easily detected by anti-His western blot. PV VP4His expression levels were higher at 30°C 
than 37°C. FMDV VP4His expression levels could not be detected at either temperature by 
Coomassie staining or anti-His western blot.  
The induction of expression for untagged VP4 from HRV was detected by Coomassie staining 
(section 2.3.4.1) and anti-VP4C-terminus western blot (section 2.3.5). The expression levels of 
PV and FMDV VP4 were too low to be detected by Coomassie staining. The lack of an antibody 
against VP4 of PV and FMDV prevented the analysis of expression levels of PV and FMDV VP4 
by western blot. 
On the basis of the observed expression levels, for the production of recombinant VP4 from 
E.coli BL21 (DE3) pLysS cells it was decided to focus on HRV VP4His.  
 
3.3.3 Purification of HRV VP4His 
Having shown that PV and FMDV VP4 or VP4His were not expressed to sufficient levels, 
remaining studies used HRV VP4His. The presence of the His-tag facilitated protein purification 
and identification by western blot. 
In order to maximise the yield of purified VP4His, optimisation of purification conditions were 
carried out. Following induction of VP4His expression in E.coli BL21 (DE3) pLysS cells, the 
bacterial pellet was harvested and lysed under denaturing or non-denaturing conditions. Lysis 
under non-denaturing conditions (section 2.12) did not give a sufficient yield of purified VP4His 
as majority of it was insoluble. Therefore, lysis using denaturing conditions was attempted.  
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Lysis using denaturing conditions is a standard approach to purify recombinant proteins which 
are expected to be insoluble. The bacterial pellet expressing VP4His was lysed using denaturing 
conditions (section 2.13). The total lysate was centrifuged to pellet the cell debris and the 
clarified supernatant applied to nickel affinity chromatography columns. The fractions 
containing His-tagged proteins were eluted from the column using increasing concentrations 
of imidazole and analysed by SDS-PAGE, Coomassie staining and anti VP4 C- terminus western 
blot (section 2.13) (Figure 3.17). Comparison of the two purification conditions showed that a 
higher yield of VP4His was purified when denaturing conditions were used for protein 
purification.  
The final yield of purified VP4His improved with an increase in urea concentration (3 M, 5 M,   
7 M). This was possibly due to increased solubilisation of VP4His. The denaturing conditions 
with 7 M urea were used for the purification of myristoylated (VP4His) and unmyristoylated 
VP4His (ΔVP4His) (section 2.13). The purified material was dialysed against a stepwise urea 
gradient and PBS to remove urea. This resulted in VP4His becoming insoluble and therefore 
precipitating out of solution. The precipitated material was collected and resuspended in 
DMSO and stored at -20°C (section 2.13). The high purity of VP4His and ΔVP4His was 
demonstrated by silver stained SDS-PAGE (section 2.3.4.2) (Figure 3.18). The use of polar 
solvents such as DMSO or methanol are routinely used for resuspending insoluble proteins and 
are compatible for use in functional assays with model membranes (StGelais et al., 2009; 
Wetherill et al., 2012). Therefore, VP4His resuspended in DMSO was used in liposome based 
permeability assays (section 2.23).   
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Figure 3.17 Purification of VP4His and ΔVP4His by nickel affinity chromatography.  
A. Unmyristoylated VP4His (ΔVP4His) and B. Myristoylated VP4His (VP4His) eluted from a 
nickel affinity column using an imidazole gradient and analysed by 16.5 % tris-tricine SDS-PAGE 
and Coomassie staining. C. VP4His fractions eluted from a nickel affinity column using an 
imidazole gradient and analysed by 16.5 % SDS-PAGE and Coomassie staining or D. Same 
samples as in panel C and analysed by 16.5 % SDS-PAGE and anti-VP4 C-terminus western blot. 
The size of molecular weight markers (kDa) is indicated to the left of the image.  
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Figure 3.18 Purified VP4His visualised by silver staining.  
VP4His and ΔVP4His precipitate resuspended in DMSO and analysed by 16.5 % tris-tricine SDS-
PAGE and silver staining. Black arrow indicates visualised VP4His and ΔVP4His at the expected 
apparent molecular weight of ~8 kDa. The size of molecular weight markers (kDa) is indicated 
to the left of the image. 
 
3.3.4 Quantification of recombinant VP4His 
Bradford assay is a standard assay used to determine the concentration of proteins. It is based 
on the principle that upon binding to protein, the absorbance maximum for an acidic solution 
of Coomassie brilliant blue (G-250) shifts from 465 nm to 595 nm. Hydrophobic and ionic 
interactions stabilise the anionic form of the dye which results in a visible colour change. 
Primarily arginine and to a lesser degree lysine and histidine participate in the binding of the 
anionic form of the dye. Binding of the anionic species to the aromatic residues (tryptophan, 
phenylalanine and tyrosine) results in a marginal contribution to the colour change (Compton 
and Jones, 1985; Georgiou et al., 2008). Due to the small size and lack of desirable amino acid 
composition of VP4His, the protein concentrations could not be accurately determined by the 
Bradford assay (section 2.3.10.2).  
BCA (bicinchoninic acid) protein assay is another standard assay used to determine the 
concentration of proteins. The principle of the BCA assay is that Cu+2 - protein complexes are 
formed under alkaline conditions, followed by the reduction of Cu+2 to Cu+1. The amino acids 
cysteine, tryptophan and tyrosine and the peptide bond participate in the reduction of Cu+2 to 
Cu+1. The extent of reduction is dependent on protein concentration in the sample. BCA forms 
a purple coloured complex with Cu+1 under alkaline conditions. This provided the basis for 
monitoring the reduction of alkaline Cu+2 by proteins at an absorbance maximum of 562 nm 
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(Stoscheck, 1990). The BCA assay was not dependent on the same amino acids as Coomassie 
brilliant blue used in the Bradford assay and was therefore used to determine recombinant 
VP4 protein concentrations (section 2.3.10.1).  
Further, spectrophotometry (Nanodrop 8000) was used to determine the concentration of 
recombinant VP4 proteins by measuring absorbance at 280 nm (section 2.3.10.3). This was 
expected to affect the determination of protein concentration due to the presence of aromatic 
amino acids.  
It was important to bear in mind that even though spectrophotometry (Nanodrop) is routinely 
used for estimating protein concentrations, BSA was used as the default reference set which 
has an amino acid composition different to VP4, therefore, may influence the measurements 
of VP4 concentration.  
As a result of these above mentioned concerns, concentration of purified VP4His estimated by 
BCA was confirmed by comparison with native VP4 present in known quantities in purified 
virus. HRV16 (3 or 1 µg, equivalent to 0.24 or 0.08 µg VP4 respectively) and VP4His (3 µg, 2 µg, 
1 µg, 0.5 µg, 0.25 µg) were subjected to SDS-PAGE and visualised by a combination of silver 
staining (section 2.3.4.2) (Figure 3.19A) and anti-VP4 C-terminus western blot (section 2.3.5) 
(Figure 3.19B). The migration of native VP4 and VP4His was consistent with their predicted 
molecular weights of approximately 7.4 kDa and 8.2 kDa, respectively (Figure 3.19). 
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Figure 3.19 Quantifying VP4His by comparison with native VP4 from virus (HRV16).  
HRV16 and VP4His were subjected to 16.5 % tris-tricine SDS-PAGE and visualised by A. silver 
staining and B. anti-VP4 C-terminus western blot. Black arrows on the left indicate the 
expected position of the viral proteins, VP1, VP2, VP3 and VP4. Black arrows on the right 
indicate VP4His at the expected size of ~8 kDa. The size of molecular weight markers (kDa) is 
indicated to the left of the image. 
 
An increase in the amounts DMSO in the sample resulted in  slower migration of VP4His. This 
was shown not to be unique to VP4 as the amounts of DMSO in a sample of aprotinin, affected 
its migration on SDS-PAGE (Figure 3.20). A dilution series of aprotinin (3 µg - 0.25 µg) was 
added to a standard volume (16.5 µl) of DMSO or SDS-PAGE loading buffer.  In both cases, 
aprotinin was observed at the expected ~6.5 kDa (Figure 3.20A). However, when a dilution 
series of aprotinin with correspondingly different amounts of DMSO was subjected to SDS-
Chapter 3 Expression and purification of recombinant VP4 
121 
 
PAGE, aprotinin samples containing a higher volume of DMSO migrated slower on SDS-PAGE 
compared to aprotinin samples containing lower volumes of DMSO (Figure 3.20B). Therefore, 
the migration of VP4His appeared slower with increasing concentration as a result of the 
increasing concentration of DMSO in these samples (Figure 3.19). 
 
    
Figure 3.20 Effect of DMSO on the migration of aprotinin.  
A. Dilution series of aprotinin (3,2, 1, 0.5, 0.25 µg) in a standard volume of 16.5 µl of DMSO or 
SDS-loading buffer. B. Dilution series of aprotinin (3, 2, 1, 0.5, 0.25 µg) in DMSO. Samples in 
panels A and B were analysed by 16.5 % tris-tricine SDS-PAGE and silver staining. Black arrows 
indicate aprotinin at the expected size of 6.5 kDa. The size of molecular weight markers (kDa) 
is indicated to the left of the image. 
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3.4 Purification of recombinant VP4 from His-trpLE-VP4  
3.4.1 Cloning of His-trpLE HRV VP4 constructs 
Although section 3.3 describes the development of an approach for successfully producing 
VP4His sufficient (approximately 0.16 mg per litre of culture) for the intended biochemical and 
functional studies, it was desirable to have a higher yield of VP4 to carry out structural studies 
such as nuclear magnetic resonance (NMR).  
The approach for optimisation of recombinant VP4 production, suitable for NMR structural 
studies, was carried out in collaboration with Professor Chou, Harvard Medical School, USA. A 
routine approach for the expression and purification of membrane proteins involved the 
expression of the protein as a C-terminal fusion to Hisx9 tag followed by trpLE in pMM-LR6 
vector (Figure 3.1). VP4 protein expressed as a fusion to His-trpLE (His-trpLE-VP4) formed 
inclusion bodies. The release of VP4 from His-trpLE-VP4 required cleavage with cyanogen 
bromide (CNBr) which hydrolyses peptide bonds at the C-terminus of methionine (section 
2.15). As methionine residues are sensitive to CNBr cleavage, the methionine at position 17 of 
VP4 was substituted for serine.  
PCR amplification of pETVP4GST template DNA was used for the generation of HRV VP4 
(methionine at position 17 substituted with serine), flanked by the restriction sites, HindIII and 
BamHI at the 5’ and 3’ end, respectively.  Overlapping PCR was carried out as described for 
VP4GST (section 3.2.1) except primers HindIII VP4_F and VP4 (MΔS)_R; VP4 (MΔS)_F and 
BamHI VP4_R (Table 3.2) were used to obtain intermediate PCR products. Overlapping PCR 
was carried out with HindIII VP4_F and BamHI VP4_R (Table 3.2). The resulting PCR products 
were analysed by 1 % agarose gel electrophoresis (Figure 3.21). 
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Figure 3.21 PCR amplification products used for the generation of HRV VP4 to be ligated into 
His-trpLE pMM-LR6 vector.  
Lane 1: PCR amplification product of HRV VP4 using primers HindIII VP4_F and VP4 (MΔS)_R; 
Lane 2: PCR amplification product of HRV VP4 using primers VP4 (MΔS)_F and BamHI VP4_R; 
Lane 3: PCR amplification product of HRV VP4 using primers HindIII VP4_F and BamHI VP4_R. 
Black arrows indicates PCR amplified products at the expected sizes. 100 bp ladder was used to 
confirm the size of the PCR amplified products. The size of molecular weight markers (100 bp 
ladder) is indicated to the left of the image and was used to confirm the size of the PCR 
amplified products.  
 
The final PCR product (Lane 3, Figure 3.21) was digested with restriction enzymes, HindIII and 
BamHI. The digested product was gel purified (section 2.2.6) and ligated into HindIII and 
BamHI digested pMM-LR6 His-trpLE (kindly provided by Bill Qingshan Fu, Chou lab). E.coli 
DH5α cells were transformed with the plasmid encoding His-trpLE-VP4 (section 2.2.8). A few 
colonies were picked and grown in LB media overnight. Positive clones containing the correct 
sequence of the insert were confirmed by sequencing (Sanger sequencing, Genomics Core 
facilities, Harvard Medical School).  
 
3.4.2 Expression of His-trpLEVP4 
Small scale expression trials were carried out to determine the optimal conditions for 
expression of His-trpLE-VP4. Small scale LB cultures of E.coli BL21 (DE3) cells (NEB) 
transformed with plasmids encoding His-trpLE-VP4 were grown at 18°C, 25°C or 37°C to OD600 
0.7 and induced with 0.5 mM IPTG for 3 hrs or o/n. The induced cells were harvested and 
expression levels compared by SDS-PAGE (section 2.3.1) and Coomassie staining (section 
2.3.4.1). The levels of expression for His-trpLE-VP4 were highest when induced o/n at 37°C. 
The levels of expression for His-trpLE-VP4 at the other temperatures and time points were 
comparatively lower as visualised by SDS-PAGE and Coomassie staining. The expression levels 
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for His-trpLE-VP4 at 37°C were lower than those observed with HRV VP4PreGST and VP4ThGST 
at 37°C (section 3.2.2) but only marginally higher than expression levels of HRV VP4His at 30°C 
(section 3.3.2). Therefore, conditions of inducing expression o/n at 37°C were used to generate 
His-trpLE-VP4.     
The conditions of temperature (37°C), IPTG concentration (0.5 mM) and duration of induction 
of expression (o/n) used for expression of His-trpLE-VP4 in LB media were also used for the 
induction of expression in M9 minimal media (section 2.15). Levels of expression obtained in 
LB media and M9 minimal media were similar. Addition of 15N labelled NH4Cl to M9 media was 
used to generate 15N labelled VP4.  
 
3.4.3 Purification of VP4 from His-trpLE-VP4 constructs 
Previous experience in the lab (Chou lab, Harvard Medical School) using His-trpLE in the pMM-
LR6 vector for expression of membrane proteins, indicated that such proteins formed inclusion 
bodies (IB). His-trpLE-VP4 protein expression was induced at 37°C and bacterial cells harvested 
after o/n induction of His-trpLE-VP4 expression (section 3.4.2). Cell pellets were lysed using 
denaturing conditions and sonication. IB were purified, lysed, debris pelleted, s/n applied to a 
nickel affinity chromatography column and His-trpLE-VP4 eluted from the column using formic 
acid. Cleavage of His-trpLE-VP4 with CNBr resulted in the release of VP4. The cleavage 
products were dialysed against water using a membrane with a 3.5 kDa molecular weight cut 
off. Dialysis resulted in the precipitation of VP4 and uncleaved His-trpLE-VP4, which were 
solubilised by the addition of acetonitrile. This solution was lyophilised o/n to obtain the 
proteins as a dried powder which was dissolved in formic acid and applied to an HPLC column. 
VP4 was purified from uncleaved fusion protein (His-trpLE-VP4) by RP-HPLC, with increasing 
concentrations of acetonitrile introduced over a linear 0-100 % gradient to elute the proteins 
from the column in order of their hydrophobicity (section 2.15). The efficiency of CNBr 
cleavage of His-trpLE-VP4 resulting in the release of VP4 was 50 %-70 %. The peak fractions 
containing proteins, identified by readings at A280 nm (indicated by peak numbers in Figure 
3.22) were collected and analysed by SDS-PAGE and Coomassie staining. 15N labelled VP4 was 
expressed as a His-trpLE fusion protein (section 3.4.2), purified and analysed as described for 
unlabelled VP4. A schematic of the purification procedure is shown in Figure 3.23 (section 
2.15).  
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Figure 3.22 Separation of His-trpLE-VP4 cleavage reaction products by RP-HPLC.  
Fractions containing protein were eluted from a C18 column by a linear acetonitrile gradient 
shown in red as percentage buffer B. Spectra were recorded at 215 nm and 280 nm. Protein 
containing fractions appear as peaks which are labelled in red.  Peak 1 corresponds to VP4 and 
Peak 2 corresponds to His-trpLE and His-trpLE-VP4. 
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Figure 3.23 Schematic of purification of VP4 from His-trpLE-VP4.  
An overview of the method used for the purification of VP4 from His-trpLE-VP4 is shown in 
steps 1-13. Briefly, E.coli BL21 (DE3) cells were transformed with plasmids encoding His-trpLE-
VP4. His-trpLE-VP4 was expressed in inclusion bodies which were lysed and His-trpLE-VP4 
purified by nickel affinity chromatography. VP4 was released from His-trpLE-VP4 by cleaving 
with CNBr. The lyophilised cleavage products were separated by RP-HPLC. IB: inclusion bodies, 
RP-HPLC: reverse phase high pressure liquid chromatography 
 
The molecular weight of RP-HPLC purified HRV VP4 was confirmed by matrix-assisted laser 
desorption/ionization (MALDI) mass spectrometry (carried out at Dana Farber, Harvard 
Medical School) which showed a molecular mass of 7312.27 Da. This was approximately the 
expected theoretical molecular weight of 7322 Da (Figure 3.24A). The concentration of VP4 
generated by this method was determined by spectrophotometry (A280 nm). Typically 5 mg of 
VP4 was purified from 1 L of culture and was of high purity as demonstrated by silver stained 
SDS-PAGE (Figure 3.24B).   
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Figure 3.24 Molecular weight and purity of purified HRV VP4.  
A. MALDI mass spectrometric analysis confirming molecular weight of purified HRV VP4. Black 
arrow indicates the observed VP4 peak at the expected molecular weight (~7000 Da)                 
B. Purified HRV VP4 visualised by silver stained 16.5 % tris-tricine SDS-PAGE. The size of 
molecular weight markers (kDa) is indicated to the left of the image. 
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Therefore, the purification of VP4 from His-trpLE-VP4 gave a much higher yield of VP4 
compared to that obtained with the previous strategies of using GST-tagged VP4 as IB or 
soluble protein and cleavage with 3C or thrombin protease (section 3.2) or by direct 
expression of VP4His (section 3.3). The purity obtained by this purification method was similar 
to that observed with direct expression of VP4His and purification under denaturing conditions 
(section 3.3). However, the yield was significantly higher (~5 mg per litre) and, therefore, this 
approach was used to generate 15N-VP4 for NMR structural studies of the VP4 membrane pore 
complex (described in Chapter 6).  
 
3.5 Purification of native VP4 from HRV16 
Methods for the production of VP4His and VP4 for functional, biochemical and structural 
studies were optimised and determined, as described in sections 3.3 and 3.4. It was desirable 
to include native VP4 from virus for use as a control in the functional studies.  
Existing laboratory stocks of HRV16 [derived from the infectious cDNA plasmid (Davis et al., 
2008)] were used to infect large scale HeLa Ohio cell cultures. Different MOIs (0.02, 0.1 and 
0.5) were tested and the optimal MOI of 0.1 was used to obtain complete CPE at 48 hrs, 
following which cells were harvested. HRV16 was purified using standard methods (section 
2.20). Sucrose gradients were used to purify HRV16 and fractions collected from bottom to 
top. The fractions were measured at A260 to identify the fractions containing HRV16 (Figure 
3.25A). Purified HRV16 was separated by SDS-PAGE (section 2.3.1) and visualised by Coomassie 
staining (section 2.3.4.1). By comparison with known amounts of BSA on Coomassie stained 
SDS-PAGE (Figure 3.25B) and measurements taken at A260 nm, concentration of HRV16 was 
estimated to be 0.15 mg/ml. Approximately 0.6 mg of HRV16 was purified and was of high 
purity as demonstrated by silver stained (Figure 3.25C).   
To make radiolabelled HRV16, the protocol was modified such that cells were metabolically 
labelled with 35S methionine to make radiolabelled virus (35S HRV16) (section 2.21). 
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Figure 3.25 Purification of HRV16. 
A. Absorbance measurements at 260 nm of HRV16 sucrose density gradient fractions. Black 
arrow indicates the fraction containing HRV16. B. Coomassie stained 16.5 % tris-tricine SDS-
PAGE to estimate the concentration of HRV16 with known concentrations of BSA. Black arrows 
indicate the expected position of the viral proteins- VP1, VP2, VP3 (VP4 was not observed).      
C. Silver stained 16.5 % tris-tricine SDS-PAGE demonstrating the purity of purified HRV16. Black 
arrows indicate the expected position of the viral proteins- VP1, VP2, VP3 and VP4. The size of 
molecular weight markers (kDa) is indicated to the left of the image in panels B and C. 
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VP4 is released from HRV during uncoating, a process that can be triggered in vitro by heating 
at 60°C. Released VP4 was thought likely to be insoluble, based on findings in this study and a 
previous report showing that VP4 indeed precipitated upon release and that this could be used 
to facilitate the separation of VP4 from virus (Talbot et al., 1973). Therefore, the isolation of 
VP4 from heated virus particles was investigated. 
35S HRV16 and pre-heated 35S HRV16 (60°C for 10 min) were analysed on a 15-45 % sucrose 
gradient. The gradient was fractionated from bottom to top. In order to include material that 
may have precipitated, the pellet was resuspended in SDS-loading buffer and included in the 
analysis. The position of radiolabelled virus particles was determined by reading a proportion 
of each fraction and the pellet on a scintillation counter. Particle alterations are often 
characterised by their sedimentation coefficients (S) in a sucrose gradient. The sedimentation 
coefficient of HRV16 is 150S and that of its empty particle is 80S. As expected, pre-heating of 
HRV16 yielded empty particles (80S), as depicted by the observed shift in particle 
sedimentation relative to the native virus particle (150S) (Figure 3.26). The fraction containing 
150S (fraction number 12, Figure 3.26) was different to that containing 80S (fraction number 
16, Figure 3.26). Given the insoluble nature of VP4, it was expected to be in the pellet 
following sucrose density gradient purification of the pre-heated HRV16 sample.  The 
scintillation counts per minute (cpm) of the fractions and pellet revealed a signal in the pellet 
(Figure 3.26) of the gradient containing the particles converted to empty particles. A similar 
peak was absent in the pellet of the gradient containing virus particles. 
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Figure 3.26 Scintillation counts of fractions obtained from sucrose density gradients 
containing virus or pre-heated virus particles.  
Virus (blue) and empty particles (red) were obtained at the expected positions in the sucrose 
density gradient. The pellets of gradients containing virus particles and pre-heated virus 
particles were resuspended and counts per minute determined. A signal, indicated by the red 
arrow, in the pellet of the gradient containing pre-heated particles was observed.     
 
In order to investigate if the signal observed in the pellet (red arrow, Figure 3.26) was due to 
VP4, the pellet was analysed by SDS-PAGE and autoradiography (section 2.3.7). Purified native 
HRV16 (0.5 µg, 3 µg), gradient fractions containing empty particles (fraction number 16, Figure 
3.26) and fractions from the top of the gradient which were expected to be free of particles 
(fraction numbers 20 and 21, Figure 3.26), were used as controls to confirm the signal in pellet 
was that of VP4 (indicated by red arrow, Figure 3.26) by using autoradiography (Figure 3.27). 
As expected, upon resolving empty particles and purified virus by SDS-PAGE, VP1, VP2 and VP3 
were detected in empty particles; and VP1, VP2, VP3 and VP4 were detected in purified virus. 
The intensity of appearance of the bands for the viral proteins increased with an increase in 
the amount of empty particles analysed by SDS-PAGE and autoradiography. However, VP4 
could only be detected when 3 µg of purified virus was analysed by SDS-PAGE and 
autoradiography (Figure 3.27). It was likely that the signal in the pellet was that of VP4 but the 
low concentration of VP4 and presence of only two 35S-labelled methionine residues in VP4 
contributed to the generation of an insufficient signal that could not be detected by 
autoradiography. Therefore, the presence of VP4 in the pellet could not be confirmed and was 
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consistent with previously reported difficulties of detection of VP4 by autoradiography (Danthi 
et al., 2003). Due to time constraints, this approach was not taken any further.  
 
Figure 3.27 Detection of 35S VP4 by autoradiography.  
The pellet of the sucrose gradient used to obtain 35S HRV16 empty particles was analysed by 
SDS-PAGE and autoradiography. Purified 35S HRV16 and the fractions of the sucrose density 
gradient containing 35S HRV16 empty particles or no particles were used as controls. Black 
arrows indicate the expected position of the viral proteins, VP1, VP2, VP3 and VP4. 
 
3.6 Discussion  
Prokaryotic systems have been successfully used for the overexpression and purification of 
small and hydrophobic membrane proteins. The protein of interest is often fused to tags such 
as GST (26 kDa) or maltose binding protein (42.5 kDa) to enhance protein solubility and 
facilitate purification. The aim of this project was to understand the role of VP4 in cell entry, 
therefore, generation of recombinant VP4 with a small tag or without a tag was considered to 
be ideal as large tags may affect VP4 function. Native VP4 is myristoylated at the N-terminus 
and both myristoylated and unmyristoylated recombinant proteins were, therefore, produced 
in E.coli. The requirement for myristoylation meant that VP4 could not be expressed as a 
fusion protein with a fusion partner at the N-terminus of VP4. Therefore, hexahistidine or GST-
tags were fused to the C-terminus of VP4.  Attempts were made at purifying VP4His from GST-
tagged VP4 or directly expressing and purifying VP4 and VP4His. Purification of VP4His using 
denaturing conditions generated sufficient yields of VP4His to carry out functional and 
biochemical assays (described in chapters 4, 5 and 7). HRV VP4 fused to His-trpLE at the N-
terminus of VP4 was used to generate a higher yield of unmyristoylated VP4, desirable for 
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carrying out preliminary structural studies on the VP4 membrane pore complex using NMR 
(described in chapter 6). HRV VP4ThGST was used to visualise the VP4 membrane pore 
complex by electron microscopy (Chapter 5).  
An established system for the production of myristoylated protein in E.coli (Duronio et al., 
1990; Matsubara et al., 2005) was used which has previously shown that myristate was added 
to VP4, as confirmed by mass spectrometry (Davis et al., 2008). Myristoylated and 
unmyristoylated forms of VP4 were produced in order to investigate the influence of 
myristoylation on VP4-mediated membrane permeability.  
The levels of GST-tagged VP4 expression observed were highest for HRV followed by PV which 
was followed by very low levels of expression for FMDV. Differences in amino acid composition 
may have contributed to the differences in expression levels. Although amino acid composition 
of VP4 from HRV, PV and FMDV are relatively similar (Figure 3.28), there are other factors such 
as codon bias that could contribute to the differences in observed VP4 expression levels.  
 
 
 
Figure 3.28 Alignment of human rhinovirus, poliovirus and foot-and-mouth disease virus 
VP4.  
VP4 residues are coloured according to their physicochemical properties-small hydrophobic 
residues (red), acidic residues (blue), basic residues (purple), hydroxyl/sulphydryl/amine 
residues (green). * (asterisk) indicates positions which have a single, fully conserved residue.     
: (colon) indicates conservation between groups of strongly similar properties, . (period) 
indicates conservation between groups of weakly similar properties. The alignment was 
obtained by submitting HRV, PV and FMDV VP4 amino acid sequences into the alignment 
programme http://www.ebi.ac.uk/Tools/msa/clustalw2. 
 
Every organism shows codon bias as the codon usage frequency varies between different 
organisms and between proteins of the same organism. Codon usage is an important factor 
influencing protein expression (Gustafsson et al., 2004) as major differences in codon usage 
between E.coli and host cells may result in decreased mRNA stability, premature termination 
of transcription or translation or inhibition of protein synthesis (as reviewed in Angov, 2011). 
In order to improve PV and FMDV VP4 expression levels, E.coli Rosetta-gami B (DE3) cells 
which supply cognate tRNAs for rarely used codons in E.coli were transformed with plasmids 
HRV16 GAQVSRQNVGTHSTQNMVSNGSSLN-YFNINY-------FKDAASSGASRLDFSQDPSKF 52 
PV    GAQVSSQKVGAHENSNRAYGGSTIN-YTTINY-------YRDSASNAASKQDFSQDPSKF 52 
FMDV  GAGQSSPATGSQNQSG--NTGSIINNYYMQQYQNSMDTQLGDNAISGGSNEGSTDTTSTH 58 
      **  *   .*::. ..    ** :* *   :*         * * ...*. . :: .*.. 
 
HRV16 TDPVK--DVLEKGIP-TLQ-------- 68 
PV    TEPIK--DVLIKTAP-MLN-------- 68 
FMDV  TTNTQNNDWFSKLASSAFSGLFGALLA 85 
      *   :  * : *  .  :.         
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encoding GST-tagged PV or FMDV VP4. This improved expression levels for GST-tagged PV VP4 
but not for GST-tagged FMDV VP4 (section 3.2.2.1).  For the comparison of the function of VP4 
from HRV, PV and FMDV, the expression levels of FMDV VP4 required improvement. 
Therefore, GST-tagged FMDV VP4 which showed very low levels of expression was selected for 
an additional strategy of codon optimisation to improve FMDV VP4 expression to a level that 
could be used to generate FMDV VP4. A codon optimised sequence for expression of FMDV 
VP4PreGST in E.coli was synthesised (DNA2.0). The level of expression with codon optimised 
FMDV VP4PreGST was improved relative to the non-codon optimised protein, however, 
expression level was still too low to give a sufficient yield of purified FMDV VP4 for the 
intended functional and biochemical assays (section 3.2.2.1).  
High frequency or clusters of rare codons in the protein being expressed in E.coli may 
contribute to low levels of protein expression. But these are absent in PV and FMDV VP4. 
Therefore, other factors contributing to low levels expression are currently unclear. 
As an alternative to expressing and purifying FMDV VP4, the use of FMDV VP4 synthetic 
peptide was considered as there is precedence for other pore forming proteins, e.g. HRV2 VP1 
N-terminus (Prchla et al., 1995) and Influenza A M2 protein (Ma et al., 2009; Rosenberg and 
Casarotto, 2010) being used as functional peptides. Several peptide synthesis companies were 
approached and either considered it unfeasible due to the size and unfavourable amino acid 
composition of FMDV VP4 (85 residues) or attempted synthesising FMDV VP4 but failed to do 
so (Peptide Protein Research Ltd).  
Overexpression of non-native proteins in E.coli often results in the formation of IB. GST-tagged 
VP4 proteins were expressed in IB. Purifying recombinant proteins from IB can be 
advantageous as IB consist mainly of the protein of interest, can be easily isolated due to 
relatively higher density and are resistant to proteases (Debernardezclark and Georgiou, 1991; 
Singh and Panda, 2005).  
VP4His was released from GST-tagged VP4 by cleavage with 3C or thrombin protease. Of the 
various constructs tested, the highest levels of expression were obtained with HRV, therefore 
GST-tagged HRV VP4 proteins were used for further large scale cleavage studies. It was clear 
from the appearance of the products of the cleavage reaction after analysis by SDS-PAGE, that 
VP4His was being released. Following cleavage of GST-tagged VP4, the presence of the 
released GST was directly related to the appearance of VP4His. The appearance of GST-tagged 
VP4 suggested cleavage was incomplete. This was not entirely unexpected as the GST-tagged 
protein was being expressed in inclusion bodies where the protease cleavage site may not 
always be accessible (section 3.2.3). However, the observed incomplete cleavage of soluble 
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GST-tagged VP4 (section 3.2.4) suggested a factor other than the restricted availability of the 
cleavage site was contributing to the incomplete cleavage. One possible explanation for the 
incomplete cleavage was the presence of a sub-optimal thrombin cleavage site. Thrombin 
protease cleaves between arginine and glycine (LVPR/GSMS). Proline at position P2 and 
arginine at position P3’ are required for maximal cleavage efficiency. A recent study showed 
that mutation of arginine residue at position P3’ reduced the cleavage efficiency of thrombin 
protease (Gallwitz et al., 2012). Therefore, the thrombin protease cleavage sequence in 
VP4ThGST (LVPR/GSMS) may be sub-optimal.  
As an alternative approach for generating recombinant VP4, plasmids encoding VP4 and 
VP4His were directly expressed (section 3.3), thereby circumventing problems associated with 
generating VP4His from GST-tagged VP4. The levels of expression of VP4His from different 
viruses showed the same pattern as GST-tagged VP4 proteins, i.e. HRV VP4His expressed to the 
highest level followed by PV VP4His followed by very low level expression for FMDV VP4His. 
Only HRV showed a level of expression sufficient for purification of VP4His with appropriate 
yield, therefore, all further work described in the following chapters used recombinant VP4 
from HRV, unless stated otherwise.  
In order to start preliminary studies of the VP4-membrane pore complex using NMR, a higher 
yield of VP4 than that obtained with expression and purification of VP4His (section 3.3) was 
necessary. The presence of a myristate group at the N-terminus of VP4 was expected to 
increase hydrophobicity and tendency to aggregate, thereby raising technical issues with 
reconstitution of VP4 required for biophysical studies such as CD and NMR. It was, therefore, 
decided to express and purify unmyristoylated VP4. The expression of VP4 as a fusion protein 
with His-trpLE was used to purify VP4 for preliminary NMR studies. In contrast to the 
inefficient cleavage of VP4ThGST and VP4PreGST with thrombin or 3C protease (sections 3.2.3 
and 3.2.4), respectively, cleavage of His-trpLE-VP4 with CNBr was efficient (up to 70 %) and 
contributed to the generation of at least 20 fold higher yield of VP4 compared to VP4His, 
desirable for NMR studies. 
The influence of myristoylation in the ability of VP4 to induce membrane permeability is 
described in section 4.2.3. Future work should therefore be carried out to optimise the 
production of myristoylated VP4 to enable a comparative NMR study of the structures of the 
VP4 membrane pore complex formed by myristoylated and unmyristoylated VP4. This would 
help gain an understanding of the influence of myristoylation on VP4 structure and membrane 
pore complex formation.  
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SDS-PAGE was used to visualise recombinant and native forms of VP4. The signal for VP4 
stained with Coomassie stain appeared lower than expected. Therefore, the two potential 
issues associated with the poor visualisation of VP4 were investigated. The first potential 
concern was that of inefficient fixation of VP4 and the second of poor staining of VP4 with 
Coomassie dye. 
Fixatives are used to prevent diffusion of proteins and to keep protein bands sharp and 
resolved in SDS-PAGE. A range of different fixatives were used with the aim of retaining the 
trapped denatured protein within the polyacrylamide gel matrix, thereby facilitating better 
protein staining. Different fixatives such as 10 % glutaraldehyde, 15 % formalin and 12 % 
trichloroacetic acid (section 2.3.3) were investigated. After fixing proteins on SDS-PAGE with 
one of the above fixatives, VP4His was stained with Coomassie blue. However, the use of the 
above fixatives did not improve VP4His staining with Coomassie blue.  
Coomassie brilliant blue dye binds to basic amino acids  such as arginine, lysine and histidine 
(Tal et al., 1985). HRV VP4 contains approximately 10 % basic amino acids (Rx2, Kx4, Hx1) 
which may have contributed to the poor binding of Coomassie stain to VP4. Therefore, 
Coomassie stain (CBR-250) was not ideal for the visualisation of VP4 band. The poor binding of 
Coomassie stain was also likely to have contributed to the underestimation of VP4 
concentration by the Bradford assay (section 3.3.4). Alternative stains including copper 
chloride, zinc imidazole, sypro orange (section 2.3.4.3) were attempted to improve the 
visualisation of VP4. Visualisation of VP4 was not significantly improved by any of the above 
stains compared to VP4 visualised with Coomassie stain.  
Silver stain is known to be up to 100 times more sensitive than Coomassie stain. Charged 
amino acids such as arginine, lysine, glutamic acid, histidine and aspartic acid bind to silver 
ions, followed by the reduction to free metallic silver which gives the visible image. (Chevallet 
et al., 2006; Merril et al., 1988; Nielsen and Brown, 1984). HRV VP4 contains the residues Ex2, 
Dx5, Rx2, Kx4, Hx1 and possibly contributed to the better visualisation of VP4 with silver stain 
better than with Coomassie stain.  
Due to the concerns associated with the visualisation of VP4, it was important to compare 
recombinant VP4 with native VP4. Recombinant VP4 was quantified by comparison with native 
VP4, using a combination of silver staining and anti-VP4C western blot (section 3.3.4). 
Although, silver staining gave an estimate of recombinant VP4 concentration relative to native 
VP4, it was important to bear in mind the hexahistidine tag in recombinant VP4 was absent in 
native VP4, which may have influenced silver staining of recombinant VP4.   
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4.1  Introduction 
Existing evidence for role of VP1 and VP4 in cell entry 
During cell entry by enteroviruses, receptor and/or pH-induced conformational changes result 
in the conversion of native virus into an altered or “A” particle from which VP4 has been 
released and in which the N-terminus of VP1 has become externalised (section 1.6.4.2). 
Enterovirus “A” particles are hydrophobic and more sensitive to proteases than native 
particles (Fricks and Hogle, 1990; Hogle, 2002). Comparison of cryoEM structures of PV “A” 
particles and “A” particles with the N-terminal 31 residues of VP1 proteolytically removed, 
demonstrated the externalisation of the N-terminus of VP1 which was therefore available for 
membrane insertion (Bubeck et al., 2005). VP1-mediated membrane interaction of “A” 
particles was confirmed by similar proteolytic cleavage studies (Tuthill et al., 2006). The 
interaction between the N-terminus of VP1 with liposome membranes was suggested for 
tethering of “A” particles to liposome membranes in a receptor independent manner (Tuthill 
et al., 2006). A recent tomographic study has proposed an “umbilicus” connecting PV capsid to 
membrane which has been hypothesised to facilitate RNA transfer across the membrane, with 
the VP1 N-terminus and/or VP4 shielding the RNA from enzymatic degradation (Strauss et al., 
2013). Therefore, there is evidence for the role of VP1 N-terminus in facilitating genome 
delivery, however, the extent and precise role of VP1 N-terminus in genome delivery remains 
unclear.   
Several experimental findings have suggested a role for VP4 in the induction of membrane 
permeability (described in section 1.6.4.4). These included studies with recombinant GST-
tagged VP4 which associated with membranes and induced permeability in intact liposomes 
(Davis et al., 2008). VP4 released from PV was also shown to be associated with liposome 
membranes (Tuthill et al., 2006). PV with mutations in VP4 formed channels in lipid bilayers 
with different electrophysiological properties. The same mutations in VP4 also either delayed 
or prevented RNA delivery during infection (Danthi et al., 2003; Tosteson et al., 2004). 
Therefore, these findings indicate that VP4 may be part of a potential channel, facilitating RNA 
delivery into the cytoplasm.  
Use of liposomes as model membranes 
Liposomes are artificially prepared vesicles composed of single or multiple lipid bilayers. 
Liposomes constitute a valuable model system, permitting experiments to be carried out 
under a tightly controlled range of conditions. Self-quenching dyes which fluoresce upon 
dilution when released into the surrounding aqueous buffer can be used to fill liposomes. Real-
time monitoring of the fluorescence allows for analysis of dye release and measurement of 
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membrane permeability induction. To investigate the role of VP4 in cell entry, liposomes 
comprised of one lipid bilayer were used as model membranes. 
The use of liposomes to study membrane permeability is a standard approach. Liposome 
membrane permeability has been shown to be  induced by several small viral proteins 
including p7 of HCV (StGelais et al., 2007), SH of RSV (Carter et al., 2010; Gan et al., 2008), M2 
of IAV (Duff and Ashley, 1992; Vijayvergiya et al., 2004), µ1N of reovirus (Zhang et al., 2009), 
VP4 of SV40 (Raghava et al., 2011). Liposomes have also been used to study membrane 
permeability by peptides such as GALA and melittin. Melittin is a well characterised pore-
forming peptide and has been shown to mediate the release of carboxyfluorescein (CF) from 
liposomes (Ladokhin et al., 1997; Schwarz et al., 1992). GALA is a pore-forming peptide that 
induces membrane permeability by pore formation at pH<6 (Nicol et al., 1996; Nicol et al., 
2000; Parente et al., 1990).  
Previous experience in the lab involved testing different liposome compositions. This led to the 
conclusion that PA:PC:cholesterol:rhod-PE (44.5:44.5:10:1) was a robust and stable 
composition. Therefore, unilamellar vesicles comprised of PA, PC, rhod-PE and cholesterol 
were used as the composition of choice for model membranes to investigate membrane 
permeability induction (section 2.22-2.23). 
Role of protein myristoylation 
Myristoylation at the amino terminus of proteins is a co-translational modification involving 
the covalent linkage of a saturated C14 fatty acid myristate via an amide bond to the N-
terminal glycine of the protein. The enzyme myristoyl CoA: protein-N-myristoyltransferase 
catalyses the transfer of myristate from myristoyl CoA to the N-terminus of the protein 
following the removal of methionine by methionine aminopeptidase (Boisson and Meinnel, 
2003; Frottin et al., 2006; Glueck et al., 2010). Protein myristoylation is known to play a role in 
several biological functions such as protein structure, stability and membrane interactions. 
Myristoylated viral proteins include HIV-1 Nef (Matsubara et al., 2005), p14 FAST (fusion 
associated small transmembrane) protein of reptilian reovirus (Corcoran et al., 2004), µ1 of 
reoviruses (Odegard et al., 2004).  
Although the addition of the myristate group is a lipid anchor modification that is likely to 
direct proteins to the membrane, a myristate group alone does not always provide enough 
binding strength to keep the protein anchored to the membrane. Other factors including 
electrostatic interactions of basic residues with acidic phospholipids can also contribute to the  
anchorage of proteins to membranes (Murray et al., 1998; Yalovsky et al., 1999).   
A precursor protein of several non-enveloped viruses undergoes cleavage to generate a 
hydrophobic peptide. At the early infection stage, the virus particles undergo conformational 
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changes in response to cellular triggers such as receptor binding, pH or binding to specific lipid 
components. This results in the release of the lipophilic peptide which ultimately induces 
membrane permeability. These peptides are often short, hydrophobic and myristoylated at the 
N-terminus. Myristoylated proteins of non-enveloped viruses include reovirus µ1 and 
picornavirus VP4 (section 1.6.3). Therefore, cleavage and release or exposure of membrane 
binding peptides bearing fatty acid modifications such as myristoylation appear to be a 
conserved feature shared by non-enveloped viruses. This suggests the relevance of 
myristoylation in the induction of membrane permeability by non-enveloped viruses. 
Triggers for conformational changes in rhinoviruses 
For cell entry of rhinoviruses, receptor binding and/or pH may serve as the trigger for entry. 
For minor group rhinoviruses such as HRV2, low density lipoprotein (LDL) receptors are used to 
gain cell entry but exposure to low pH is an essential trigger for irreversible structural changes 
necessary for the transfer of the genome into the cytoplasm for replication (Prchla et al., 
1994). For major group rhinoviruses, dependence on pH varies from partial to complete (Bayer 
et al., 1999; Nurani et al., 2003; Schober et al., 1998). HRV infection of HeLa cells treated with 
bafilomycin (inhibitor of vacuolar-type H+ATPase that raises the endosomal pH to neutral) 
showed receptor bound HRV16 required a low pH5.5-6.0 environment to uncoat whereas 
HRV3 uncoated even at pH7.0 (Nurani et al., 2003) (section 1.6.4.1).  
 
Effect of membrane composition on viral membrane protein function 
Phospholipids are the fundamental building blocks of cell membranes. They spontaneously 
form bilayers in aqueous solutions due to the fatty acid tails which are hydrophobic. Their 
polar head groups are hydrophilic and are therefore in contact with water. Lipid composition 
varies between membranes of cellular compartments. The structures and properties of some 
of the lipid components of membranes are shown in Table 4.1. Early endosomes have a 
membrane composition similar to plasma membranes with a high percentage of cholesterol. 
Upon maturation to late endosomes, the lipid composition is modified as there is a decrease in 
cholesterol and an increase in bis(monoacylglycero)phosphate (BMP) (van Meer et al., 2008). 
Cholesterol is required for a number of important biological processes such as signal 
transduction (Maxfield and Wustner, 2002) and regulation of membrane fluidity over a range 
of temperatures. The fluidity of membranes is known to be reduced in membranes enriched 
with cholesterol (Bastiaanse et al., 1997). This reduction in fluidity is because the rigid 
hydrocarbon rings of cholesterol interact with the fatty acid chains of the lipid components of 
the membrane. On the other hand, the presence of cholesterol in the membrane prevents 
tight packing of interactions between fatty acid chains, thereby making membranes fluid at 
lower temperatures. The cholesterol content in plasma membranes is higher than in 
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subcellular membranes. The interaction of cholesterol with other lipids and proteins present in 
the membrane may influence functions of transmembrane proteins.  
The lipid composition of membranes has been reported to influence the activity of non-
enveloped viral membrane proteins. Echovirus 1 infection was demonstrated to be dependent 
on cholesterol (Siljamaki et al., 2013). Poliovirus entry has also been shown to be dependent 
upon cholesterol (Danthi and Chow, 2004). Flock house virus γ1 peptide is lipophilic with 
membrane permeabilising activity and speculated to play a role in the transmembrane passage 
of viral RNA. γ1 peptide showed preference for membranes with negatively charged 
headgroups, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG) over membranes with 
zwitterionic lipids, 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) (Bong et al., 
2000). A decrease in dye release induced by γ1 peptide was observed from liposomes enriched 
in cholesterol (Maia et al., 2006).  
In addition to non-enveloped viruses, lipid composition has been reported to influence activity 
of membrane proteins of enveloped viruses. For instance, HIV-1 group specific antigen (Gag) 
membrane interactions were reported to be influenced by the phospholipid head groups, 
cholesterol content and acyl chain unsaturation (Dick et al., 2012). E1 of alphaviruses such as 
Chikungunya virus, Semliki Forest virus and Sindbis virus fuses with the endosomal membrane 
during viral entry and this is a cholesterol dependent process (as reviewed in Leung et al., 
2011). Dengue fusion occurs only in the late endosome by using anionic lipids like BMP, a lipid 
specific to the late endosome, as a trigger for fusion of the viral membrane with late 
endosome membrane (Zaitseva et al., 2010). Therefore, membrane protein function is 
dependent on membrane composition. 
In this study two types of recombinant VP4His were used: myristoylated VP4His (VP4His) and 
unmyristoylated VP4His (ΔVP4His). The generation of VP4His and ΔVP4His is described in 
chapter 3. This chapter describes membrane permeability induced by recombinant VP4 and 
characterises the effect of VP4 concentration, myristoylation, pH, temperature and membrane 
composition on the induction of membrane permeability. 
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Table 4.1 Membrane lipids and their structures. www.avantilipids.com 
Lipid Name Structure of predominant lipid species 
L-α-phosphatidylcholine (PC)  
 
L-α-phosphatidylethanolamine 
(PE) 
 
 
 
 
L-α-phosphatidic acid (PA)  
 
L-α-phosphatidylinositol (PI) 
 
 
 
bis(monooleoylglycero)phosphate 
(BMP) 
 
 
L-α-Phosphatidylethanolamine-N-
(lissamine rhodamine B sulfonyl) 
(Rhod-PE) 
 
 
Sphingomyelin (SM) 
 
Cholesterol 
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4.2 Characterisation of VP4-induced membrane permeability 
4.2.1 Recombinant VP4 induces membrane permeability in liposomes 
VP4 has been shown to partition into membranes and implicated to play a role in facilitating 
the delivery of the genome into the cytoplasm (section 4.1). Given this proposed role of VP4 in 
cell entry, VP4His was expected to interact with and permeabilise model membranes.  
GST-tagged HRV VP4 has been shown to induce membrane permeability in liposomes without 
membrane disruption (Davis et al., 2008). GST is a large fusion partner (26 kDa) which may 
influence the activity of VP4. Therefore, recombinant forms of VP4 that more closely mimicked 
native VP4, e.g. VP4 with smaller C-terminal tags (e.g. VP4His) were generated (section 3.3).  
Lipids were dried, rehydrated in the presence of CF dye and extruded to form liposomes. 
Liposomes containing CF were purified away from unencapsulated CF by serial pelleting and 
washing (section 2.22). When liposomes containing self-quenching fluorescent dyes such as CF 
became permeabilised, CF was released and became unquenched (section 2.23) (Figure 4.1A). 
The fluorescence was measured at λex485nm /λem520nm.  
The membrane permeability assay using liposomes (section 2.23) is a well established 
approach that has been widely used to study the induction of membrane permeability by a 
range of different peptides (section 4.1). The real-time nature of the assay enables 
measurement of induced membrane permeability. Membrane permeability induced by 
recombinant VP4 was investigated using this membrane permeability assay.   
VP4His and ΔVP4His were expressed in E. coli and purified (section 3.3) to investigate the 
mechanism of induction of membrane permeability in liposomes. Myristoylated VP4His 
(VP4His) has been used in this chapter to describe the induction of membrane permeability. 
Release of CF contained within liposomes was observed upon addition of VP4His to the 
membrane permeability assay. An increase in membrane permeability showed a concomitant 
increase in the release of CF from within liposomes. This was depicted by the increase in 
relative fluorescence units. This finding demonstrated the functional ability of VP4His to 
induce membrane permeability. Addition of Triton X-100 to the membrane permeability assay 
resulted in abrupt and complete CF release as a consequence of lysis of liposome membranes. 
In contrast, the model pore-forming peptide, melittin, induced controlled CF release from 
within liposomes. VP4His mediated CF release was  similar to that obtained with melittin 
(Figure 4.1). This finding suggested that VP4-induced membrane permeability involved a 
mechanism which did not disrupt liposome membranes. 
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Figure 4.1 HRV VP4His-mediated membrane permeability.  
A. Liposomes containing self-quenching carboxyfluorescein (CF) dye. B. VP4His and liposome 
assay controls (DMSO, melittin and Triton X-100) were incubated with liposomes containing 
CF. Released CF dye became unquenched and was measured by fluorimetry (λex 485 nm  λem 
520 nm). Dye release was monitored in real-time with readings recorded every 30 seconds for 
1 hr. Liposomes only, liposomes with solvent (5 % v/v DMSO), 10 µM melittin, Triton X-100 (5 
% v/v), 5 µM VP4His were used to assess the induction of membrane permeability. Background 
levels of CF release were generated by liposomes only and liposomes with DMSO. 
 
PV VP4His was purified using the same purification method as used for HRV VP4His (described 
in chapter 3). To rule out the effect of negligible contaminants, bacterial lysate was used as a 
control sample. Upon incubating PV VP4His with liposomes, CF release observedwas similar to 
that observed with HRV VP4His (Figure 4.2). 
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Figure 4.2 PV VP4His-mediated membrane permeability.  
PV VP4His and liposome assay controls (bacterial lysate) were incubated with liposomes 
containing CF. Released CF dye became unquenched and was measured by fluorimetry (λex 
485nm  λem 520nm). Dye release was monitored in real-time with readings recorded every 30 
seconds for 1 hour. Liposomes only, bacterial cell lysate (5 % v/v) and 5 µM VP4His were used 
to assess the induction of membrane permeability. Background levels of CF release were 
generated by liposomes only and liposomes with bacterial cell lysate. Data shown here is 
representative of n=2 experiments. 
 
Following the observation of VP4-induced membrane permeability in liposomes (Figures 4.1 
and 4.2), the next step was to demonstrate the association of VP4 with liposome membranes. 
To achieve this, ficoll liposome floatation assays were carried out (section 2.26). Since VP4-
induced membrane permeability was demonstrated by CF release, it seemed reasonable to 
assume that VP4 was associating with membranes. VP4, was therefore, expected to localise 
with liposomes that floated to the top (or membrane interface) of the ficoll gradient (Figure 
4.3A). Liposomes were made fluorescent by including lissamine rhodamine B-labeled 
phosphatidylethanolamine lipid in their generation. Ficoll gradients were fractionated from the 
top and liposomes detected by measuring rhodamine fluorescence (λex 544 nm/λem 590 nm) 
(Figure 4.3B). Eleven fractions of 200 µl each were collected and the pellet resuspended in SDS 
sample loading buffer. Upon analysis by SDS-PAGE and western blot (section 2.3.5), VP4His 
was detected in the pellet but not in the membrane fractions (Figure 4.3C). Therefore, it was 
possible that only a proportion of VP4His associated with liposome membranes and was below 
the detection limit of western blot. The minority of VP4His molecules integrated into 
liposomes, therefore appeared to be sufficient to induce membrane permeability.  
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Figure 4.3 Association of VP4His with liposome membranes.  
VP4His was incubated with liposomes for 30 min prior to layering on a 20 % ficoll 
discontinuous gradient layered over it. A. Pictorial representation of the ficoll liposome 
floatation assay. B. Gradient fractions (top to bottom) were collected post 
ultracentrifugation and liposome distribution detected by rhodamine fluorescence 
measured at (ʎex520 nm /ʎem570 nm). C. Samples from each fraction (top to bottom) 
were separated by SDS-PAGE and VP4His was detected by anti-VP4C-terminus specific 
western blot. The size of molecular weight markers (kDa) is indicated to the left of the image.  
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4.2.2 VP4 mediates concentration-dependent release of carboxyfluorescein from 
liposomes 
A range of concentrations of VP4His were used in the membrane permeability assay, in order 
to determine if VP4His induced membrane permeability in a dose-dependent manner and 
whether this was related to the increase in the extent and rate of CF release from liposomes. 
Viral membrane proteins such as HCV p7 (StGelais et al., 2007) and HPV E5 (Wetherill et al., 
2012) have been shown to induce concentration-dependent CF release from liposomes. Upon 
addition of VP4His, membrane permeability was induced and CF release measured by 
fluorimetry (λex 485 nm λem 520 nm) (section 2.23). To determine if the nature of CF release 
was concentration-dependent, increasing concentrations of VP4His (0.3 – 5 µM) were 
incubated with CF-containing liposomes. For all the concentrations tested, membrane 
permeability was observed and an increase in VP4His concentration showed an increase in the 
observed fluorescence signal. Therefore, with increasing concentration, the rate and extent of 
permeability increased (Figure 4.4). Maximum membrane permeability observed with 2.5 µM 
VP4His, at which point, no further significant increase in CF release was observed with increase 
in VP4His concentration (e.g. 5 µM).  
 
 
 
Figure 4.4 VP4His-induced concentration-dependent CF release from liposomes.  
Increasing concentrations of VP4His were incubated with liposomes and CF release was 
measured by fluorimetry (λex 485 nm λem 520 nm) and monitored in real-time. Background 
levels of CF release were generated by liposomes only.  
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4.2.3 Induction of membrane permeability by VP4 is enhanced by myristoylation and 
acidic pH conditions 
N-terminally myristoylated capsid proteins of non-enveloped viruses such as VP4 of 
picornaviruses and µ1 of reoviruses, are thought to interact with membranes to facilitate 
delivery of viral genetic material into the cytoplasm (section 1.6.3). To investigate the influence 
of myristoylation on the ability of VP4 to induce membrane permeability, myristoylated and 
unmyristoylated forms of VP4His were made. Recombinant VP4His was normally made by co-
expressing VP4His with NMT to make myrisotylated VP4His (VP4His). In order to make 
unmyristoylated VP4His (ΔVP4His), VP4His was expressed in the absence of NMT (section 3.3).  
VP4His or ΔVP4His were incubated with liposomes and analysed using the membrane 
permeability assay (section 2.23). VP4His-induced more extensive CF release as compared to 
ΔVP4His  (Figure 4.5).  
 
 
Figure 4.5 Membrane permeability induced by myristoylated and unmyristoylated VP4.  
VP4His and ΔVP4His were incubated with liposomes. CF release was measured by fluorimetry 
(λex 485 nm λem 520 nm) and monitored in real-time. Background levels of CF release were 
generated by liposomes only. 
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HRVs vary in their dependence on pH to trigger conformational changes. Major group HRV16 
shows an absolute dependence on low pH as do minor group human rhinoviruses such as 
HRV2. In contrast, major group rhinovirus HRV3 is not strictly pH dependent and receptor 
binding is sufficient to trigger conformational changes for the release of RNA (section 1.6.4.2). 
The effect of pH on VP4 function of inducing membrane permeability was studied for two main 
reasons: 
1. There is existing evidence for the requirement of acidic conditions of pH5.5-6.0 for efficient 
uncoating of receptor primed HRV16 (Nurani et al., 2003). Whether a particular pH is required 
only for virus uncoating or if VP4 has evolved to require that pH for optimal membrane 
permeabilising activity, requires investigation. 
2. VP4 possesses ionisable residues (Rx2, Hx1, Kx5, Dx4, Ex2). Due to the lack of structural 
information on membrane associated VP4, the location of these residues in a potential VP4 
membrane complex is unknown. Ionisable residues are known to be stably inserted in the 
membrane and affect TM packing in membranes (Bano-Polo et al., 2012). Therefore, the effect 
of pH on ionisable residues may influence shape, orientation, proportion and distribution of 
positive and negative charges, thereby affecting VP4 structure and function.  
To investigate the effect of decreasing pH on the ability of VP4 to induce membrane 
permeability, liposomes were diluted to 50 µM lipid content in buffers of varying pH (pH5.5, 
6.5, 7.0) in the membrane permeability assay (section 2.23). However, when studies on the 
effect of pH on VP4 function were initiated, problems with CF fluorescence quenching were 
encountered. These are described and shown in Figures 4.6 and 4.7.  
To confirm the effect of pH on CF fluorescence in the membrane permeability assay, liposomes 
were diluted to 50 µM lipid content in buffers at pH5.5-7.5. Triton X-100 was added to the 
liposomes and caused membrane disruption at all pH conditions tested. This resulted in the 
complete release of CF. CF fluorescence was recovered by the addition of 1 M Tris pH7.5, 
demonstrating that CF fluorescence was quenched by acidic pH (Figure 4.6). Quenching of CF 
fluorescence by acidic pH prevented the comparison of real-time CF release induced by VP4 at 
neutral and acidic pH. 
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Figure 4.6 CF fluorescence before and after neutralisation of pH.  
Triton X-100 (5 % v/v) was added to liposomes at pH5.5, 6.5, 7.0 and 7.5. Membrane disruption 
resulted in the expected complete release of CF at all pH conditions tested. CF fluorescence 
quenched by low pH (before neutralisation) was recovered by addition of 1 M Tris pH7.5 (after 
neutralisation).  
 
For the comparison of end point data collected at different pH values, the end point samples 
were normalised for pH by separating released fluorescence from liposomes and adjusting to 
the same Triton X-100 and pH conditions as the Triton X-100 released control. However, for 
the comparison of real-time dye-release at different pH values the membrane permeability 
data collected had to be normalised differently and is explained below. 
In contrast to the pH sensitive pore-forming peptide GALA, melittin (which is a pH independent 
pore-forming peptide) induced membrane permeability at all pH conditions tested. The 
fluorescence was reduced at acidic pH compared to that obtained at pH7.0 (Figure 4.7). 
Therefore, the combination of pH and Triton X-100 had a severe effect on fluorescence. When 
melittin-induced released fluorescence was separated from liposomes and adjusted to neutral 
pH, the signal obtained at all pH values was equivalent to the values observe at pH7.0.  This 
confirmed the pH independent induction of membrane permeability by melittin. Thus, dye 
release data obtained at different pH values was normalised to maximum release by a melittin 
control at that same pH.  
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Figure 4.7 Effect of pH and Triton X-100 on CF fluorescence.  
Triton X-100 (5 % v/v), Melittin (10 µM) and GALA (1 µM) added to liposomes at pH 5.5, 6.5, 
7.0. GALA mediated CF release from liposomes at pH 5.5. Melittin mediated CF release from 
liposomes at all pH conditions tested. Triton X-100 caused complete CF release at all pH 
conditions tested. Acidic pH quenched CF fluorescence. 
 
Having identified and resolved the problems with quenching of fluorescence, studies to 
investigate the effect of pH on VP4 function were undertaken.  
The site of HRV16 uncoating is currently unknown. Other major group rhinoviruses such as 
HRV14 are known to uncoat in the early endosome (Bayer et al., 1999). Therefore, it is possible 
that HRV16 may also uncoat in the early endosome. However, existing studies have 
demonstrated the requirement of pH5.5-6.0 for HRV16 uncoating (Nurani et al., 2003), which 
is likely to be in the late endosome. Studies to investigate the effect of pH on VP4 
permeabilising activity were carried out to determine the optimal pH for VP4 function and, 
therefore, an indication of the cellular compartment for HRV16 uncoating (release of VP4).  
The pH range of 5.5-7.0 was used to mimic the pH conditions likely to be encountered by 
HRV16 during the cell entry process. The pH of early endosome is predicted to be between pH 
5.9 and 6.8 and that of late endosomes pH 4.9 and 6.0 (Maxfield and Yamashiro, 1987). VP4His 
or ΔVP4His (5 µM) was added to liposomes at pH5.5, 6.5 or 7.0 and membrane permeability 
analysed. GALA (1 µM) was used as a positive control for pH as it is known to induce 
membrane permeability at pH<6.0 (Figure 4.8A). Both, VP4His and ΔVP4His-induced 
membrane permeability at all pH conditions tested. However, the real-time dye release data 
showed membrane permeability mediated by VP4His was more extensive than that by 
ΔVP4His. Also, a decrease in pH highlighted an increase in the extent of membrane 
permeability induced by VP4His and ΔVP4His (Figure 4.8C, D). Additionally, the presence of 
myristoylation and pH5.5 were shown to be associated with faster initial rates of release 
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(Figure 4.8F). The above results were summarised as end point fluorescence measurements. 
Each data point was normalised to end point CF release obtained with 10 µM melittin 
measured at the corresponding pH representative of three experiments. Melittin and GALA 
were used as positive controls for induction of pH independent and pH dependent membrane 
permeability, respectively (Figure 4.8A, B). Taken together, both myristoylation and acidic pH 
conditions were required for the optimal induction of membrane permeability by VP4. 
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Figure 4.8 Effect of pH and myristoylation on VP4-induced membrane permeability.                  
A. GALA. B. Melittin. C. VP4His. D. ΔVP4His added to liposomes at pH5.5, 6.5 and 7.0. CF 
release was measured by fluorimetry (λex 485 nm λem 520 nm) and monitored in real-time. 
Background levels of CF release were generated by liposomes only and the average CF read 
subtracted from each data point of GALA, mellitin, VP4His and ΔVP4His mediated CF release. E. 
End point reads of membrane permeability induced by VP4His, ΔVP4His and the controls 
melittin and GALA at pH5.5, 6.5 and 7.0. F. Relative initial rates of release for VP4His and 
ΔVP4His at pH5.5, 6.5 and 7.0 as calculated by fitting a straight line to the initial four data 
points of the real-time CF release measured at λex 485 nm λem 520 nm (experiments n=3). 
Error bars represent standard deviation of the mean. Statistical significance of difference of 
membrane permeability induced at different pHs were assessed by one way Anova (p*<0.05).  
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4.2.4 Membrane permeability induced by VP4 is influenced by membrane composition 
In addition to pH, membrane composition provides cellular compartmentalisation for the 
uncoating process. Membranes of cellular compartments differ in their lipid composition (van 
Meer et al., 2008). Cholesterol is a prominent component of membranes which regulates 
membrane rigidity (section 4.1). As an initial step to study the role of membrane lipid 
composition in VP4 function, the effect of cholesterol on the ability of VP4His to induce 
membrane permeability was investigated. Liposomes with or without cholesterol were 
generated (section 2.22), VP4His or ΔVP4His added and membrane permeability analysed 
(section 2.23). VP4His and ΔVP4His induced membrane permeability in both types of 
liposomes, with more extensive permeability in liposomes devoid of cholesterol (Figure 4.9).  
 
Figure 4.9 Effect of cholesterol on VP4His-induced membrane permeability.   
A. VP4His or B. ΔVP4His added to liposomes with or without cholesterol. CF release was 
measured by fluorimetry (λex 485 nm/λem 520 nm) and monitored in real-time. 
Background levels of CF release were generated by liposomes only. 
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As mentioned previously, the cellular compartment for HRV16 uncoating has not been 
identified. HRV16 may uncoat in the early endosome like other major group HRVs. However, 
the findings observed in Figure 4.8 showed requirement of low pH for optimal VP4 function. 
This combined with existing studies for the requirement of low pH for HRV16 uncoating 
(Nurani et al., 2003), suggested the possibility of HRV16 uncoating in the late endosome. 
Therefore, the effect of pH formed part of the rationale for looking at different compositions 
of the endocytic pathway. 
Early endosomes and late endosomes are composed of different proportion and types of lipids 
e.g. early endosomes are comprised of PC, PE, SM and cholesterol whereas late endosomes 
are comprised of PC, PE, cholesterol, PI and BMP (Figure 4.10). In order to compare the effect 
of membrane composition on VP4-induced membrane permeability, liposomes mimicking the 
composition of early endosomes (referred to as EE) and late endosomes (referred to as LE) 
were generated (section 2.22). This comparison would provide fundamental insight by 
identifying key lipid components likely to influence mechanism of VP4-induced membrane 
permeability.  
 
Figure 4.10 Membrane composition of liposomes.  
Proportion of different lipids in A. Standard liposomes. B. Liposomes mimicking early 
endosomes. C. Liposomes mimicking late endosomes. PC: dark blue, PE: red, PI: light green, 
BMP: yellow, cholesterol: purple, PA: dark green, SM: light blue. 
 
Addition of VP4His to standard liposomes or LE showed CF release with characteristics similar 
to what had been observed with membrane pore forming peptides, such as GALA and melittin 
in Figure 4.8A, B. In contrast, a clear difference in the nature of CF released from EE and LE was 
observed (Figure 4.11). VP4His induced abrupt and complete release of CF from EE. This was 
characteristic of previously observed CF release obtained with Triton X-100 from standard 
liposomes, as shown in Figure 4.1.  
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Figure 4.11 VP4His-induced membrane permeability in liposomes mimicking composition of 
early or late endosomes. 
VP4His added to standard liposomes or EE or LE. CF release measured by fluorimetry (λex 485 
nm λem 520 nm) and monitored in real-time. Background levels of CF release were generated 
by liposomes only. Background levels have been subtracted for clarity. 
 
If membrane composition of early endosomes was more susceptible to permeabilisation by 
VP4His, it was possible that a vast excess of VP4His was being used in the membrane 
permeability assay, resulting in the abrupt and complete release of CF from EE. To determine if 
this was the case, a twofold dilution of VP4His was carried out. VP4His (5 µM or 2.5 µM) was 
added to standard liposomes, EE or LE and membrane permeability analysed. Real-time CF 
release showed that with a decrease in concentration of VP4His, a decrease in the extent of 
permeability induced was observed in all three types of liposomes (Figure 4.12). This was in 
agreement with previously observed dose-dependent induction of membrane permeability 
observed in Figure 4.4. In EE, VP4His appeared to induce either abrupt and complete or no 
membrane permeability (Figure 4.12B). The membrane permeability observed in EE, confirmed 
that the observed abrupt and complete CF release was not due to using excessive 
concentrations of VP4. 
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Figure 4.12 Effect of membrane composition on VP4-induced membrane permeability.    
Two concentrations of myristoylated VP4His (VP4His) and unmyristoylated VP4His (ΔVP4His) 
were incubated with A. Standard liposomes or B. Liposomes mimicking the composition of 
early endosomes (EE) or C. Liposomes mimicking the composition of late endosomes (LE). CF 
release was monitored in real-time and measured by fluorimetry (λex 485 nm λem 520 nm). 
Background levels of CF release were generated by liposomes only.   
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The observed difference in VP4-mediated membrane permeability induced in EE or LE (Figure 
4.12B and C), led to the investigation of specific lipids influencing VP4-mediated membrane 
permeability. As a starting point, cholesterol and sphingomyelin membrane components of EE 
were investigated. EE were generated without cholesterol (referred to as EE-chol) or without 
sphingomelin (referred to as EE-SM). Upon addition of VP4His to EE-Chol, membrane 
permeability was induced with CF release similar to that observed with standard liposomes 
(Figure 4.13A, C). On the other hand, upon addition of VP4His to EE-SM, membrane 
permeability was induced with CF release similar to that observed with EE.  Membrane 
permeability induced by VP4His in EE-SM was abrupt and complete (Figure 4.13B, D). 
Therefore, these findings suggested that the presence of high percentage cholesterol in EE 
probably resulted in the observed abrupt and complete release of CF.   
 
Figure 4.13 Effect of sphingomyelin and cholesterol in early endosome membrane 
composition on VP4-induced membrane permeability.  
Myristoylated VP4His (VP4His) was incubated with A. Standard liposomes. B. Liposomes 
mimicking the composition of early endosomes (EE). C. EE without cholesterol (EE-chol). D. EE 
without sphingomyelin (EE-SM). VP4His-mediated CF release was monitored in real-time and 
measured by fluorimetry (λex 485 nm λem 520 nm). Background levels of CF release were 
generated by liposomes, EE, EE-chol or EE-SM only.  
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4.2.5 VP4His-induced membrane permeability is not temperature dependent 
Receptor mediated HRV16 uncoating has been demonstrated to occur efficiently at 
temperatures  above 30°C (Casasnovas and Springer, 1994; Hooverlitty and Greve, 1993). The 
internal capsid protein VP4 and the N-terminus of VP1 become exposed when the capsids of 
picornaviruses including PV and HRV14 breathe at physiological temperature (Fricks and Hogle, 
1990; Lewis et al., 1998). HRV16 uncoating was shown to be both temperature and pH 
dependent. When HRV16 was bound to its receptor ICAM-1 at 20°C, uncoating was prevented 
even after the virus-receptor complex was exposed to low pH and higher temperatures (Nurani 
et al., 2003). 
The temperature required to induce a change in the physical state of the lipid from an ordered 
gel phase to a disordered fluid phase is referred to as the phase transition temperature. In the 
gel phase the lipid hydrocarbon chains are tightly packed whereas in the fluid phase the 
hydrocarbon chains are randomly oriented and lipids can diffuse freely inside the lipid bilayer.  
The transition temperature of lipid components in standard liposomes was estimated to be 
above the temperatures used in the experiments (25°C and 37°C). Therefore, membrane 
fluidity was not expected to be significantly affected at 25°C or 37°C. 
Towards determining if HRV16 induced more extensive membrane permeability at 
physiological temperature than at room temperature, HRV16 was incubated with liposomes at 
37°C or 25°C.  At 37°C, HRV16 induced membrane permeability to a greater extent and with a 
faster initial rate of release than that induced by HRV16 at 25°C (Figure 4.14A). To investigate if 
VP4His membrane activity was influenced by temperature, VP4His was added to liposomes 
and membrane permeability assay carried out at 25°C or 37°C (section 2.23). Liposomes used 
for studying membrane permeability induced at 37°C were pre-warmed at 37°C. The nature 
and extent of membrane permeability induced by VP4His at 25°C and 37°C were similar(Figure 
4.14B).  
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Figure 4.14 Effect of temperature on HRV and VP4His-induced membrane permeability.  
A. HRV16 or B. VP4His was incubated with liposomes at 25°C or 37°C. Released CF was 
measured by fluorimetry (λex 485 nm λem 520 nm) and kinetics monitored in real-time. 
Background levels of CF release were generated by liposomes only. For clarity, liposomes only 
baseline has been subtracted from CF fluorescence measurements obtained from HRV16 and 
VP4His-mediated CF release at 25°C and 37°C. Data shown here is representative of multiple 
experiments (n=3). 
 
4.3 Discussion and future work 
Picornavirus VP4 has been implicated to play a role in the cell entry process (section 4.1). 
However, the mechanism for VP4-induced membrane permeability remains to be defined. In 
this chapter, membrane permeability mediated by recombinant VP4 in model membranes was 
demonstrated and conditions influencing membrane permeability were characterised. VP4His 
and ΔVP4His-mediated membrane permeability were broadly similar to that observed with the 
model membrane pore forming peptide, melittin. VP4His-induced permeability was dependent 
on membrane composition but independent of temperature. VP4His and ΔVP4His activity was 
shown to be dose-dependent and enhanced at acidic pH. Additionally, the presence of 
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myristoylation increased the extent of induced membrane permeability relative to 
unmyristoylated VP4.  
VP4 is released from the virus and is known to partition into cellular membranes during 
infection (section 1.6.4.4) and recombinant VP4 (VP4His and ΔVP4His) was observed to induce 
permeability in model membranes (Figure 4.5). It was, therefore, reasonable to assume 
association or binding of VP4His with liposome membranes. Indeed, GST-tagged VP4 had 
previously been demonstrated to associate with liposome membranes (Davis et al., 2008). In 
order to demonstrate a membrane association with VP4His, liposome floatation assays were 
carried out. Based on the analysis of ficoll gradient fractions by western blot, VP4His was not 
detected in membrane fractions but was clearly detected in the pellet (Figure 4.3C). This may 
indicate that only a small proportion of VP4 was integrating into membranes and was below 
the detection limits of subsequent western blot. One possible explanation for the observation 
of GST-tagged VP4 in liposome membranes but not that of VP4His is that GST-tagged VP4 may 
be less efficient at inducing membrane permeability than VP4His and, therefore, a greater 
number of GST-tagged VP4 molecules may be required for the induction of membrane 
permeability. This concentration of GST-tagged VP4 associated with liposome membranes 
could be detected by western blot. GST-tagged VP4 was a soluble form of VP4 whereas VP4His 
was largely insoluble and majority observed in the pellet. It was possible that majority of 
VP4His did not participate in the induction of membrane permeability. Therefore, VP4His may 
be more efficient at inducing membrane permeability and the number of VP4His molecules 
integrated with liposome membranes was below the detection limit of western blot.  
VP4His membrane permeability and lipid floatation assays used 8-80 times more protein than 
that used in similar membrane permeability and liposome floatation studies using GST-tagged 
VP4 reported by Davis et al., 2008. Although a higher amount of VP4His was used, VP4His was 
largely insoluble, and it was likely that only a small proportion of VP4His participated to form 
functional membrane pores.  
When virus VP4 is released in the absence of membrane it appears to precipitate, as shown by 
the cpm in the pellet when pre-heated HRV was purified on a sucrose gradient (section 3.5). 
However, when VP4 is released in the presence of membranes, VP4 partitions into 
membranes. Thus, during infection the virus capsid is likely to be held close to the membrane, 
possibly by the N-terminus of VP1, and this proximity to membrane would facilitate the 
released VP4 to insert directly into the membrane and induce membrane permeability. We are 
aware that the model system described here, does not entirely mimic HRV entry as VP4His is in 
DMSO which is then added to liposomes.  
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Two other scenarios could explain the clear observation of VP4His in the pellet and not in 
association with liposome membranes. The first possible scenario is that VP4 had inserted and 
permeabilised membranes, following which VP4 detached from membranes and was detected 
in the pellet. However, this was an unlikely event as it would be energetically unfavourable for 
a viral protein to insert into membrane and then disengage from it. The second possible 
scenario is that VP4 molecules inserted into membranes but not all of them multimerised to 
form a functional VP4-membrane pore. This proportion of VP4 which does not participate in 
forming the pore may have detached from membranes and as a result observed in the 
insoluble pellet.   
As outlined below, VP4His : liposomes ratio was calculated to determine the number of VP4His 
molecules in the reaction.  
Surface area of liposomes = 4πr2 
         = 4 x 22 / 7 x (200)2 
         = 502655 nm2 
Approximate surface area per lipid head group = 0.7 nm2  
Lipid in one layer of liposome = 502655 / 0.7  
    = 718079  
Therefore, lipid per liposome = 2 x 718079 
    = 1436157 
 
Lipid concentration per liposome = 50 µM 
         = 50 x 10 -6 moles/ litre 
Lipid content in reaction        = 5 x 10-9 moles / 100 µl  
Number of liposomes in 100 µl       = 5 x 10-9 x 6 x 1023 (Avogadro’s number) / 1436157 
            = 2.08 x 109  
1 M of VP4His = 8000 g/L  
Therefore, 5 µl of VP4His at a typical concentration of 0.8 mg/ml in 100 µl reaction is 
approximately 5 µM 
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Number of VP4 molecules in 100 µl = 5.0 x 10-10 x 6 x 1023 (Avogadro’s number) 
            = 3 x 1014  
 
Therefore, VP4His : liposome = 3 x 1014 : 2.08 x 109 
           = ~ 145, 000 : 1 
It was not possible to estimate the proportion of input VP4His molecules associated with 
liposome membranes as VP4His could not be detected in the fractions of the liposome 
floatation assay by anti VP4 C-terminus western blot (Figure 4.3). In addition, only a small 
proportion of these inserted VP4His molecules may be involved in forming functional 
membrane pores. Therefore, only a fraction of 145,000 VP4 molecules would be involved in 
the formation of the VP4-membrane pore complex. The VP4His:liposome ratio required for 
membrane permeabilisation could not be determined. Despite the difficulties with quantifying 
and determining the proportion of VP4His that was associated with membranes, our model 
system using VP4His was valid for investigating VP4 because functional consequences of 
different assay conditions were readily detectable.  
Unsurprisingly, initial rate and extent of release induced by VP4His were dependent upon the 
concentration of VP4His added to the liposomes in the membrane permeability assay (Figure 
4.4). Similar findings of dose-dependent activity have been made with other membrane 
proteins such as GALA (Kuehne and Murphy, 2001). 
In order to determine if myristoylation influenced the induction of membrane permeability by 
VP4, myristoylated (VP4His) and unmyristoylated (ΔVP4His) forms of VP4 were expressed and 
used in membrane permeability assays. Our findings showed that myristoylation was not 
essential for the induction of membrane permeability by recombinant VP4. However, 
myristoylation contributed to faster and more extensive induction of membrane permeability 
(section 4.2.3). These findings with VP4His are consistent with previously reported 
observations with myristoylated and unmyritoylated GST-tagged HRV VP4. Both forms of GST-
tagged VP4 induced membrane permeability, however, myristoylated form of the protein 
induced more extensive membrane permeability compared to its unmyristoylated form (Davis 
et al., 2008). The increase in membrane permeability observed with VP4His (Figure 4.5), was 
not unexpected as the myristate group constitutes a signal for incorporation into membranes 
and has been noted to be one of the common features of non-enveloped virus penetration 
proteins (Chandran et al., 2002; Corcoran et al., 2004). The myristate group has been shown to 
be sufficient for membrane binding by a chimeric protein comprised of the first nine amino 
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acids from the N-terminus of PV VP4 fused to GFP. The nine amino acids conferred N-terminal 
myristoylation and membrane binding to the GFP chimera (Martin-Belmonte et al., 2000). 
Alternatively, reports have shown the myristate group alone cannot confer membrane 
attachment and the cooperation of other factors such as clusters of basic residues to facilitate 
interactions with headgroups of anionic lipids is required (Murray et al., 1998) and (as 
reviewed in Yalovsky et al., 1999). The hydrophobicity of VP4 is not sufficient for it to be 
expected to target membranes (Grand average of hydropathicity scores HRV VP4 is -0.16, 
hepatitis C virus p7 is 1.2, GALA is 0.77, melittin is 0.3 http://web.expasy.org/cgi-
bin/protparam/protparam) and does not have a cluster of basic residues. Thus, the factors in 
addition to myristoylation which may contribute to membrane binding of VP4 are unclear. 
Members of the picornavirus family vary in their dependence on receptor binding and pH for 
the initiation of conformational changes in their capsids necessary for the delivery of RNA into 
the cytoplasm. Although HRVs are phylogenetically closely related their pH dependence for 
uncoating is variable. Minor group HRVs like HRV2 have an absolute dependence on low pH for 
uncoating (Brabec et al., 2003) whereas major group human rhinoviruses depend on receptor 
binding and/or low pH. pH dependence of major group rhinoviruses ranges from none to 
complete as was demonstrated by the treatment of cells with bafilomycin and ammonium 
chloride. HRV16 infection of HeLa cells in the presence of bafilomycin inhibited uncoating 
completely whereas HRV3 uncoating was partially reduced (Nurani et al., 2003) and (as 
reviewed in Fuchs and Blaas, 2012). Therefore, the observation of increased induction of 
membrane permeability by VP4His at pH5.5 is in agreement with existing evidence for acidic 
pH requirement for efficient HRV16 uncoating in HeLa cells. Further evidence in support of a 
requirement for acidic pH for HRV16 uncoating is suggested by a study showing that HRV16 
interacts only weakly with ICAM-1 compared with HRV14, as shown by cryo-EM 
reconstructions and functional binding studies (Xiao et al., 2004). This relatively low efficiency 
of HRV16 binding to ICAM-1 may be compensated by greater efficiency at the stage of HRV16 
uncoating at acidic pH in the endosome. The pocket factor present in the crystal structure of 
HRV16 but absent in HRV14 and HRV3 (Hadfield et al., 1999; Rossmann et al., 1985; Zhao et 
al., 1996) may contribute to increased stability of HRV16. These reasons may explain the 
requirement for exposure of the ICAM-1 bound HRV16 complex to low pH to release the 
pocket factor present which decreases virus stability to facilitate conformational changes. It is 
possible that HRV16 uncoats close to pH5.5 which was observed to be the most favourable for 
VP4His-mediated membrane permeability (section 4.2.3).  
It is also possible that VP4 may have evolved to function optimally at pH5.5 to match the 
uncoating environment of HRV16. Future experiments comparing VP4 from picornaviruses 
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dependent on pH for uncoating (e.g. HRV2, FMDV) and others that are pH independent (e.g. 
HRV3, PV) should be carried out to help verify if VP4 has evolved differently in different 
picornaviruses to match their respective uncoating environments or if it is an artefact of the 
assay that favours low pH for optimal VP4 function. A counter argument to VP4 evolving to 
function at a pH optimal for HRV uncoating is that of HRV adapting to the pH of the 
environment it is infecting at. For example, major group rhinovirus HRV89 was reported to 
depend on low pH for uncoating when infecting COS-7 cells which lack ICAM-1 expression. As 
suggested in the same report, HRV particles needed to be more unstable when infecting cells 
devoid of ICAM-1 as uncoating could only be achieved by the acidic pH in the endosome 
(Vlasak et al., 2005). The location and nature of mutations rendering the HRV particle less 
stable were not investigated. This may have included a mutation in VP4 that enabled HRV89 
uncoating to match its environment.  
The investigation of the effect of temperature on the induction of membrane permeability by 
HRV16 showed that HRV16 induced more extensive membrane permeability at 37°C than at 
25°C. This was in contrast with VP4His which induced membrane permeability to largely the 
same extent at both 25°C and 37°C (Figure 4.14). The observed increase in induced membrane 
permeability by HRV at 37°C compared to 25°C could be explained by the phenomenon of 
increased capsid breathing at 37°C. Capsid breathing at 37°C resulted in increased exposure of 
VP4 and N-terminus of VP1 compared to 25°C (Katpally et al., 2009; Li et al., 1994). The 
enhanced externalisation of these membrane active peptides likely contributed to the 
increased induced membrane permeability at 37°C. Membrane permeability was induced by 
HRV16 at both 25°C and 37°C (Figure 4.14A) as the capsid also breathes at 25°C, although less 
efficiently. One possible explanation for the observed difference in temperature dependence 
between HRV16 and VP4His could be because uncoating is a stepwise process and 37°C is 
required to maximise capsid breathing, however, 37°C may not be crucial for the membrane 
permeabilising function of VP4. Therefore, temperature dependence was not observed when 
analysing the permeabilising activity of VP4His in liposome membranes.  
Priming of pH independent picornaviruses such as PV by Ig-like receptors may be temperature 
dependent. However, for picornaviruses dependent on low pH for the triggering of 
conformational changes in the capsid may be less dependent on temperature. Although, in this 
study, experiments have not included the use of ICAM-1 decorated liposomes, virus breathing 
and induction of membrane permeability in naked liposomes triggers conformational changes 
akin to those triggered in ICAM-1 bound virus complexes. Membrane permeability was 
induced at physiological temperature by PV native particles and receptor modified “A” 
particles in lipid bilayers devoid of receptors (Tosteson and Chow, 1997). Also, PV and FMDV 
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particles have been shown to interact with naked liposome membranes, resulting in induction 
of permeability and the release of RNA (unpublished work carried out at The Pirbright 
Institute).  
The effect of pH on VP4-induced membrane permeability was carried out at 25°C. A clear 
preference for acidic pH was observed for VP4-mediated membrane permeabilisation at 25°C 
(Figure 4.8). In the future, it would be interesting to see if breathing observed at higher 
temperature is influenced by pH. Studying effects of temperature in combination with pH will 
help determine if lower pH can compensate for lower temperature and induce as efficient 
membrane permeability as that observed at 37°C.  
VP4His and ΔVP4His-induced more extensive permeability in liposomes devoid of cholesterol 
(Figure 4.9) which was unsurprising as cholesterol is known to increase membrane rigidity (see 
section 4.1). Presence of cholesterol in the membrane has been reported to reduce 
permeability induced by peptides such as GALA (Nicol et al., 2000) and viruses such as PV (see 
section 4.1). The difference in the extents of membrane permeability induced by ΔVP4His in 
liposomes with or without cholesterol was much greater than the difference observed with 
VP4His (Figure 4.9). This suggested that VP4His and ΔVP4His could permeabilise both types of 
liposomes, however, the presence of myristate group in VP4 perhaps somehow compensated 
and resulted in a less pronounced difference between extents of permeability induced in 
membranes with or without cholesterol.  
Upon incubating VP4His with liposome with early endosome composition, complete and 
abrupt membrane permeability was induced. In contrast, VP4His-induced membrane 
permeability in liposomes with late endosome composition showed CF release similar to that 
observed with melittin in standard liposomes (Figure 4.12). The difference in the nature of CF 
release may suggest VP4His employs a different mechanism to induce membrane permeability 
in EE and LE. Standard liposomes contained 10 % cholesterol, while LE was 5 % and EE was 45 
%. Since the main difference between EE and LE lipid composition was cholesterol and 
sphingomyelin, these two lipids were investigated as a starting point to determine the effect of 
membrane composition on the mechanism of action of VP4His. Investigation of cholesterol in 
EE showed that VP4His-induced abrupt release of CF from EE containing cholesterol and as 
expected, VP4-induced more extensive permeability in EE not containing cholesterol. 
Membrane permeability induced by VP4His in EE not containing cholesterol was similar to that 
induced by VP4His in standard liposomes. EE with or without sphingomyelin induced similar 
extents of membrane permeability (Figure 4.13). Therefore, this suggested the high 
percentage of cholesterol (45 %) in EE and not sphingomyelin contributed to the abrupt nature 
of membrane permeability induction by VP4His. Other lipid components such as BMP, PI and a 
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range of cholesterol concentrations need to be further investigated to identify lipid 
components contributing to abrupt membrane permeability. These experiments using VP4 and 
other membrane pore forming proteins such as melittin and GALA will help determine 
whether this nature of abrupt membrane permeability is specific to VP4.  
VP4His-induced similar membrane permeability in standard liposomes and LE (Figure 4.12). 
The nature of  dye release observed was typical of that expected from pore forming peptides 
like melittin and not membrane lytic agents like Triton X-100. Therefore, VP4His may be 
mediating CF release from LE as would be expected from the formation of membrane pores. 
The attraction between VP4 and membrane would be affected by charge present on lipid 
headgroups. This was likely to influence membrane permeability induced by VP4. The data 
described above indicate that VP4 may have a preference for late endosomal membranes due 
to the presence of anionic lipids such as PI and BMP. These key lipid determinants may prevent 
premature activation of VP4-induced membrane permeabilisation by acidic pH in the absence 
of the target membrane. Lipid dependence has been observed with other viral proteins such as 
dengue virus E fusion protein. Dengue virus fusion required the anionic lipid BMP as a cofactor 
during low pH induced fusion for the opening of the fusion pore to transfer RNA from 
endosome to cytoplasm. This dependence on BMP ensured dengue virus fusion in the LE 
(Zaitseva et al., 2010). Therefore, like dengue virus, HRV16 may use lipid dependency as an 
additional control for ensuring uncoating occurs in the appropriate compartment.  
HRV14 uncoats in early endosomes (Bayer et al., 1999) and other enteroviruses such as PV 
release their RNA very close (100-200 nm) to the plasma membrane (Brandenburg et al., 
2007). However, the site of HRV16 uncoating has not been demonstrated. As described 
previously, there are differences in pH dependence of major group HRV to trigger uncoating 
(Nurani et al., 2003). VP4His was shown to induce efficient membrane permeability at pH5.5 
(section 4.2.3) which matches the pH reported for efficient uncoating of HRV16. Moreover, the 
observed membrane permeability induced by VP4His in LE was broadly characteristic of that 
induced by pore forming peptides in standard liposomes. This combined evidence indicated 
late endosomes as a possible site of HRV16 uncoating and VP4-membrane pore formation. 
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5.1 Introduction 
Site of RNA exit  
Since the first structures of PV and HRV were determined, openings at the capsid fivefold axis 
were identified. This led to the “fivefold” model to explain RNA egress. It was tempting to think 
that VP1, VP4 and RNA exited from the fivefold axis as it was possible to envisage five receptor 
molecules at the base of the canyon and five copies of VP1 and/or VP4 exiting at the fivefold 
axis directed onto the membrane. However, studies over the last few years have contradicted 
the above fivefold RNA exit model. These studies have suggested openings at the twofold axis, 
large enough for the passage of unwound ssRNA (< 2 nm), as the site for RNA egress (described 
in section1.6.4.3).  
 
Site of VP1 N-terminus externalisation  
Structural studies with PV “A” particles showed that a VP3 plug remained in place at the 
fivefold axis during conversion from PV native particles (160S) to “A” particles (135S) and 
therefore there was insufficient room to contain the externalised capsid subunits, VP1 N-
terminus and VP4 at the fivefold axis (Bubeck et al., 2005). The site of VP1 N-terminus 
externalisation during capsid breathing was subsequently demonstrated to be at the twofold 
axis whereas in the PV “A” particles VP1 N-terminal was externalised at the propeller tip (Lin et 
al., 2012) (described in section 1.6.4.2).  More recently, cryo-tomography of PV uncoating in 
the presence of model membranes showed an umbilicus linking the virus surface near an 
opening at the quasi threefold axis to the membrane. The umbilicus was hypothesised to 
comprise the VP1 N-terminus and VP4 to shield the RNA from enzymatic degradation during 
RNA delivery into the cytoplasm (Strauss et al., 2013).  
 
Nature of HRV mediated membrane permeability 
During virus infection in cell culture under conditions that prevented uncoating, HRV14 was 
shown to be associated with endosomes whereas when uncoating was triggered the 
proportion of free HRV14 particles increased with the simultaneous disappearance of virus 
associated endosomal peaks. This was indicative of disruption of the endosomal membrane by 
HRV14, resulting in the release of genetic material into the cytoplasm. In contrast, HRV2 was 
found associated with endosomes under conditions that both allowed or prevented uncoating. 
This suggested that HRV2 delivered its RNA across the endosomal membrane into the 
cytoplasm without disrupting the membrane and the empty capsids were subsequently 
degraded in lysosomes (Schober et al., 1998). HRV2 (Brabec et al., 2005; Schober et al., 1998) 
and HRV2 VP1 peptide (Prchla et al., 1995) induced membrane permeability by formation of 
size-selective membrane pores as determined by the selective release of dextrans of increasing 
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molecular weights. These studies demonstrated that HRV14 permeabilised membranes by 
disruption and HRV2 by pore formation. 
The real time CF release induced by HRV16 VP4 had characteristics similar to that obtained 
with melittin when used at a concentration which induced membrane permeability by pore 
formation (Davis et al., 2008) and (section 4.2.1). To establish that permeability was due to 
pore formation and not non-specific loss of membrane integrity, it was important to determine 
pore size-selectivity.  Further, it was useful to determine pore dimensions as a first step 
towards understanding the structure and function of such pores. 
Multimerisation of VP4 
VP4 has been shown to partition into cellular membranes during infection (Danthi et al., 2003), 
associate with and induce membrane permeability in liposomal membranes (Tuthill et al., 
2006), however, the mechanism for this is not known. In a previously published study by 
Katpally et al., 2009, under conditions that allowed capsid breathing (37°C), HRV14 with VP4 N-
terminus bearing cysteine mutations formed disulphide linked dimers. Similar VP4 
dimerisation was not observed at 4°C. This finding showed that capsid breathing was required 
for VP4 to be externalised and form dimers. Also, the observation that all of the VP4 
dimerised, indicated a specific rather than stochastic interaction of extruded VP4 (Katpally et 
al., 2009). This provided evidence for VP4 multimerisation during picornavirus capsid 
breathing, however, to date there is no existing evidence for VP4 multimerisation in the 
presence of membranes. The requirement for a lipidic environment for VP4 multimerisation 
was therefore investigated here.  
The information provided in this section highlighted that although there is some evidence to 
support parts of the picornavirus cell entry model, the mechanism of how the membrane is 
permeablised to facilitate RNA delivery lacks experimental evidence.  
This chapter presents evidence for VP4 multimerisation resulting in the formation of a size-
selective VP4 membrane pore with dimensions consistent with those required for the release 
of RNA. 
5.2 VP4 forms a pentameric or hexameric multimer 
VP4 has been shown to permeabilise membranes, yet the mechanism by which VP4 induces 
membrane permeability is unknown. Towards determining if VP4-mediated membrane 
permeability involved the formation of a pore, the multimeric state of VP4His was 
investigated.  
Native PAGE is a technique used to determine the migration of protein complexes in their 
native state by subjecting them to electrophoresis under non-denaturing conditions. 
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Therefore, protein migration is dependent on proteins size, shape and intrinsic charge. The pH 
at which protein carries no net electrical charge is defined as its isoelectric point (pI). The 
predicted isoelectric point for VP4His is 6.8. Native PAGE was performed at pH 8.3, thereby 
giving VP4His an overall negative charge which would give an expected electrophoretic 
migration of VP4His in PAGE. The formation of higher order structures was observed when 
VP4His was premixed with liposomes (50 µM lipid content) or DHPC (300 mM), and analysed 
by native PAGE (section 2.3.2) and silver staining (section 2.3.4.2). However, VP4His alone       
(5 µg) was not observed to migrate into the native polyacrylamide gel (Figure 5.1A). One 
possible explanation for this observation was that the interaction of VP4His (in the absence of 
DHPC or liposomes) with the polypropylene tubes used in sample preparation caused VP4His 
to adhere to the plasticware. This may have contributed to the failure to load the VP4 sample 
and analyse VP4His migration by native PAGE and silver staining. Following loading of samples 
from the tubes onto the native polyacrylamide gel, SDS-PAGE loading buffer was added to the 
“apparently empty tubes” and heated to 96°C. This treatment was expected to break up 
potential VP4 aggregates and resuspend VP4His adhering to the polypropylene tubes. Analysis 
of the contents of the “apparently empty tubes” revealed VP4His present in the tube that had 
contained VP4His (in the absence of DHPC or liposomes) when analysed by SDS-PAGE (section 
2.3.1) and silver staining (section 2.3.4.2) whereas only a small proportion of VP4His adhered 
to polypropylene tubes in the presence of DHPC or liposomes (Figure 5.1B). Therefore, the 
concern of VP4His adhering to polypropylene tubes in the absence of a lipidic environment 
was confirmed. Consequently, it was not possible to confirm if migration and formation of VP4 
protein complexes required a lipidic environment, using this approach.  
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Figure 5.1 VP4His forms higher order structures in a favourable environment.  
A. VP4His premixed with DHPC or liposomes and analysed by 4-20 % tris-glycine gradient 
native PAGE and silver staining. Black arrows indicate the observed higher order structures of 
VP4His. B. Analysis of material potentially adhered to polypropylene tubes by 4-20 % tris-
glycine gradient SDS-PAGE and silver staining. Black arrow indicates VP4 at the expected 
apparent molecular weight of ~8 kDa. The size of molecular weight markers (kDa) is indicated 
to the left of the image. 
 
Native PAGE was not suitable for accurate molecular weight determination due to absence of 
uniform charge on protein molecular weight markers. An alternative way of looking at VP4His 
multimerisation was by chemical crosslinking. Subjecting VP4His treated with chemical 
crosslinkers to denaturing gel electrophoresis was carried out to estimate the size of the 
oligomers formed. Uncrosslinked VP4His would be expected to migrate as a monomer on SDS-
PAGE. 
A range of crosslinkers reactive towards different protein functional groups were tested to 
investigate the multimeric state of VP4. The chemical crosslinkers tested included water 
soluble and membrane permeable crosslinkers with different spacer arm lengths. SDS-PAGE 
analysis of VP4His treated with chemical crosslinkers would determine the molecular weight of 
the observed VP4His multimers. Glutaraldehyde (used for membrane proteins,  membrane 
associated proteins and soluble proteins, spacer arm length of 5 Å) dithiobis 
(succinimidylpropionate) [(DSP), membrane permeable, spacer arm length of 12 Å], 1,5-
difluoro-2,4-dinitrobenzene [(DFDNB), membrane permeable, spacer arm length of 3 Å], 
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dithiobis (sulfosuccinimidylpropionate) [(DTSSP), water soluble, spacer arm length of 12 Å)], 
dimethyl adipimidate [(DMA), water soluble, spacer arm length of 8.6 Å] were the chemical 
crosslinking reagents used to investigate VP4His multimerisation. 
Preliminary studies in the project used PV VP4His. PV VP4His was expressed, purified (section 
3.3) and treated with the crosslinker, glutaraldehyde (section 2.3.8.2). PV VP4His (5 µg) was 
treated with 0.1 % glutaraldehyde either in the presence or absence of liposomes. When 
treated in the presence of liposomes and analysed by SDS-PAGE (section 2.3.1) and anti-His 
western blot (section 2.3.5), multimers consistent with the molecular weight of PV VP4His 
pentamers (~40 kDa) were observed. When treated in the absence of liposomes, the formation 
of PV VP4His multimers consistent with the molecular weight of PV VP4His dimers (~15 kDa) 
and trimers (~25 kDa) were observed (Figure 5.2).   
Due to the higher expression levels observed with HRV VP4His compared to PV or FMDV 
VP4His (section 3.3), further studies were carried out using HRV VP4His. 
 
Figure 5.2 Multimerisation of PV VP4His in the presence or absence of liposomes. 
PV VP4His pre-mixed with or without liposomes and treated with glutaraldehyde. The treated 
samples containing PV VP4His multimeric species were analysed by 16.5 % tris-tricine SDS-
PAGE and anti-His western blot. Middle lanes on the gel are removed for clarity. Arrows 
indicate observed migration of PV VP4His monomer, dimer, trimer, tetramer and pentamer. 
The size of molecular weight markers (kDa) is indicated to the left of the image. 
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The only other chemical crosslinker that yielded VP4His multimers was DSP and this was taken 
forward. DSP is a chemical crosslinker containing an amine reactive N-hydroxysuccinimide 
(NHS) ester at each end of an eight carbon spacer arm. HRVVP4His was expressed in E.coli and 
purified under denaturing conditions (sections 2.11 and 2.13). Following treatment of VP4His 
with DSP in the presence or absence of liposomes (section 2.3.8.1), potential VP4His multimers 
were subjected to denaturing SDS-PAGE (section 2.3.1) and detected by anti-VP4 C-terminus 
western blot (section 2.3.5).  
α-lactalbumin was used as a control for the crosslinking of VP4His with DSP. VP4His (~8 kDa) 
and α-lactalbumin (~15 kDa) contain 4 and 12 primary amines, respectively. Treatment of α-
lactalbumin (1 µg) with DSP did not result in the formation of multimers and only monomers 
were observed (Figure 5.3A) whereas treatment of VP4His (5 µg) with DSP yielded VP4His 
multimers (Figure 5.3B). This demonstrated that crosslinking with DSP was protein specific. 
Treatment of VP4His  in the presence or absence of liposomes (50 µM lipid content) resulted in 
the detection of a ladder of bands, corresponding in size to VP4His monomer (~8 kDa) and 
VP4His multimers in increasing numbers, up to a VP4His multimeric complex with a molecular 
weight ~50 kDa, indicative of  VP4His hexamers (Figure 5.3B). The detection of VP4His species 
with uniform and incremental increase in apparent molecular weight equal to the addition of a 
VP4His monomer, suggested multimerisation of VP4His monomers rather than random 
aggregation. VP4His multimers observed in the absence of liposomes were similar to those 
obtained in the presence of liposomes (Figure 5.3B). The observation of VP4His 
multimerisation in the absence of liposomes suggested that the presence of a lipid membrane 
for VP4His multimerisation was not critical. This finding raised the question of VP4 
multimerisation occurring before or after insertion into the endosomal membrane. When 
crosslinking of VP4His with DSP was reversed by the addition of DTT, the intensity of the 
multimeric species decreased and that of monomeric VP4His increased (Figure 5.3B). Similarly, 
densitometry analysis (section 2.3.6) of the products of VP4His crosslinked with DSP showed a 
decrease in the proportion of VP4His monomer with a concomitant increase in VP4His 
multimers upon treatment of VP4His with DSP (Figure 5.3C). The above observations 
suggested that the multimeric protein complexes were indeed comprised of monomeric 
VP4His. Interestingly, multimers of VP4His were also observed in the absence of treatment 
with DSP. These observed intermediate multimers made up of an intermediate number of VP4 
molecules were diminished in intensity, similar to those observed upon reversal of 
crosslinking. However, VP4His dimers and hexamers were clearly detected with and without 
treatment with DSP and also upon reversed crosslinking (Figure 5.3B). This likely indicated that 
VP4His dimers and hexamers were more stable than the other VP4His intermediate species. 
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Figure 5.3 Multimerisation of VP4His in the presence or absence of liposomes.    
A. α-lactalbumin crosslinked with DSP in the presence of liposomes. Samples were separated 
by 16.5 % tris-tricine SDS-PAGE and analysed by silver staining. Black arrow indicates α-
lactalbumin monomer observed at the expected molecular weight (~15 kDa). B. VP4His 
crosslinked with DSP in the presence or absence of liposomes. Samples were separated by   
16.5 % tris-tricine SDS-PAGE and VP4His detected by anti-VP4 C-terminus western blot. Black 
arrows indicate the observed migration of VP4His at the expected apparent molecular weights 
for monomer, dimer, trimer, tetramer, pentamer and hexamer. C. Densitometry analysis of the 
distribution of VP4His monomeric and multimeric species in the presence of liposomes. The 
net intensity was calculated for each band using Kodak Molecular Imaging Carestream MI NE 
programme.  
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5.3 VP4 forms a size-selective pore 
During infection of cells, minor group rhinovirus HRV2 was demonstrated to form size-selective 
membrane pores whereas HRV14 was shown to induce membrane permeability by membrane 
disruption as demonstrated by the release of FITC labelled dextrans of a range of molecular 
weights (section 5.1). HRV2 VP1 peptides showed the induction of membrane permeability by 
forming size-selective pores (Prchla et al., 1995). Mutations in PV VP1 affected kinetics of RNA 
delivery during infection (Kirkegaard, 1990). Therefore, there is evidence for VP1 being 
involved in membrane binding and playing a role in transfer of RNA across the membrane 
(described in section 1.6.4.4). Mutations in PV VP4 were correlated with the delay or 
prevention in genome delivery, suggesting VP4 was likely to be involved in forming a channel 
for the transfer of RNA into the cytoplasm (Danthi et al., 2003). GST-tagged VP4 of major group 
HRV16 was shown to induce membrane permeability through intact membranes (Davis et al., 
2008). Furthermore, membrane permeability induced by VP4His shared characteristics with 
that induced by the model pore forming peptide, melittin. This suggested that VP4His did not 
disrupt liposomes to release their contents (section 4.2.1.). The possibility of pore formation 
by VP4His was investigated by gauging the dimensions of the molecules that could pass 
through and those that were retained within the membrane. A standard approach for 
characterising membrane permeability induced by pore forming peptides and viral proteins 
was used. For this, liposomes containing FITC labelled dextrans (FD) of different sizes 4 kDa,    
10 kDa, 70 kDa, 250 kDa and correspondingly different stokes radii 1.4 nm, 2.3 nm, 6 nm, 
stokes radius undetermined for FD250, were prepared and purified (section 2.22). The non-
selective release of FDs from within liposomes would indicate large scale membrane disruption 
whereas release of only low molecular weight FDs would indicate formation of a size- 
restrictive pore. 
Melittin is a well characterised membrane pore forming peptide and has been shown to form a 
membrane pore of defined diameter of 2.5 - 3 nm (Ladokhin et al., 1997). Melittin was used as 
a positive control in the studies to determine size-selectivity of the membrane pore formed by 
VP4His. Melittin or VP4His were incubated with liposomes containing FD and membrane 
permeability analysed (section 2.24). When liposomes were incubated with 10 μM melittin, 
efficient release of FD4 (stokes radius 1.4 nm) was observed which was consistent with the 
expected pore size formed by melittin. Minimal release of FD10, FD70 and FD250 was 
observed (Figure 5.4A). In comparison, VP4His (5 µM) induced the release of FD4 and FD10 but 
significantly lower extents of release for FD70 and FD250 (Figure 5.4B). The selective release of 
FD from within liposomes, as induced by VP4His, indicated that VP4His formed size-selective 
membrane pores. 
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Figure 5.4 VP4His forms size-selective membrane pores. 
The release of FDs of different molecular weights (4 kDa, 10 kDa, 70 kDa, 250 kDa) contained 
within liposomes, induced by A. Melittin. B. VP4His. (Experiments n=2 for panel A and n=4 for 
panel B). Error bars represent standard deviation of the mean. Statistical significance was 
calculated by one way Anova (p* < 0.05). 
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5.4 Visualising the VP4-membrane pore complex  
The information gained from models for picornavirus cell entry combined with biochemical 
and structural studies (sections 1.5 and 1.6.4.3) will contribute towards the understanding of 
the mechanism of membrane permeabilisation that facilitates RNA transfer across the 
membrane. 
Following the observation of VP4-mediated CF release similar to membrane pore forming 
peptides (section 4.2.3), higher order structures of VP4His by native PAGE and VP4His 
hexamers by crosslinking studies (section 5.2), and selective dextran release indicating size-
restrictive pore formed by VP4His (section 5.3), the next step was the visualisation of the VP4-
membrane pore complex. 
Transmission electron microscopy (TEM) uses a beam of electrons to create an image of the 
specimen. TEM has higher resolving power and magnifications compared to light microscopy. 
This enables detailed visualisation of smaller objects. Negative staining is a technique used in 
EM, in which stain surrounds the sample and is excluded from the area occupied by the 
sample. As a result, deflection of the introduced electron beam is higher through stain-rich 
regions of the carbon grid compared to the protein sample. This generates high contrast but 
includes drawbacks such as particle distortion as part of the drying step used during the 
staining procedure. 
Negative staining has been used previously to visualise channels formed by viral membrane 
proteins of sizes similar to VP4His by TEM. Due to resolution limits of TEM, the approaches 
have relied on the use of tags such as GST and FLAG to enable visualisation of the membrane 
pore complexes. These include visualising membrane channels formed by E5 of HPV (Wetherill 
et al., 2012), p7 of HCV (Clarke et al., 2006) and SH of RSV (Carter et al., 2010). 
In order to study the native state of membrane proteins, they must be placed in environments 
that mimic natural conditions. There is no structural data for the visualisation of free VP4 or 
VP4 inserted in membranes. The approach for visualising the VP4 membrane pore complex by 
negative stain TEM included the use of VP4 (section 3.4) and GST-tagged VP4 (section 3.2); 
liposomes (section 2.22) and detergent micelles as favourable environments for protein 
reconstitution. 
Attempts at visualising VP4 in liposomes were unsuccessful due to the size limits required for 
high resolution images of protein complexes using TEM. Therefore, VP4ThGST was 
reconstituted in liposomes for the visualisation of the VP4 membrane pore complex. Although 
pore complexes formed by VP4ThGST multimers in liposomal membranes were expected to be 
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visualised, the negative staining procedure involved drying which resulted in the collapse of 
liposomes. This made the identification of pore complexes formed by VP4ThGST in liposome 
membranes very difficult. An alternative and established approach to reconstitute VP4 and 
VP4ThGST in detergent micelles was used. 
Membrane proteins naturally occur in a complex mosaic bilayer. It is difficult to mimic the 
exact native environment of membrane proteins, however, the use of detergent micelles for 
the reconstitution of proteins in their native state is standard practice. Detergents are 
amphipathic molecules containing a polar head group and a hydrophobic tail and 
spontaneously form spherical micelles in aqueous solutions. Detergents are classified into 
three classes based on charge: ionic (anionic, cationic and bile acid salts), non-ionic and 
zwitterionic. Detergents serve to mimic the lipid bilayer environment membrane proteins are 
naturally found in (Seddon et al., 2004). Reconstitution of proteins in detergent micelles to 
determine structures of proteins in their native state has been reported for a number of viral 
membrane binding proteins including M2 of influenza A virus (Schnell and Chou, 2008) and p7 
of HCV (Cook and Opella, 2011).  
To determine which detergent would be optimal for VP4 reconstitution, a range of detergents 
were tested (Table 5.1).  An approach using recommended detergent critical micellar 
concentrations (CMC) (by members of the Chou lab, Harvard Medical School, USA) under 
different pH conditions of 5.5-8.0 was used to reconstitute VP4 (section 2.16).   
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Table 5.1 Range of detergents used for the optimisation of conditions for the reconstitution 
of VP4. Sodium acetate (NaAc) pH5.5, sodium phosphate (NaPO4) pH7.0 or 7.5, 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) pH8.0. 
Name of 
detergent 
Type of 
detergent 
CMC (mM)  Buffers pH 
CHAPSO zwitterionic 10, 25 NaAc, Hepes  5.5, 8.0 
LDAO zwitterionic 10, 25 NaAc, Hepes 5.5, 8.0  
DPC (FOS-12) zwitterionic 25, 100 NaAc, NaPO4 5.5, 7.5, 7.0 
FOS-9 zwitterionic 25, 100 NaAc, NaPO4 5.5, 7.5, 7.0  
FOS-14 zwitterionic 25, 100 NaAc, NaPO4 5.5, 7.5, 7.0 
OG Non-ionic 25, 100 NaAc, NaPO4 5.5, 7.5, 7.0 
DHPC(hexa) zwitterionic 25, 100 NaAc, NaPO4 5.5, 7.5, 7.0 
DHPC (hepta) zwitterionic 25, 100 NaAc, NaPO4 5.5, 7.5, 7.0 
LMPG anionic 25, 100 NaAc, NaPO4 5.5, 7.5, 7.0 
DDM Non-ionic 25, 100 NaAc, NaPO4 5.5, 7.5, 7.0 
LAPAO zwitterionic 25, 100 NaAc, NaPO4 5.5, 7.5, 7.0 
SDS anionic 10, 25, 100 NaAc, NaPO4 5.5, 7.5, 7.0 
 
 
Optimal detergent conditions to reconstitute VP4 (0.1 mg) were identified by mixing VP4 with 
a range of detergents at different CMCs and pH conditions, followed by clarification using 
centrifugation. At each stage reconstituted VP4 was checked for visible precipitation. To 
confirm the incorporation of protein in detergent micelles, reconstituted protein was 
subjected to size exclusion chromatography (section 2.16). Calibration experiments had 
previously been carried out on the size exclusion columns (Superdex 200 10/300 or Superose 6 
10/300 GL), according to manufacturer’s instructions. This enabled determination of void 
volumes and molecular weight estimations of populations obtained in the elution peaks. VP4 
eluted as aggregates with most of the detergents tested, however, VP4 reconstituted in DPC or 
LMPG in NaAc buffer at pH5.5, gave an optimal elution profile (Figure 5.5). Protein aggregates 
and empty DPC or LMPG detergent micelles eluted under ~10 ml and above ~22 ml, 
respectively. A clear peak was observed in the elution profile at ~15 ml (red arrow, Figure 5.5) 
which indicated 35000-13600 Da for VP4 in DPC or LMPG micelles. A proportion of protein 
eluted before or after ~15 ml (indicated by blue arrows, Figure 5.5), suggesting there might be 
a mixed population including VP4 monomers and multimers incorporated into the detergent 
micelles. Clearly, the majority of VP4 was successfully reconstituted in DPC or LMPG micelles, 
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in NaAc buffer at pH5.5. This amount of reconstituted VP4 (~ 0.015 mM) could be used for 
visualising potential structures of VP4 membrane pore complex by TEM (described further in 
this section), for the determination of secondary structure of VP4 in a lipid environment using 
CD (described in Chapter 6) and for obtaining 1D NMR spectra (described in Chapter 6). 
However, 2D heteronuclear single-quantum correlation (HSQC) NMR studies required 0.5-1 
mM of reconstituted VP4. Therefore, a higher amount of VP4 (1 mg) was reconstituted in DPC, 
LMPG and SDS. Upon scaling up, VP4 remained reconstituted in LMPG and SDS, with elution 
profiles similar to those shown in Figure 5.5. However, VP4 precipitated when its 
reconstitution was attempted in DPC. The majority of the protein appeared to have aggregated 
and therefore eluted at ~1 ml (blue arrow, Figure 5.6) and only a  proportion of VP4 
incorporated in DPC micelles eluted at ~15 ml (red arrow, Figure 5.6). 15N labelled VP4 was 
similarly reconstituted in SDS or LMPG micelles and used to acquire 2D NMR spectra of VP4 in 
detergent micelles and is described in Chapter 6.  
VP4ThGST (0.1 mg) reconstituted in DPC showed a clear peak in the elution profile at ~15 ml 
(red arrow, Figure 5.7), which indicated 67000-13700 Da for VP4ThGST in DPC micelles. A 
proportion of protein eluted after ~15 ml (indicated by blue arrow, Figure 5.7), which 
suggested there might be a mixed population of VP4ThGST multimers incorporated into DPC 
micelles.  
Therefore, Figures 5.5 and 5.7 demonstrated successful reconstitution of VP4 and VP4ThGST in 
detergent micelles which could be taken forward for visualisation by EM and other structural 
studies such as CD and preliminary NMR. 
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Figure 5.5 Reconstitution of VP4 in detergent micelles. 
Size exclusion chromatography elution profiles by measuring absorbance at 280 nm of A. VP4 
reconstituted in DPC. B. VP4 reconstituted in LMPG. Red arrows indicate elution volume at ~15 
ml for VP4 incorporated in DPC or LMPG micelles. Blue arrows indicate secondary peaks in the 
elution profile. 
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Figure 5.6 Reconstitution of VP4 in DPC micelles.  
Size exclusion chromatography elution profiles by measuring absorbance at 280 nm of VP4     
(1 mg) reconstituted in DPC micelles. Red arrow indicates elution volume at ~15 ml for VP4 
incorporated in DPC micelles. Blue arrow indicates aggregated VP4. 
 
 
 
Figure 5.7 Reconstitution of VP4ThGST in DPC detergent micelles.  
Size exclusion chromatography elution profiles by measuring absorbance at 280 nm of 
VP4ThGST in DPC. Red arrow indicates elution volume at ~15 ml for VP4ThGST incorporated in 
DPC micelles. Blue arrow indicates mixed population of VP4ThGST monomers or multimers 
incorporated in DPC micelles. 
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Due to the small size of VP4 and associated low resolution by TEM, VP4 incorporated in 
detergent micelles could not be used to determine the structure of the VP4 membrane pore 
complex using TEM. To overcome this problem, VP4 with a larger GST-tag (VP4ThGST) was 
used. VP4ThGST has been functionally characterised in dye release studies (Davis et al., 2008). 
TEM was used to determine whether recombinant VP4ThGST formed oligomeric structures in 
a micellar environment and provide information towards determining pore dimensions of the 
VP4 membrane pore. Uranyl formate has a smaller grain size and better contrast than uranyl 
acetate (Booth et al., 2011). Therefore, uranyl formate and was used as the negative stain of 
choice for visualising the VP4ThGST membrane pore complex by TEM. 
A sample of VP4ThGST incorporated in DPC micelles and purified by size exclusion 
chromatography (red peak, Figure 5.7) was stained with uranyl formate and analysed by TEM 
(section 2.19). Aggregates were observed when an undiluted sample was visualised by TEM 
(Figure 5.8A). Sample dilutions of 1:100, 1:500 and 1:1000 were tested to determine the 
optimal dilution for observing individual VP4ThGST oligomeric complexes. With increasing 
sample dilution, individual VP4ThGST oligomeric ring-like structures became increasingly easier 
to visualise (Figure 5.8A-D). Upon 1:1000 dilution, individual VP4ThGST ring-like structures 
were readily observed as “top-down” views of multimeric pores (Figure 5.8D). A set of 
oligomers were selected to give a more detailed view of the ring-like arrangement (Figure 
5.9A, B). Similar oligomeric structures were observed in other regions of the grid. Some of 
these structures appeared as single individual ring-like structures and others as a pair of ring-
like structures (Figure 5.9A, B).  The carbon grid alone or stained with uranyl formate or with 
DPC adsorbed and stained with uranyl formate were used as controls for the experiment and 
did not show the presence of ring-like structures (Figure 5.9C, D, E). The VP4ThGST ring-like 
structures were observed to have a lumen diameter of ~5 nm, in agreement with the dextran 
release studies, suggesting a VP4 pore size cut-off between 4.6 nm - 12 nm (section 5.3). This is 
the first reported observation of VP4 oligomeric ring-like structures. 
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Figure 5.8 Sample optimisation for the visualisation of VP4ThGST oligomeric structures by 
TEM.  
A-D show increasing dilution of VP4ThGST reconstituted in DPC micelles A. neat sample.          
B. 1:100 C. 1:500 D. 1:1000. TEM images visualised at 100 000 X magnification. 
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Figure 5.9 Visualisation of VP4ThGST oligomeric structures by TEM.  
TEM image of VP4ThGST reconstituted in DPC micelles A. 1:500 dilution of VP4ThGST 
reconstituted in DPC micelles to visualise VP4ThGST oligomers. B. A set of oligomers were 
selected (highlighted in black boxes in panel A) to give a more detailed view of the potential 
ring-like arrangement. C-E controls for TEM. C. Carbon grid only. D. Carbon grid stained with 
uranyl formate. E. Carbon grid with DPC and stained with uranyl formate. TEM images in 
panels A, C, D, E visualised at 100 000 X magnification. 
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5.5 Discussion and Future Work 
Picornavirus VP4 has been suggested to contribute to the transfer of viral RNA across the 
cellular membrane and into the cytoplasm (section 1.6.4.4). VP4His was shown to permeabilise 
membranes and the conditions influencing it characterised in Chapter 4. The mechanism for 
VP4-mediated membrane permeabilisation was explored in this chapter. The results in this 
chapter showed that VP4His induced size-selective membrane permeability. VP4His was 
shown to form a multimeric complex composed of five to six copies of VP4His. Recombinant 
VP4 was successfully reconstituted in a lipid-mimetic environment (detergents) which enabled 
visualisation of the VP4 membrane pore complex for the first time, demonstrating pore 
dimensions, consistent with dextran release studies and with a pore size required for the 
release of ssRNA. The combination of biochemical multimerisation data and analysis of TEM 
image suggested a VP4 pore comprising of 5 or 6 copies of VP4.  
VP4 was unlikely to form a functional pore with only one copy of VP4, therefore, VP4 
multimerisation was expected for the formation of a membrane pore with appropriate 
dimensions required for the transfer of RNA across the membrane. Two scenarios for VP4 
multimerisation are possible. The first scenario is that VP4 multimerises to form an oligomeric 
complex prior to membrane insertion or the second scenario where VP4 inserts into the 
membrane and multimerisation follows, leading to the formation of a membrane pore. 
Whether VP4 multimerisation occurred prior to or following membrane insertion was 
investigated by treatment of VP4His with chemical crosslinkers, analysed by SDS-PAGE and 
western blot; or by pre-mixing VP4His  with liposomes (or DHPC) and analysed by native PAGE 
and silver staining (section 5.2). VP4His multimers were formed upon crosslinking VP4His with 
DSP, both in the presence and absence of liposomes (Figure 5.3B). This suggested that lipid 
membrane was not critical for VP4His multimerisation. In the context of VP4 released from 
virus, contributing to pore formation for the transfer of RNA across the membrane, this makes 
the scenario of VP4 multimerisation before inserting into the lipid membrane, plausible. 
However, the observation on native-PAGE wherein VP4His did not form detectable higher 
order structures as those formed in the presence of DHPC or liposomes (Figure 5.1A) 
suggested the requirement for a lipidic environment. VP4His was not observed as an aggregate 
in the stacking gel nor did it enter the gel (Figure 5.1A). In the absence of a lipidic environment 
VP4His was confirmed to adhere to polypropylene tubes used in sample preparation (Figure 
5.1B). Thus, it was unclear if VP4 multimerisation was lipid dependent. 
The importance of the presence of membranes, for capsid proteins such as picornavirus VP4 
and rotavirus VP5* is discussed in section 1.6.3. In contrast, VP4 was  shown to dimerise upon 
extrusion from the capsid during breathing at physiological temperature (Katpally et al., 2009), 
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which demonstrated that lipid was not critical for the dimerisation of VP4. When visualised by 
TEM, recombinant VP4 formed oligomeric ring-like structures only in the presence of DPC 
micelles, a lipid-mimetic environment (section 5.5). This requirement for a lipidic environment 
for VP4 multimerisation was consistent with the membrane requirement in the formation of 
the “umbilicus” connecting the PV “A” particles to the liposome membrane. The “umbilicus” 
was hypothesised for the transfer of RNA across the membrane (Strauss et al., 2013). These 
findings suggested the potential significant role of lipid membrane in VP4 multimerisation. This 
led to the hypothesis of VP4 released from the capsid inserting into the membrane, reaching a 
critical concentration with VP4 molecules in the appropriate proximity to each other and then 
multimerising to form a pore which facilitates the transfer of RNA across the membrane. Both 
VP1 N-terminus and VP4 may be required for the transfer of RNA across the membrane and 
this is discussed further in Chapter 7.  
As shown in section 5.2 chemical crosslinking was used to determine the multimeric state of 
VP4His. It was important to bear in mind that this was carried out using recombinant VP4 in a 
cell free system and, thus, was devoid of complete infectious virus and membranes containing 
both lipid and protein. The advantages of using liposomes included tighter experimental 
control of liposome membrane composition, pH conditions, temperature and VP4His 
concentration.  Hence, crosslinking studies were carried out with VP4His in the presence of 
liposomes.  Crosslinking of virus with cell membranes will be a useful experiment to undertake 
to confirm findings of VP4His multimerisation in the presence of liposomes. 
The empirical treatment of VP4His with a range of crosslinking reagents such as DFDNB, DTSSP 
and DMA did not yield any observable VP4His multimers whereas treatment with DSP yielded 
multimers comprised of five or six copies of VP4 (section 5.2). This observed difference 
following treatment of VP4His with different crosslinkers could be due to variable spacer arm 
lengths of the crosslinkers, proximity of VP4His molecules to each other, presence of different 
functional reactive moieties carried by the crosslinker molecule and accessibility of reactive 
groups of VP4His residues to the crosslinkers. It is possible that the number of crosslinks 
obtained experimentally using DSP may be different to that observed in the structure of the 
VP4 multimeric complex when inserted into the endosomal membrane. Chemical crosslinking 
of scrambled VP4 sequences can be carried out to confirm the specificity of these interactions. 
DSP reacts with primary amines of amino acids such as lysines and the residue at the N-
terminus of the polypeptide to form stable amide bonds at pH 7-9. VP4His activity was shown 
to be optimal at pH5.5 (section 4.2.3) and in liposomes with a membrane composition 
mimicking that of late endosomes (section 4.2.4). Therefore, future work should include 
treatment of VP4His with crosslinkers compatible with low pH and using liposomes with a 
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composition mimicking that of late endosomes, thereby investigating VP4His multimerisation 
under conditions optimal for VP4 function. 
Preliminary studies with PV VP4His showed that PV VP4His multimerisation with 
glutraldehyde, generated multimers up to a pentamer (Figure 5.2) whereas crosslinking of HRV 
VP4His with glutaraldehyde, resulted in the absence of detectable mulitmerisation. However, 
HRV VP4His crosslinked with DSP generated multimers up to a pentamer or hexamer (Figure 
5.3B). Treatment of PV VP4His with DSP was not carried out. Both DSP and glutraldehyde are 
amine dependent crosslinkers. PV VP4 and HRV VP4 contain 5 and 4 lysines, respectively. 
Therefore, the difference in the observed PV and HRV VP4 multimeric species generated  upon 
treatment with different crosslinkers may be due to differences in spacer arm lengths of the 
crosslinkers  (5 Å for glutatraldehyde and 12 Å for DSP) or amino acid differences and 
accessibility of reactive groups in PV and HRV VP4 residues to the crosslinker. Furthermore, 
treatment of PV VP4His with glutaraldehyde resulted in the complete disappearance of 
monomeric and dimeric species of PV VP4His (Figure 5.2). This could be due to glutaraldehyde 
being a more effective crosslinker than DSP.  
In the absence of treatment with DSP, VP4His hexamers were also observed on SDS-PAGE 
(Figure 5.3B). One possible explanation for this observation is that the VP4His hexamer was 
the more readily formed multimeric species of VP4His and other intermediate multimers were 
only observed when VP4His was multimerised using chemical crosslinkers. This was not an 
unprecedented finding as p7 of HCV also formed higher order structures in the absence of lipid 
or crosslinkers when electrophoresed on SDS-PAGE (PhD thesis, Toshana Foster, University of 
Leeds, 2010). It was therefore possible that SDS offered a micellar environment for the 
multimerisation of VP4His. This was supported by the detection of VP4His hexamers both in 
the presence and absence of liposomes and DSP, and when analysed by SDS-PAGE and 
western blot (Figure 5.3B). Further, SDS-resistant multimers have been reported in the past for 
other viral membrane proteins including those of E5 of HPV (PhD thesis, Laura Wetherill, 
University of Leeds, 2012), p7 of HCV (Clarke et al., 2006) and other membrane pore forming 
proteins such as 2B of poliovirus (Agirre et al., 2002) and  M glycoprotein of avian coronavirus 
(Weisz et al., 1993). Until the last decade models for picornavirus entry followed a ‘fivefold’ 
model (section 1.6.4.3) where it was tempting to speculate that five copies of VP4 and VP1 N-
terminus would exit at the fivefold axis and insert into the membrane to form a pore for the 
egress of RNA. However, evidence for VP4His multimers comprised of up to six copies of 
VP4His upon crosslinking with DSP (Figure 5.3B) was not consistent with the ‘fivefold’ model. 
However, recent studies have suggested the capsid twofold symmetry axis faced the 
membrane and RNA was likely to be released from the capsid near the two fold axis (Bostina et 
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al., 2011; Levy et al., 2010). Therefore, it could be envisaged that six copies of VP4 formed the 
membrane pore for the egress of RNA from the viral capsid through its membrane facing 
twofold axis.  
Despite the key roles played by membrane proteins in pathological and physiological 
processes, the forces that determine their structure and dynamics in the lipid bilayer are 
poorly understood. Detergent micelles are used as membrane-like environments to produce 
homogenous, stable and structurally relevant samples of membrane bound peptides and 
proteins (Baleja, 2001; Fernandez and Wuthrich, 2003). In this study, different classes of 
detergents were tested as shown in Table 5.1. Size exclusion elution profile showed successful 
incorporation of VP4 in DPC and LMPG micelles (Figure 5.5) and VP4ThGST in DPC micelles 
(Figure 5.7). Size exclusion chromatography cannot be used to determine the number of copies 
of VP4 or VP4ThGST present in detergent micelles. This is because protein-detergent complex 
shows anomalous behaviour when subjected to size exclusion chromatography, thereby 
presenting a challenge in the determination of molar mass and oligomeric state of the protein. 
Other techniques such as multiple angle light scattering (MALS) are available for determining 
the number of copies of VP4 contained in micelles. Unfortunately, the detergents successfully 
used for VP4 reconstitution, were not compatible with MALS. However, successful 
reconstitution of VP4 and VP4ThGST in detergent micelles enabled further studies to 
understand the structure of the VP4 membrane pore complex. 
Oligomeric ring-like structures formed by VP4ThGST reconstituted in DPC micelles were clearly 
visualised by negative stain TEM (Figures 5.8D and 5.9). The negative staining process may 
have caused particle distortion, possible chemical interactions and given rise to artefacts. 
Therefore, immunogold labelling should be carried out in the future to confirm the number of 
VP4 molecules forming the mulitmeric complex. Further, 2D crystallography can be carried out 
to potentially yield a high resolution structure of the VP4-membrane pore complex.  
Previously, GST-tagged VP4 was shown to induce membrane permeability whereas GST-tag 
was shown not to associate with or induce membrane permeability in liposomes (Davis et al., 
2008). Due to this prior knowledge, we considered it not critical to test GST incorporation and 
oligomerisation in DPC micelles by EM.  
The secondary structure of RNA may influence the directional exit of the viral RNA from the 
capsid. The 3’end of viral RNA has less secondary structure compared to the 5’ end. RNA exit 
studies from HRV2 suggested RNA partially released from the capsid lacked secondary 
structure but completely released RNA had some secondary structure similar to the clover leaf 
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structure of the IRES present at the 5’ end of RNA (Kienberger et al., 2004). A recent study 
showed that RNA egress of HRV2 began with its 3’ end (Harutyunyan et al., 2013).  
The release of dextrans contained within liposomes to investigate the nature of membrane 
permeability is a well established approach and has been used in several studies to determine 
membrane-pore size formed by adenovirus, HRV2, HRV2 VP1 and µ1 of reovirus (Brabec et al., 
2005; Prchla et al., 1995; Zhang et al., 2009). Co-internalisation of HRV2 with FD10 and FD70 
resulted in virus mediated endosomal release of FD10 but not of FD70 (Brabec et al., 2005). 
The diameter of RNA is 1-1.5 nm (Kienberger et al., 2004). The inferred lumen diameter from 
the FD release studies was between 4.6 nm and 12 nm (section 5.3) and the oligomeric ring-
like structures visualised by TEM revealed a pore diameter of approximately 5 nm (Figures 
5.8D and 5.9A). Both these findings are in agreement with the pore dimensions required for 
the release of RNA that has lost some of its secondary structure. There are limitations to the 
use of dextrans in determining the size cut-off of membrane pores. Dextrans are linear, 
flexible, long chain glucose polysaccharides and of limited use as they are different to RNA 
with secondary structure. It would be possible to refine the assay by using globular protein 
molecules or single stranded nucleic acids of a range of lengths and extents of secondary 
structure mimicking the exiting viral RNA. The use of such molecular size probes would 
complement the experimental results obtained with FDs of different sizes and begin to answer 
the question of effect of RNA secondary structure on genome delivery. 
 
 
 
 
Chapter 6 Structural analysis of VP4 
192 
 
 
 
 
 
 
 
6 Chapter 6 
Structural analysis of VP4: 
Bioinformatics predictions 
and characterisation using 
biophysical techniques 
 
 
 
 
 
  
Chapter 6 Structural analysis of VP4 
193 
 
6.1 Introduction 
Picornaviruses undergo structural changes upon receiving the appropriate trigger such as 
receptor binding and/or exposure to low pH. These structural changes include the 
externalisation of the N-terminus of VP1 and the release of VP4.  Capsid alterations are 
required for the release of RNA from an enclosed vesicle such as the early endosome, into the 
cytoplasm for replication. Although much information has been gathered about the structural 
changes in the capsid, little is known regarding the mechanism of transfer of RNA across the 
membrane. VP1 and VP4 have been implicated in the cell entry process (section 1.6.4.4). The 
structure of free VP4 upon release from the virus particle or upon membrane insertion is 
entirely unknown. Despite this lack of structural information, there is sufficient evidence 
including VP4-mediated membrane permeabilisation (section 4.2.1) and formation of a size-
selective pore (sections 5.2, 5.3 and 5.4), to predict VP4 to be a membrane binding protein.  
Structure of VP4  
Determining the alterations in VP4 conformation upon externalisation from the virus particle 
and membrane interaction is crucial for a better understanding of the picornavirus cell entry 
process.  
VP4 is not in a membrane when part of the virus particle. Due to the separate functions of VP4 
when part of the virus (section 1.3.1.1) and when released from the virus (section 1.6.4.4.), 
VP4 structure is likely to be different in order to contribute effectively to the two separate 
roles of VP4 in virus stability and cell entry, respectively. When VP4 is present as part of the 
capsid, it is likely to be structurally constrained due to its interactions with other proteins 
whereas similar constraints would not be present when VP4 is released from the capsid and 
inserted into the endosomal membrane.  
In the context of virus structures determined by X-ray crystallography, in some picornaviruses 
such as PV3 (Filman et al., 1989), HRV2 (Verdaguer et al., 2000) and HRV16 (Hadfield et al., 
1997), a small portion of the N-terminus of VP4 was observed to have an anti-parallel beta 
strand structure. Whereas VP4 N-terminus was observed to be disordered in other 
picornavirus structures such as HRV14 (Arnold and Rossmann, 1990) and HRV3 (Zhao et al., 
1996). Overall, picornavirus VP4 has little regular structure. However, the conformation that 
VP4 adopts after release from the capsid and upon binding to the endosomal membrane and 
the structure of the VP4 membrane pore complex are not known. Therefore, in the absence of 
any structural information, bioinformatics tools were employed in attempts to predict VP4 
protein properties and structure.   
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Bioinformatics predictions of VP4 
Structure prediction programmes are used for determining sequence similarities, predicting 
accessibility of protein residues to solvents, protein secondary structure, transmembrane 
domains and domains likely to have signal peptides. Protein structures cannot be determined 
solely based on computational predictions, however, they can provide a useful starting point 
for protein characterisation and complementary information about protein structure and 
function.  
Computational predictions have their limitations as they predict models based on proteins 
with similar sequences of known structures in the existing database (Zhang, 2008). As a 
general limitation, bioinformatics predictions use a reference database which is mainly 
comprised of soluble globular proteins. The prediction tools have to include a model of the 
protein environment. A homogeneous and isotropic environment is simpler and therefore, an 
aqueous environment is used to model the protein environment. Features of a lipid bilayer 
including the parallel orientation of lipid chains to maximise their interactions, are likely to 
enforce constraints on the protein arrangement in the bilayer. Therefore, an aqueous 
environment is a potential problem when predicting structures of insoluble membrane 
proteins (Chen and Rost, 2002; Wallace et al., 2003). VP4 structure is likely to be different in an 
aqueous versus lipid or lipid mimetic environment. Therefore, bioinformatics predictions for 
VP4 structure must be used with caution.  
Circular dichroism spectroscopy to determine protein secondary structure  
Circular dichroism (CD) spectroscopy is a valuable and well established technique for the 
determination of protein secondary structure. CD spectroscopy measures the difference in the 
absorption of left and right handed circularly polarised light. The peptide bond is the main 
chromaphore in the far UV spectral region (190-260 nm).  A signal is detected when the 
protein is folded in the provided environment. The characteristic shape and magnitude of the 
CD spectrum generated provides information on protein secondary structure as alpha helical, 
beta sheet or random coil (Kelly and Price, 2000; Wallace et al., 2003).  
Similar to the problems with bioinformatics predictions, the CD spectra generated depends on 
spectral reference datasets of proteins with known structures. This data set is mainly 
comprised of globular soluble proteins and works well for soluble proteins. In order to 
determine the secondary structure of a membrane protein, it has to be provided with the right 
environment for it to be properly folded. This membranous environment is provided by lipid or 
detergent micelles. The difference between a good correlation between calculated structures 
for soluble proteins and CD data for soluble proteins and not for membrane proteins may be 
due to the difference in dielectric constants of the membrane-like environment relative to that 
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of water surrounding soluble proteins (Evans et al., 2007; Wallace et al., 2003). Therefore, CD 
spectra of membrane proteins should be interpreted with caution. 
Horse myoglobin (Mb) is a soluble protein and mechanosensitive channel (MscL) from 
Mycobacteria tuberculosis is a membrane protein. Both proteins have known predominant 
alpha helical content. Comparison of CD spectra for Mb in deionised water and MscL in 
detergent (n-Dodecyl-ß-D-maltoside) micelles, showed that although the magnitude of the 
peaks differed between soluble and membrane proteins, both types of proteins generated far 
UV spectra with similar shaped curves. Both proteins gave negative peaks at 222 nm and       
208 nm and positive peaks at 192 nm, consistent with the presence of alpha helices (Figure 
6.1) (Wallace et al., 2003).  
 
Figure 6.1 Far UV CD spectra of soluble and membrane proteins.  
Horse myoglobin, Mb (light blue) and mechanosensitive channel, MscL (dark blue) are soluble 
and membrane proteins respectively. CD spectra indicating both have high alpha helical 
content with similar shaped curves. Figure adapted from (Wallace et al., 2003). 
 
CD spectra have been used to determine the secondary structure of non-enveloped virus 
proteins with membrane binding properties. Examples include γ1 peptide of flock house virus 
and p14 of reovirus. γ1 peptide of the non-enveloped flock house virus contains the N-terminal 
21 residues of the γ peptide. γ1 peptide has membrane binding properties and has been 
implicated to play a role in the process of viral RNA transfer across the endosomal membrane. 
CD spectroscopy showed that γ1 adopted a predominantly alpha helical conformation in 
hydrophobic environments of SDS or liposomes but had random coil when in water (Bong et 
al., 2000; Maia et al., 2006). Another example is that of the N-terminus of p14 fusion-
associated small transmembrane (FAST) protein of reptilian reovirus. p14 is known to facilitate 
cell to cell fusion aiding syncytia formation to increase virus spread. Analysis of the CD spectra 
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suggested the structural plasticity of the N-terminus of p14 as it was capable of adopting alpha 
helical or beta turns in a hydrophobic environment but was disordered when in an aqueous 
solution (Corcoran et al., 2004).  
Although CD spectroscopy gives reliable information on the overall alpha or beta secondary 
structure content, it does not indicate which regions of the protein are of which structural type 
(Greenfield, 2006; Kelly and Price, 2000). Therefore, techniques such as X-ray crystallography 
or nuclear magnetic resonance spectroscopy are required to obtain high resolution structures 
that provide residue specific information.  
Nuclear magnetic resonance spectroscopy to determine protein structure  
Nuclear magnetic resonance (NMR) is a powerful and versatile biophysical technique used to 
determine atomic resolution structures and conformational dynamics of proteins and their 
complexes. NMR has the advantage of measurements being made under potentially 
physiological conditions. Therefore, NMR is a highly suitable technique for studying the 
structure of VP4 in a membrane-like environment.  
NMR has been used to determine the structure of a number of viral membrane proteins. These 
include M2 of influenza A virus (Schnell and Chou, 2008), viral protein R (Vpr) of HIV-1 
(Morellet et al., 2003) and p7 of Hepatitis C virus (HCV) (Montserret et al., 2010). These 
proteins are known to multimerise in membranes to form channels or pores that facilitate the 
transfer of ions, viral genome or subviral particles, across the membrane. All of these viral 
membrane proteins are small, consisting of approximately 100 residues and contain at least 
one transmembrane domain. Some of these features are shared by VP4.   
A major factor limiting the determination of protein structure by NMR is the tumbling rate of 
the protein. An increase in molecular weight causes slower tumbling of the molecule in 
solution which decreases the efficiency of magnetisation transfer through bonds. 
Reconstitution of proteins in lipid or detergent micelles inevitably increases the size of the 
complex but one of the challenges is to reconstitute the protein in an appropriate lipid-like 
environment that will not lead to slow tumbling in solution. Therefore, the size limit of 
molecules that can be used for structural determination by solution NMR is ~35 kDa (Iwai and 
Zuger, 2007). In order to study membrane protein structure by NMR spectroscopy, membrane 
proteins are required to be reconstituted in a suitable lipidic or lipid-mimetic environment. 
Membrane proteins are found in a complex lipid bilayer (section 5.4) and a suitable substitute 
such as detergent micelles have to be employed for structural determination of membrane 
proteins using NMR. Liposomes are avoided as their use results in a drastic increase in size and 
hence slow tumbling. The membrane mimetic environments most commonly used for solution 
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NMR include micelles of SDS, DPC or DHPC; bicelles and small unilamellar vesicles (Wang, 
2008) and http://www.drorlist.com/nmr/MPNMR.html     
In an ideal scenario, reconstituted protein would be expected to adopt its native, biologically 
active conformation. This can be challenging as the protein is only reconstituted and correctly 
folded in a select few detergents at a given pH and temperature. Therefore, finding the right 
detergent or lipid environment requires the screening of several reconstitution conditions 
which is time consuming.  VP4 was successfully reconstituted in DPC, LMPG and SDS detergent 
micelles (described in section 5.4).  
 
6.2  Prediction of VP4 structure and topology 
Due to the lack of available information on VP4 when it is released from the capsid or when it 
is inserted into membranes, bioinformatics predictions were used to predict folding and 
structure of VP4.  
Many membrane proteins have a high alpha helical content and contain both hydrophobic and 
hydrophilic regions, known as amphipathic helices. Amphipathic helices are often associated 
with proteins that interact with membranes and form pores, such that the hydrophobic side 
interacts with the membrane lipid and the hydrophilic side points towards the pore lumen.  
A helical wheel projection allows the visualisation of the helix showing hydrophobic residues 
on one side of the helical wheel and hydrophilic residues on the other side. Melittin is a well-
characterised pore-forming peptide (sections 4.1 and 5.3) and its helical projection is shown in 
Figure 6.2A. The thickness of a cellular lipid bilayer is about 30 Å, which would take a helix 
comprised of ~20 amino acids to span. Therefore, helical wheel projection analysis of VP4 was 
carried out using a length of approximately 20 amino acids starting from the N-terminus of 
VP4. The helical wheel projection of the model membrane pore-forming peptide, melittin, 
showed that hydrophilic residues were concentrated on one side of the helical wheel, while 
hydrophobic residues showed a higher frequency on the other side of the helical wheel 
projection (Figure 6.2A). In contrast, a sliding window analysis along the residues of VP4 did 
not show such a clear difference in the distribution of hydrophilic and hydrophobic residues 
and some of the examples of this analysis are shown in Figure 6.2B-D.  
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Figure 6.2 Helical wheel projection for viral membrane proteins.  
A. Helical wheel projection for melittin. B. Helical wheel projections for VP4 residues 1-22.       
C. Helical wheel projections for VP4 residues 23-45. D. Helical wheel projections for VP4 
residues 46-68. Helical wheel projections were generated by submitting amino acid sequences 
into the helical wheel projection program http://rzlab.ucr.edu/scripts/wheel/wheel.cgi. The 
most hydrophobic residues are shown in green, with least hydrophobic residues in yellow. 
Hydrophilic residues are shown in red. The amount of red decreases proportionally with 
hydrophilicity. Potentially charged residues are shown in purple. 
 
 
VP4 was also analysed using hydrophobicity plots, transmembrane (TM) tendency, alpha 
helical and beta sheet predictions (http://web.expasy.org/protscale). This analysis predicted 
VP4 to contain alpha helical and beta sheet structure with no clear indication of the location of 
the TM domain (Figure 6.3A). In contrast, using the same bioinformatics prediction tools, the 
HCV p7 was predicted to contain two TM domains (Figure 6.3B), consistent with its NMR 
structure (Montserret et al., 2010). Therefore, relative to p7, the predictions for VP4 were not 
clear.  
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The protein topology predictor SPLIT 4.0 is used to predict sequence location of beta 
structures and amphipathic helical content in the protein sequence through an automatic 
selection of optimal amino acid residues (http://split4.pmfst.hr). VP4 structural prediction 
using SPLIT 4.0 indicated some beta structure throughout the VP4 sequence. VP4 showed a TM 
helix preference between residues 1-10, 20-30 and 64-69 (Figure 6.4).  
The amphipathic helical content of VP4 was also predicted using HeliQuest programme. Based 
on the primary amino acid sequence of the protein, HeliQuest programme computes 
physicochemical properties of the protein. The results are then used to screen the databank to 
identify protein segments with similar properties (Gautier et al., 2008). When a sliding window 
analysis of VP4 was carried out using HeliQuest, hydrophobic regions were predicted 
throughout VP4. However, preference for amphipathic regions were not identified 
(http://heliquest.ipmc.cnrs.fr/cgi-bin/ComputParamsV2.py).  
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Figure 6.3 Bioinformatics predictions for VP4 and p7.  
Hydrophobicity score, transmembrane tendency, α-helical content and β-content for A. HRV16 
VP4. B. HCV p7. Plots were generated by submitting amino acid sequences into the prediction 
programme  http://web.expasy.org/protscale. 
  
Chapter 6 Structural analysis of VP4 
201 
 
Figure 6.4 Prediction of VP4 amphipathic helical and β-sheet content.  
Amphipathic helix and β-sheet content of VP4 was predicted by submitting the VP4 amino acid 
sequence into the prediction programme http://split4.pmfst.hr. 
 
Protein TM prediction based on primary amino acid sequence can be carried out using 
bioinformatics programmes such as membrane protein structure and topology (MEMSAT3) 
and support vector machine (MEMSAT-SVM) based predictions. MEMSAT3 predicts secondary 
structure and topology of helical integral membrane proteins. It uses a neural network that has 
been trained on a set of 184 TM proteins to determine which residues constitute the TM 
helices and which residues are on the cytoplasmic side (Jones, 2007). MEMSAT-SVM prediction 
is based on a set of protein sequences with known X-ray crystal structures. It is used for the 
prediction of signal peptides and alpha helices (Nugent and Jones, 2009). MEMSAT3 predicted 
the location of a TM domain in the N-terminus whereas MEMSAT-SVM predicted it to be in the 
C-terminus of VP4 (Figure 6.5).  
Taken together, bioinformatics predictions did not clearly illustrate the location of amphipathic 
helices and TM domain(s) in VP4.  
 
 
  
Chapter 6 Structural analysis of VP4 
202 
 
 
Figure 6.5 Location of TM domain in VP4.  
A. VP4 N-terminus (residues 3-22) predicted to constitute the TM domain by MEMSAT3. B. VP4 
C-terminus (residues 50-65) predicted to constitute the TM domain by MEMSAT-SVM. 
Predictions were generated by submitting VP4 amino acid sequence into the prediction 
programme http://bioinf.cs.ucl.ac.uk/psipred. 
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6.3 Circular dichroism spectroscopy to investigate VP4 
secondary structure 
VP4 has been demonstrated to associate with and permeabilise membranes (section 1.6.4.4 
and 4.2.1). VP4 is likely to undergo structural changes upon membrane insertion and adopt a 
conformation distinct from that when it is a viral capsid protein. Membrane insertion of VP4 
may lead to a final protein conformation facilitating membrane pore-formation required for 
the transfer of RNA across the membrane.  
Recombinant untagged VP4 was expressed and purified from inclusion bodies (section 3.4), 
followed by reconstitution in a membrane-mimetic environment. A range of detergents were 
screened for VP4 reconstitution (Table 5.1) and VP4 (1 mg) was successfully reconstituted in 
LMPG and SDS, as demonstrated by size exclusion chromatography (section 5.4). 
CD spectroscopy is a technique used to determine protein secondary structure (section 6.1). 
VP4 reconstituted in detergent (SDS or LMPG) micelles was subjected to CD to investigate VP4 
structure in a membrane-mimetic environment (section 2.18). Pilot studies were carried out to 
determine VP4 concentration, buffer and salt conditions for obtaining optimal CD spectra. 
Liposomes (section 2.22) were not used as they were too large to be subjected to size 
exclusion chromatography which was used to demonstrate VP4 reconstitution. A further 
problem was introduced as liposomes were prepared in 10 mM HEPES buffer (section 2.22) 
which was suboptimal for use in CD as HEPES absorbs wavelengths in the far UV range (190-
260 nm). Liposomes can also cause scattering of light, resulting in signal loss. Therefore, 
detergent micelles were used to provide a membrane-like environment. 
In the absence of a lipid-mimetic environment VP4 did not yield a CD spectrum, most likely due 
to precipitation of VP4. In contrast, VP4 reconstituted in LMPG micelles exhibited a CD 
spectrum typical of α-helical conformation with a maximum at 192 nm and two minima at 208 
nm and 222 nm (Figure 6.6A). VP4 was used at 17.5 µM or 9 µM in 12.5 mM LMPG. At these 
two concentrations, the maxima and minima of the magnitude spectra showed subtle 
differences but the overall shape was typical of α-helix conformation (Figure 6.6A). A similar 
spectrum was obtained with VP4 (12.5 µM) reconstituted in SDS (8 mM) micelles with a 
maximum at 192 nm and two minima at 208 nm and 215 nm (Figure 6.6B). CDSSTR algorithm 
(section 2.18) was used to estimate protein secondary structure of VP4 reconstituted in LMPG 
or SDS. This showed VP4 reconstituted in LMPG had 45% alpha helical content and 12% beta 
strand content. VP4 in reconstituted SDS showed 37% alpha helical content and 17% beta 
strand content. Therefore, VP4 reconstituted in a membrane-like environment had a 
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predominantly alpha helical content. The estimation of protein secondary structure was kindly 
carried out by Franz Hagn (Harvard Medical School).  
 
 
Figure 6.6 Far UV CD analysis of VP4 reconstituted in detergent micelles.  
Far UV CD spectra of VP4 reconstituted in detergent micelles and recorded in the 190-260 nm 
wavelength range at 25°C. CD spectra demonstrating secondary structure of A. VP4 
reconstituted in LMPG. CD spectra obtained with 17.5 µM VP4 in 12.5 mM LMPG shown in 
blue and 9 µM VP4 in 12.5 mM LMPG shown in black. Both spectra showed minima at 208 nm 
(green arrow) and 222 nm (red arrow) and a peak at 192 nm (purple arrow). B. VP4 
reconstituted in SDS (12.5 µM VP4 in 8mM SDS). Spectrum showed minima at 208 nm (green 
arrow) and 215 nm (red arrow) and a peak at 192 nm (purple arrow).  
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6.4 NMR to investigate VP4 membrane pore complex structure 
Recombinant VP4 was shown to multimerise in a hydrophobic environment to form a 
multimeric size-selective pore which was visualised by TEM (section 5.4). A step forward from 
the visualisation of the VP4 oligomeric ring-like structure by TEM, would be the determination 
of the atomic structure of the VP4 membrane pore complex. NMR spectroscopy, has been 
used to determine the structure of several viral membrane proteins that share characteristics 
with VP4 (section 6.1), therefore, this technique was used to investigate and determine the 
structure of the VP4 membrane pore complex.  
Solution NMR methods are suitable for the investigation of the structure of proteins and their 
complexes in solution, with some limitations. Membrane proteins embedded in a lipid bilayer 
are not amenable to structural determinations using solution NMR mainly due to slow 
tumbling rates of protein-lipid complexes. Slow tumbling leads to broad NMR signals, which 
lowers spectral resolution and dramatically reduces the signal to noise ratio. However, solution 
NMR can be used to investigate the structure of membrane proteins that have been extracted 
from their host membrane and reconstituted in other membrane-like environments. 
Detergent micelles do not truly represent the complex lipid environment that membrane 
proteins are naturally found in. However, detergent micelles tumble quickly and provide well 
resolved NMR spectra. Detergent micelles serve as lipid mimetic reagents and can be 
appropriate substitutes of the lipid bilayer. For a number of membrane binding peptides, 
evidence for the use of detergents as suitable substitutes for membrane bilayers was provided 
by the observation that a number of them adopted similar NMR structures when reconstituted 
in lipid bilayers (anionic phosphatidylglycerols) or in detergent micelles (SDS micelles) (Li et al., 
2006; Wang et al., 2003). The solution NMR structure of influenza haemagglutinin also showed 
similar structures in lipid bilayers (POPC) and detergent micelles (DPC) (Han et al., 2001). 
Therefore, there was existing evidence to show that detergent micelles could be used to mimic 
membrane environments. Hence, 15N-VP4 (section 3.4.3) was reconstituted in detergent 
micelles and used towards determining the structure of the VP4 membrane pore complex. 
 In addition to screening of detergents for the reconstitution of VP4 (section 5.4), bicelles were 
tested. Bicelles are a mix of long and short chain lipids. The long chain phospholipid forms the 
central bilayer while the short chain phospholipid shields the bilayer from the surrounding 
aqueous medium. Long chain:short chain ratio (q) is used to control the size of bicelles (Whiles 
et al., 2002). This ratio is crucial as high values of q give rise to slow tumbling. At low values of 
q, bicelles tumble quickly, thereby giving well resolved NMR spectra. Bicelles with q ≤0.5 are 
generally amenable to solution NMR. However, the 1,2-Dimyristoyl-sn-Glycero-3-
Phosphocholine:1,2-Dihexanoyl-sn-Glycero-3-Phosphocholine (DMPC:DHPC) ratio 
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corresponding to the long chain:short chain phospholipids ratio which successfully 
reconstituted VP4 was high (q=1) and expected to give slow tumbling. Therefore, VP4 
reconstituted in bicelles was considered unsuitable for solution NMR.  
Pilot studies aimed to find optimal reconstitution conditions were carried out using 0.1 mg of 
15N-VP4. At a concentration of 0.042 mM, 15N-VP4 was successfully reconstituted in 100 mM 
DPC and LMPG (section 5.4).  Typically, using current NMR instrumentation approximately 0.05 
and 0.2 mM of protein is required for carrying out 1D and 2D heteronuclear single-quantum 
correlation (HSQC) NMR experiments, respectively. Upon increasing the concentration of 15N-
VP4 to 0.42 mM, reconstituted in 100 mM SDS, LMPG or DPC, 15N-VP4 precipitated from DPC 
micelles but continued to be reconstituted in SDS and LMPG micelles (section 5.4).   
1D NMR spectra of 15N-VP4 reconstituted in SDS or LMPG detergent micelles (in NaAc buffer, 
pH5.5) were collected to provide initial information on the folded state of the protein. This 
would serve to guide subsequent NMR structural determination studies. Thirty two scans were 
used to acquire 1D spectra of 15N-VP4 (~0.05 mM) in SDS or LMPG (100 mM) at 25°C at 600 
MHz (section 2.17). The spectra of well folded proteins contain sharp and narrow peaks which 
are well dispersed, whereas spectra of unfolded proteins are broad and less well dispersed. 
The 1D spectra of reconstituted VP4 showed well dispersed narrow peaks and some regions 
with overlapping peaks. More information on the VP4 residues could be obtained by 
introducing an additional spectral dimension. Therefore, the next step was to obtain 2D HSQC 
NMR spectra on 15N-VP4. This experiment correlates the chemical shift of protons with the 
chemical shift of a directly bonded nitrogen atom, in proteins typically from peptide H-N bonds 
and NH2 side chain of glutamine and asparagine. The spectra acquired from this experiment 
would provide information on the conformation of the protein and help determine if the 
conditions used for VP4 reconstitution are amenable to 3D NMR structural determination 
studies. Each peak in the spectrum is derived from a proton attached to a nitrogen atom and 
can be mapped to a single amide bond in an amino acid (No peaks are observed for the first 
amino acid and proline residues due to the absence of a free amide group).  
15N-VP4 (0.42 mM) reconstituted in SDS or LMPG were used for the 2D HSQC experiments. 300 
scans were recorded at 700MHz, 25°C (section 2.17). VP4 is comprised of 68 residues, 3 of 
which are prolines, and the first residue of the protein is not detected, therefore 64 peaks 
would be expected to be detected. In the 2D HSQC spectra of VP4 in SDS, 61 residues 
(depicted as purple peaks, Figure 6.7) are clearly observed. Approximately 60 residues in the 
2D HSQC spectra of VP4 in LMPG were observed, although with less sharp peaks (depicted as 
red peaks, Figure 6.7). The peak positions observed in the 2D HSQC spectra of VP4 
reconstituted in LMPG or SDS could be used initially to assess the changes in protein folding 
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when reconstituted in different detergents. The peaks of VP4 when reconstituted in LMPG or 
SDS were well dispersed signifying protein folding. The peaks observed with VP4 reconstituted 
in LMPG were broader, less well resolved (red peaks, Figure 6.7) and had moved significantly 
when compared to the peaks obtained with VP4 reconstituted in SDS (purple peaks, Figure 
6.7). Although the influence of different detergents on the spectral properties of a protein 
could be significant, this change in the spectra between VP4 reconstituted in LMPG or SDS 
could also indicate that VP4 adopted a different conformation or aggregation number in LMPG 
compared to SDS. There are NMR structures of membrane proteins solved in SDS micelles. 
However, SDS is usually known as a protein denaturant and therefore, VP4 may be more likely 
to adopt its native conformation when reconstituted in LMPG. 1D and 2D NMR spectra were 
acquired and Figure 6.7 kindly generated by Dr Fu and Dr Brüeschweiler (Chou lab, Harvard 
Medical School).  
In summary, our preliminary studies showed a good spectrum allowing the observation of 
resolved peaks representing majority of the VP4 residues using 2D HSQC NMR.  Based on 1D 
and 2D spectra we can say that VP4 reconstituted in LMPG or SDS is folded at least to some 
extent. Therefore, VP4 reconstitution conditions amenable to future 3D NMR studies of the 
VP4 membrane pore complex were successfully identified. 
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Figure 6.7 Overlay of 2D HSQC spectra of 15N-VP4 reconstituted in LMPG or SDS micelles.  
Peaks representing VP4 residues for 15N-VP4 reconstituted in LMPG (red) or in SDS (purple). 
ppm: parts per million. Plot generated by Dr Brüeschweiler using NMR pipe and NMR draw. 
 
 
6.5 Discussion and future work 
VP4 is a membrane protein implicated in the cell entry process. VP4 is known to partition into 
liposome and cellular membranes and induce permeability. Existing evidence suggested VP4 
contributed to the formation of channels in membranes which facilitated the delivery of viral 
RNA across the membrane (section 1.6.4.4). VP4His was shown to induce membrane 
permeability similar to those induced by the membrane pore-forming peptide, melittin 
(section 4.2.1). Recombinant VP4 was shown to multimerise to form a size-selective 
membrane pore which was visualised by TEM (sections 5.2, 5.3 and 5.4). However, the 
structure adopted by VP4 upon binding membranes was unknown. In this chapter, several 
bioinformatics predictions were used to provide information on VP4 properties and structure. 
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Circular dichroism and NMR spectroscopy were used to investigate the structure of VP4 in a 
membrane-like environment. 
Overall, prediction models based on VP4 primary amino acid sequence did not give a clear 
prediction for where the TM domain may be present. This was in contrast to the clear 
prediction observed for other viral membrane proteins such as p7 (Figure 6.3B). Structural 
studies on VP4 reconstituted in detergent micelles demonstrated a predominantly alpha 
helical content by far UV CD spectroscopy (Figure 6.6) which was consistent with observations 
of secondary structure for a number of proteins with TM domains. The well resolved 2D HSQC 
spectra (Figure 6.7) demonstrated the suitability of reconstituted VP4 for future structure 
determination of the VP4 membrane pore complex by 3D NMR. 
In the absence of existing structural information on VP4, bioinformatics predictions were used 
to gain information on protein properties and indications of protein structure. The helical 
wheel projection did not clearly show if VP4 was likely to contain an amphipathic helix because 
no preference was shown for hydrophobic residues being located on one side of the helical 
wheel (Figure 6.2). Additional bioinformatics predictions indicated alpha helical and beta sheet 
content of VP4 but did not suggest clear and distinct regions that were likely to form the VP4 
TM domain (Figure 6.3A). In addition to the above bioinformatics prediction tools, SPLIT 4.0 
and Heliquest were used. The SPLIT server showed only a slight preference of the N-terminal 
region for containing an amphipathic helix (Figure 6.4). While SPLIT 4.0 is indeed a dedicated 
tool for predicting sequence segments likely to interact with membrane, like other existing 
bioinformatics predictions, it does not take into account the attachment of a fatty acid such as 
myristic acid, to the peptide sequence. VP4 is N-terminally myristoylated and attachment of 
fatty acids such as myristic acid can influence protein affinity for membranes (section 4.1). 
Thus, the presence of the myristic acid at the N-terminus of VP4 is likely to increase the 
membrane affinity of the indicated N-terminal amphipathic helix in Figure 6.4.  The structural 
predictions using VP4 primary sequence by SPLIT 4.0, heliquest and 
http://web.expasy.org/protscale, indicated a large alpha helical content (Figures 6.3A and 6.4) 
However, the regions with alpha helical content as predicted by different bioinformatics 
prediction tools showed slight variation. This was likely due to the differences in reference 
datasets and algorithms used in the different prediction programmes. The predominantly 
alpha helical content of VP4 was in agreement with protein secondary structure predictions for 
TM proteins. Although, the secondary structure predictions were carried out without 
considering the effect of the environment on protein structure, the predominantly alpha 
helical content prediction was in agreement with the observed CD spectra of VP4 
reconstituted in a membrane-mimetic environment of SDS or LMPG micelles (Figure 6.6).  
Chapter 6 Structural analysis of VP4 
210 
 
Structures of membrane proteins are often determined by reconstitution in a membrane-like 
environment. Membrane proteins are known to behave differently in different detergents due 
to the inherent differences in protein stability and structure. The ideal detergent of choice for 
membrane protein reconstitution should be gentle to prevent protein denaturation, yet strong 
enough to prevent protein aggregation. A range of different detergents were screened for 
reconstitution of VP4 (Table 5.1). DPC, LMPG and SDS were the detergents in which VP4 did 
not precipitate and remained reconstituted as evidenced by size exclusion chromatography 
(section 5.4). A large proportion of VP4 precipitated upon increasing the concentration of VP4 
in DPC micelles (figure 5.6). Therefore, preparations of VP4 incorporated in DPC micelles could 
not be used for obtaining 2D HSQC NMR spectra. Attempts at VP4 reconstitution at 100 mM in 
SDS or LMPG micelles were successful and well resolved 2D HSQC spectra acquired (Figure 
6.7).  
Analysis of far UV CD spectra showed that VP4 reconstituted in LMPG gave characteristic 
positive and negative peaks as expected of a protein with alpha helical secondary structure. 
Interestingly, VP4 reconstituted in SDS showed similar CD spectra (section 6.3). Although, 
clearly indicating that VP4 reconstituted in SDS contained alpha helical secondary structure, 
VP4 may be monomeric in SDS micelles as SDS is a strong anionic detergent and therefore, less 
likely to permit formation of VP4 multimers. However, it was also possible that SDS provided a 
micellar environment which permitted VP4 multimerisation and this would be in agreement 
with the VP4 hexamers observed in the absence of treatment with DSP and liposomes, when 
analysed by SDS-PAGE (Figure 5.3B).  
To further investigate protein folding, the process towards determining solution NMR 
structure of the VP4 membrane pore complex was initiated. Although the spectrum of VP4 
reconstituted in LMPG showed good dispersion, NMR signals on the spectrum of VP4 
reconstituted in SDS showed sharper peaks. This could be indicative of differences in 
conformation adopted by or aggregation number of VP4 when reconstituted in SDS or LMPG 
(Krueger-Koplin et al., 2004). LMPG is a milder detergent and less likely to cause protein 
denaturation compared to SDS. Peak overlap in 2D HSQC spectra is often observed in 
membrane proteins due to the hydrophobic residues contained within alpha helical regions 
(Reckel et al., 2008). The observation of spectral overlap in the 2D HSQC spectra of VP4 
reconstituted in LMPG (Figure 7.7) was encouraging as it indicated possible TM region(s) in 
VP4. LMPG has previously been used as a medium for the structural determination of 
membrane proteins such as T-cell receptor zeta chain (Duchardt et al., 2007), human 
Potassium voltage-gated channel subfamily E member 1, KCNE1 (Kang et al., 2008), E. coli 
histidine kinase receptors (Maslennikov et al., 2010). Therefore, the knowledge of the above 
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structures determined in LMPG, in combination with the 2D HSQC NMR spectra acquired for 
VP4 reconstituted in LMPG (Figure 6.7), provides confidence that a structure of the VP4 
membrane pore complex using 3D NMR is achievable with VP4 reconstituted in LMPG. 
VP4 is relatively well conserved among pircornaviruses, is essential for viral infectivity and 
stability and, therefore, presents an excellent target for antiviral drugs. 3D structural 
determination of the biological process of VP4 multimerisation would aid the development of 
antivirals and small molecule inhibitors to block virus infection at the early stage of virus cell 
entry. 
The X-ray crystal structure of HRV16 showed VP4 residues 1-7 and 23-44 form beta strands 
and the remaining residues are either disordered or not visible (Hadfield et al., 1997). Bringing 
together the structural information of HRV16 VP4 when present in the virus and when 
reconstituted in membrane-like environments, it can be hypothesised that VP4 adopts an 
alpha helical structure upon inserting into the membrane, at the appropriate concentration 
when VP4 molecules are at the right proximity to each other, VP4 multimerises to form a pore, 
through which RNA is delivered across the membrane into the cytoplasm. This is supported by 
the observation that recombinant VP4 and VP4 released from the virus are insoluble in 
aqueous solution and require the presence of a membrane to be functional. Furthermore, VP4 
multimeric pore was observed by TEM when in the presence of a membrane-like environment 
(section 5.4). In conclusion, there is a clear indication for the requirement of a membrane-like 
environment for VP4 to be functional.  
The presence of myristic acid at the N-terminus of VP4 suggested that this end of the protein 
would be directly involved in membrane interactions. Studies with peptides corresponding to 
the N or C-terminal halves of VP4 (described in Chapter 7) showed that a much lower 
concentration of VP4 N-terminal peptide was required to induce membrane permeability, 
relative to VP4 C-terminal peptide, indicating that the N-terminus is perhaps more likely to 
contain a TM domain. However, bioinformatics predictions described in this chapter, 
suggested that N and/or C-termini could contain the TM domain, therefore, the possibility of 
both N and C-termini inducing membrane permeability cannot be ruled out.  
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7.1 Introduction 
Evidence for VP4 and N-terminus of VP1 in membrane interactions 
VP4 and the N-terminus of VP1 have been implicated in membrane interactions to facilitate 
the transfer of RNA across the membrane (described in section 1.6.4.4). Additional evidence 
supporting a role for VP4-mediated membrane permeability during viral entry has been 
demonstrated elsewhere in this thesis. For example VP4-induced membrane permeability 
(Chapter 4), VP4 multimerisation to form a size-selective pore (Chapter 5), reconstitution and 
structural studies on VP4 in a lipid-mimetic environment (Chapter 6).  
Although VP4 has been shown to interact with membranes, there is little evidence regarding 
which region of VP4 is directly involved. During HRV capsid breathing, there is evidence that 
the N-terminus of VP4 is transiently externalised (Katpally et al., 2009), suggesting that the N-
terminus leaves the capsid and becomes available for membrane interactions before the 
remainder of the protein. In addition, the N-terminus of VP4 is myristoylated which is likely to 
be involved in targeting VP4 to membranes (section 4.1). Therefore, limited information 
available appears to favour the involvement of the VP4 N-terminus in membrane interactions.  
Identification of the membrane active terminus 
In general, the N and/or C termini of proteins identified as being responsible for membrane 
binding and permeabilisation have hydrophobic domains able to form an amphipathic alpha 
helix, or may possess myristoylation or palmitoylation, or may be products of cleavage of a 
precursor protein and contain a motif of polybasic residues (Bordag and Keller, 2010). Some 
examples of such membrane binding proteins of non-enveloped viruses include the following: 
adenovirus protein VI (Maier and Wiethoff, 2010), γ1 of flock house virus (Maia et al., 2006), 
µ1 of reoviruses (Zhang et al., 2006) (described in section 1.6.3). These properties of 
membrane binding proteins can be identified by bioinformatics prediction programs. Such 
predictions were used for VP4 and defined regions with high alpha helical content and 
domains likely to form transmembrane regions were not clearly identified (section 6.2). In 
contrast, for viral proteins such as p7 of HCV, defined common hydrophobic regions with alpha 
helical content were predicted which clearly correlated with regions predicted to contain TM 
domains (section 6.2) and which were confirmed by NMR (Montserret et al., 2010). 
 
This chapter investigates if one or both termini of VP4 are involved in mediating membrane 
permeability and if the N-terminus of VP1 may modulate VP4-induced membrane 
permeability.  
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7.2 VP4 N-terminus induces more extensive membrane 
permeability than VP4 C-terminus or VP1 N-terminus 
peptides 
The structure of VP4 in the presence of membranes is unknown and bioinformatics prediction 
tools did not clearly indicate regions containing potential TM domains (section 6.2), therefore, 
mapping of the function of VP4 was initiated with the synthesis of peptides corresponding to 
the N or C-terminal halves of VP4.  Myristoylated VP4 N-terminus specific peptide will be 
referred to as VP4N (52mer) and VP4 C-terminus specific peptide as VP4C (51mer).  
In addition to the release of VP4, the conformational changes in the capsid during transition 
from native to “A” particles includes the irreversible externalisation of the VP1 N-terminus, 
which has been shown to associate with membranes (section 1.6.4.4). In order to investigate 
the potential involvement of the VP1 N-terminus in modulating VP4-induced membrane 
permeability, a peptide corresponding to the N-terminus of VP1 was also synthesised. VP1 N-
terminus peptide will be referred to as VP1N (30mer). 
Six lysine residues were added to the C-terminus of each of the peptides to facilitate solubility.  
The addition of lysine residues is a standard approach for increasing peptide solubility (Kato et 
al., 2007; Torres et al., 2007; Yang et al., 2004). The peptides were resuspended in aqueous 
solution and dissolved readily. Membrane permeability induced by VP4N, VP4C and VP1N was 
investigated using the membrane permeability assay (section 2.23).  
VP4His and ΔVP4His (2.5 µM) were mixed with liposomes (50 µM) and both forms of 
recombinant VP4-induced membrane permeability (Figure 7.1), consistent with previous 
findings (Figure 4.5). The model pore forming peptide, melittin (10 µM and 1 µM) was used as 
the positive control. Melittin induced expected membrane permeability, characteristic of pore 
forming peptides. VP4C (5 µM) and VP1N (5 µM) induced membrane permeability broadly 
similar to that induced by melittin. Membrane permeability induced by VP4C was more 
extensive than that induced by VP1N. In contrast, the VP4N-induced membrane permeability 
appeared dramatically different to that induced by any of the other proteins or peptides, 
producing an abrupt and more extensive permeability (Figure 7.1). This suggested that VP4N 
was able to induce membrane permeability by a different mechanism when used at 5 µM.  
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Figure 7.1 Membrane permeability induced by VP4 and VP1 peptides.  
VP4 N and C-terminus peptides, VP1 N-terminus peptide, VP4His or ΔVP4His was incubated 
with liposomes. Released CF dye was measured by fluorimetry (λex 485 nm λem 520 nm) and 
CF release monitored in real time. Negligible levels of CF release were recorded from 
liposomes in the absence of protein or peptide (Liposomes only). Data shown here is 
representative of multiple experiments. 
 
In order to determine the effect of peptides at different concentrations and confirm whether 
the rapid VP4N-induced permeability a real effect (and not an artefact of using excessive 
amounts of peptide), a twofold dilution series of VP4N, VP4C or VP1N were incubated with 
liposomes and membrane permeability analysed (Figure 7.2).  
VP4C and VP4N induced dose-dependent release from liposomes and at each peptide 
concentration tested, membrane permeability induced by VP4C (10 µM, 5 µM, 2.5 µM,                 
1.25 µM, 0.625 µM) was more extensive than VP1N (10 µM, 5 µM, 2.5 µM, 1.25 µM, 0.625 µM, 
0.32 µM) (Figure 7.2B, C). Membrane permeability mediated by VP4C and VP1N was broadly 
similar to that observed with melittin. However, when VP4N (5 µM, 2.5 µM, 1.25 µM) was 
incubated with liposomes, abrupt and complete release of CF was observed as before. Despite 
using a twofold dilution of 5 µM VP4, there was no observed difference in the nature of 
membrane permeability induced with these peptide concentrations (Figure 7.2A). With further 
twofold dilutions of VP4N (1.25 µM, 0.625 µM, 0.32 µM, 0.16 µM), a dose-dependent effect 
was observed but the membrane permeability induced continued to be rapid and extensive. 
VP4N induced extensive permeability at 0.32 µM but relatively minimal membrane 
permeability at 0.16 µM (Figure 7.2A). The large increase in relative extents of VP4N activity 
between 0.16 µM and 0.32 µM, suggested a threshold for VP4N acting with a potentially 
different mechanism at the concentrations above 0.32 µM. 
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Figure 7.2 Membrane permeability induced by dilution series of VP4 and VP1 peptides.  
Twofold dilutions of peptides were incubated with liposomes and released CF dye was 
measured by fluorimetry (λex 485 nm λem 520 nm). A. VP4 N-terminus peptide. B. VP4 C-
terminus peptide. C. VP1 N-terminus peptide. D. Comparison of end point fluorescence 
measurements of membrane permeability induced by VP4 and VP1 peptides from panels A-C. 
Data shown here is representative of multiple experiments. Background levels of CF release 
were generated by liposomes only. Data shown here is representative of multiple experiments. 
 
In order to further compare the peptides with recombinant proteins, peptide concentrations 
were chosen by comparing data in Figures 7.1 and 7.2, 5 µM VP1N, 0.16 µM VP4N, 0.625 µM 
VP4C were chosen as concentrations as they induced levels of membrane permeability 
relatively similar to that observed with 2.5 µM ΔVP4His.  Similarly, 10 µM VP1N, 2.5 µM VP4C 
and 0.16 µM VP4N were chosen for inducing release relative to VP4His.  
Comparison of concentrations of each peptide required to yield CF release similar to that 
obtained with ΔVP4His, demonstrated the requirement of low concentration VP4N (0.16 µM), 
whereas VP4C and VP1N required higher concentrations of 0.625 µM and 5 µM, respectively 
(Figure 7.3A). When attempting to compare membrane permeability induced by peptides with 
VP4His, VP4N used at 0.32 µM was observed to induce membrane permeability that was more 
extensive than that induced by VP4His whereas VP4N at 0.16 µM induced permeability 
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relatively lower compared to VP4His. VP4C (2.5 µM) and VP1N (10 µM) were observed to 
induce membrane permeability comparable to that induced by VP4His (Figure 7.3B).  
These observations demonstrated that VP4N was able to induce membrane permeability 
comparable to that induced by recombinant forms of VP4 at a lower concentration than VP4C 
or VP1N. In comparison to the membrane permeability induced by peptides similar to 
ΔVP4His, twofold more of VP1N (10 µM) and fourfold more of VP4C (2.5 µM) were required to 
induce membrane permeability similar to VP4His (Figure 7.3). 
 
Figure 7.3 Comparison of membrane permeability induced by VP4 and VP1 peptides, VP4His 
and ΔVP4His.  
VP4N or C-terminus or VP1 N-terminus specific peptides were incubated with liposomes 
and membrane permeability analysed. Peptide mediated membrane permeability 
compared to      A. ΔVP4His and B. VP4His. Released CF dye was measured by fluorimetry 
(λex 485 nm/λem 520 nm) and CF release monitored in real time. Background levels of CF 
release were generated by liposomes only.  
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7.3 VP1N-terminus and VP4 act synergistically to induce 
membrane permeability 
VP4 and the N-terminus of VP1 have been shown to be involved in membrane permeability 
(section 1.6.4.4). Whether membrane permeability is induced by VP4, VP1 N-terminus or by 
VP4 in concert with VP1 N-terminus has been a long standing subject of debate but remains 
unknown.  
In order to investigate if VP4-induced membrane permeability was modulated by VP1, VP4 and 
VP1N were added in combination to liposomes and membrane permeability analysed. For 
initial experiments, VP4N and VP4C values were chosen based on comparative analysis carried 
out with VP4His (Figure 7.3) and a standard concentration of VP1N was added to determine 
the effect of VP1N on membrane permeability induced by VP4N, VP4C and VP4His. Upon 
incubating VP4N (0.16 µM) and VP1N (2.5 µM) with liposomes, membrane permeability was 
induced by both peptides individually. This was consistent with previous observations shown in 
Figures 7.2 and 7.3. The combined effect of VP4N and VP1N on the induction of membrane 
permeability was dramatic, becoming more rapid and extensive than the individual effects of 
each peptide (Figure 7.4A). Therefore, the combination of VP4N and VP1N showed a 
synergistic effect on the induction of membrane permeability. 
Upon incubating VP4C (2.5 µM) with liposomes, moderate membrane permeability was 
induced. However, in contrast to the increase in membrane permeability observed with 
combined VP4N and VP1N, the combined effect of VP4C and VP1N, decreased the extent of 
induced membrane permeability (Figure 7.4B). Although, the concentration of VP4C was 
fifteen-fold higher than VP4N, the permeability induced by VP4N was more extensive than that 
induced by VP4C. 
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Figure 7.4 Combined effect of VP4 and VP1 peptides on the induction of membrane 
permeability.  
A. VP4 N-terminus with VP1 N-terminus peptides were incubated with liposomes. B. VP4 C-
terminus with VP1 N-terminus peptides were incubated with liposomes and membrane 
permeability analysed. Released CF dye was measured by fluorimetry (λex 485 nm λem 520 
nm) and CF release monitored in real time. Background levels of CF release were generated by 
liposomes only.  
 
The next step was to determine if VP1N modulated VP4His induced membrane permeability in 
a similar way as observed with VP4N induced membrane permeability (Figure 7.4). Towards 
achieving this, 2.5 µM VP4His was incubated with a range of VP1N concentrations (5 µM, 2.5 
µM, 1.25 µM) and membrane permeability analysed.  
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As previously observed, VP4His and VP1N individually induced membrane permeability at all 
the concentrations tested. For a given VP4His concentration of 2.5 µM, the extent of 
membrane permeability induced by VP4His and VP1N was greater than that induced 
individually by VP4His or VP1N (Figure 7.5). This study showed that when combined with 
VP1N, the extent of membrane permeability induced by VP4His was enhanced. Interestingly, 
the greatest enhancement of VP4His activity was observed at a VP1N concentration of 2.5 µM 
while VP1N concentrations either side of this (5 µM and 1.25 µM) showed reduced enhancing 
effect (Figure 7.5). This finding suggested the requirement of an optimal concentration of 
VP4N and VP1N to permeabilise membranes most efficiently.  
 
 
Figure 7.5 Combined effect of VP4His and VP1 N-terminus peptide on the induction of 
membrane permeability.  
VP4His (2.5 µM) and VP1 N-terminus peptide (5 µM, 2.5 µM and 1.25 µM) were incubated 
with liposomes and membrane permeability analysed. Released CF dye was measured by 
fluorimetry (λex 485 nm λem 520 nm) and CF release monitored in real time. Background 
levels of CF release were generated by liposomes only.  
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7.4 Comparison of membrane permeability induced by 
recombinant VP4 and virus 
Membrane permeability induced by either recombinant VP4 (VP4His) or a peptide 
corresponding to the N-terminus of VP4 (VP4N) was enhanced by the addition of VP1N 
(Figures 7.4A, 7.5). It was important to relate the membrane permeabilising activity of 
recombinant VP4 with virus. To achieve this, HRV (1 µg) or VP4His (5 µM) was incubated with 
liposomes and membrane permeability analysed. Consistent with previous observations 
(Figure 4.14), membrane permeability was induced by HRV and VP4His at both 25°C and 37°C. 
VP4His induced similar extents of membrane permeability at 25°C and 37°C (Figure 7.6), in 
agreement with a previously demonstrated lack of effect of temperature on the induction of 
membrane permeability by VP4His (Figure 4.14B). In contrast, HRV-induced membrane 
permeability was enhanced at 37°C compared to 25°C (Figure 7.6). This was not unexpected as 
HRV capsid breathing would be expected to be taking place more efficiently at 37°C. Samples 
of HRV which had been pre-heated (to convert virus to empty particles) (1 µg) gave minimal CF 
release upon incubation with liposomes at either  25°C or 37°C (Figure 7.6).  
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Figure 7.6 HRV and VP4His induced membrane permeability.  
HRV (1 µg), pre-heated HRV (1 µg) or VP4His (5 µM) were incubated with liposomes at A. 
25°C and B. 37°C. Released CF dye was measured by fluorimetry (λex 485 nm/λem 520 
nm) and CF release monitored in real time. Background levels of CF release were 
generated by liposomes only and subtracted from fluorimetry measurements generated 
by HRV, pre-heated HRV and VP4His.  
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7.5 Discussion and future Work 
Synthetic peptides were used to map the function of VP4. We hoped to use bioinformatics 
predictions of hydrophobic regions in VP4 containing TM domains/amphipathic helices to 
determine the design of peptides. However, the predictions obtained did not clearly define 
these features (section 6.2). Therefore, VP4 peptides of specific sequence length based on the 
predicted location of TM domains could not be synthesised. As an alternative, peptides 
corresponding to the N-terminus (VP4N) and the C-terminus of VP4 (VP4C) were synthesised 
to carry out experiments with the aim of beginning to map the function of VP4. In addition to 
VP4, the VP1 N-terminus has been implicated in the cell entry process of picornaviruses. Thus, 
a peptide corresponding to the first 24 amino acids at the VP1 N-terminus (VP1N) was 
synthesised to investigate its role in the induction of membrane permeability. VP4N, VP4C and 
VP1N induced permeability in liposome membranes with VP4N being markedly more active 
than the other peptides. To investigate if either of the VP4 termini acted in combination with 
VP1 N-terminus, VP1N was used together with VP4N or VP4C or VP4His. The addition of VP1N 
to VP4N or VP4His resulted in the enhancement of induced membrane permeability, but a 
similar effect was not observed when VP1N was used together with VP4C. Membrane 
permeability induced by VP4His was compared with permeability induced by virus. VP4His 
induced permeability was not affected by temperature, whereas HRV induced more extensive 
permeability at 37°C than at 25°C.  
All three peptides, VP4N, VP4C and VP1N induced membrane permeability. The nature and 
extents of membrane permeability induced differed between peptides. At relatively high 
concentration (5 µM) VP4N induced abrupt and extensive CF release, and which therefore 
seemed to suggest this peptide may be acting by inducing membrane disruption. This was in 
contrast to the CF release induced by VP4C and VP1N which were similar to that observed with 
VP4His and the model pore forming peptide, melittin (Figure 7.1).  
Analysis of CF release showed that VP4N, at 0.16 µM and 0.32 µM, induced membrane 
permeability with CF release characteristics broadly similar to that observed with VP4His or 
melittin. There was a large increase in relative levels of permeability between VP4N 
concentrations of 0.16 µM and 0.32 µM (Figure 7.2), suggesting a threshold for VP4N activity 
with a different mechanism of membrane permeability induction at higher concentrations.  
A low concentration of VP4N was required to induce robust membrane permeability, whereas 
a higher concentration of VP4C was required to induce similar extents of permeability. VP4N 
induced more extensive permeability than VP4C even when thirtyfold greater amounts of 
VP4C was used in the membrane permeability assay (Figure 7.2). Therefore, VP4N seemed to 
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be the more active peptide and a possible reason for this was the presence of the myristate 
group at the N-terminus of VP4 which was likely to target membranes and facilitate VP4 
membrane permeabilising activity. The presence of N-terminal myristoylation is a common 
feature of a number of viral proteins such as µ1 of reoviruses and Nef of HIV-1 which are 
known to interact with membranes (section 4.1). The findings in Figures 7.2 and 7.3, indicated 
that the N-terminus of VP4 was the most membrane-active region of the protein. VP4N may 
be acting by two different mechanisms depending on its concentration in the membrane. It is 
conceivable that when VP4N was used at a concentration above the threshold of 0.32 µM, CF 
release was induced by membrane disruption. But when VP4N was used at a concentration at 
or below 0.32 µM, CF release was induced by membrane pore formation. Future work could 
confirm this hypothesis, by determining CF release induced by VP4N when used at 
concentrations in the range between 0.16 µM and 0.32 µM.  
Several findings have indicated the N-terminus may be the region of VP4 with the ability to 
induce membrane permeability during picornavirus cell entry. For example, presence of the 
myristate group at the N-terminus of VP4, mutations in threonine at position 28 showed that it 
was critical for channel formation and RNA delivery during infection (Danthi et al., 2003), 
evidence that the N-terminus of VP4 emerges first during capsid breathing was provided by 
the dimerisation of  the N-terminus of HRV VP4 (Katpally et al., 2009).  In addition to the above 
studies, the findings described here show that more extensive membrane permeability was 
induced by VP4N compared to VP4C (section 7.2), thereby adding weight towards the evidence 
for N-terminus of VP4 functioning as the membrane active region of the protein.  
Membrane permeability induced by VP4His was enhanced by the addition of VP1N. VP4His 
and VP1N appeared to have a synergistic effect on the induction of membrane permeability 
(Figure 7.4). There appeared to be an optimal ratio of VP4His:VP1N for maximum synergistic 
effect and if peptide or recombinant protein concentration was changed to alter this ratio, 
permeability decreased (Figure 7.5).   
The peptides used in these studies appeared to be highly soluble in aqueous solution and it 
was therefore assumed that majority of peptide molecules were available to take part in 
membrane interactions. In contrast, as VP4His was largely insoluble, only a small proportion of 
VP4His molecules were likely to participate in the membrane interaction and formation of the 
membrane pore but this proportion of membrane active VP4His molecules could not be 
accurately determined (section 4.3). Nevertheless, it was possible to estimate that if for 
example, 10% of VP4His molecules were participating in membrane intreactions, a VP4His: 
VP1N of 1:10 would be required for membrane permeabilisation and if 1% of VP4His molecules 
were participating then a VP4His :VP1N of 1:100 would be required.  
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Similar to the observations made with VP4His, membrane permeability induced by VP4N also 
increased upon the addition of VP1N. The extent of membrane permeability induced was 
greater than the sum of the extents of permeability induced by VP4N or VP1N individually 
(Figure 7.4A). This suggested that VP4N and VP1N acted synergistically to induce membrane 
permeability. In contrast, membrane permeability induced by VP4C decreased upon addition 
of VP1 N-terminus peptide (Figure 7.4B). Thus, synergy was observed with VP1N and VP4N and 
VP4His. This suggested that VP4 and the N-terminus of VP1 acted in concert with each other. 
However, it should be noted that these were preliminary studies. 
VP4N and VP1N were soluble peptides and it was therefore possible to calculate VP4N:VP1N 
ratio.  The experiments in which maximum synergy between VP4N and VP1N was observed 
(Figure 7.4) used a VP4N:VP1N ratio determined as 1:15. Therefore, for the experiments with 
peptide or protein in which synergistic effects were observed, the ratios of VP4N:VP1N and 
estimated ratio VP4His:VP1N were broadly similar.  
It is important to remember that the peptides (VP4N, VP4C and VP1N) have six lysine residues 
at the C-terminus to increase their solubility which may inadvertently affect biophysical 
properties of VP4 such as membrane affinity and insertion, consequently impacting the 
resulting peptide topology. To confirm membrane targetting and induction of permeability was 
not due to the presence of polybasic residues, a non-membrane permeabilising peptide with 
six lysines could be included as a control. Also, the lysine residues render the peptides soluble 
and, therefore, do not entirely reflect the native viral capsid proteins VP1 and VP4.  
As mentioned previously, there is no evidence to show a direct contribution of VP4 at the 
stage of virus entry where the altered particle is tethered to the membrane. The findings in 
Figures 7.4 and 7.5 provide the strongest evidence to date that the membrane 
permeabilisation machinery is likely to involve concerted actions of VP4 and N-terminus of 
VP1. These findings for the involvement of VP4 and VP1 N-terminus, support various iterations 
of picornavirus entry models that have proposed the involvement of VP4 and VP1 N-terminus 
in membrane interactions and induction of membrane permeability, and the transfer of RNA 
across the membrane (section 1.6.4). 
In the context of the virus, it is possible that VP4 N-terminus contains the membrane 
interacting domains but VP4 C-terminus may or may not be required at the stage of genome 
transfer. Possibilities of whether VP4 C-terminus is redundant at this stage of virus entry or is 
required for the function of VP1 N-terminus, requires further investigation.  
Permeability induced by recombinant VP4His and permeability induced by virus were 
compared. Exposing enteroviruses to elevated temperatures (~60°C) results in the formation 
Chapter 7 Towards mapping the function of VP4 and the role of VP1  
226 
 
of empty particles (80S) (Breindl, 1971; Schober et al., 1998). HRV particles induced membrane 
permeability but empty particles induced minimal membrane permeability (Figure 7.6). This 
was expected as empty particles have lost the majority of VP4 during the conversion from 
virus. In addition, they may possibly not contain externalised VP1 N-terminus in a form primed 
to bind membranes and therefore, empty particles might not even be able to bind 
membranes. However, it is also possible that not all copies of VP4 are lost from the empty 
particle as  some VP4 has been detected in or associated with HRV empty particles (Greve et 
al., 1991; Hooverlitty and Greve, 1993). The X-ray structure of HRV14 identified missing or 
disordered density corresponding to VP4 and VP1 N-terminus in the empty particles compared 
to the native particles. It is, therefore possible that residual VP4 in empty particles may have 
contributed to the observed low level membrane permeability (Figure 7.6). The observed 
extensive membrane permeability mediated by HRV and low level membrane permeability 
mediated by pre-heated HRV particles, provided further weight to the contribution of VP4 and 
N-terminus of VP1 in the induction of membrane permeability, thereby implying the 
importance of the capsid proteins, VP4 and VP1, in facilitating genome transfer across the 
membrane.  
Membrane permeability induced by VP4His (5 µg) was more extensive than that observed with 
HRV (1 µg) at 25°C (Figure 7.6). This may have resulted from the possibility that a greater 
number of VP4His molecules were available for membrane insertion compared to the number 
of native VP4 molecules released from HRV and available for membrane insertion. Due to the 
low solubility of VP4His, it was not possible to quantify the number of VP4 molecules inserting 
into membranes and forming pores resulting in the release of CF from within liposomes 
(section 4.3). The low solubility of VP4His made it likely that only a proportion of VP4His took 
part in the formation of functional membrane pores. If this active proportion was 10% of the 
total (5 µg), this would be equivalent to 500 ng and if it was 1% of the total, it would be 50 ng 
of active VP4His per assay. 50 ng is approximately equal to the amount of native VP4 in 1 µg of 
virus.  
Membrane permeability induced by HRV was more extensive at 37°C than at 25°C. This was 
consistent with the expectation of increased virus breathing at 37°C compared to 25°C (Figure 
7.6). Breathing involves the transient externalisation of hydrophobic membrane binding capsid 
proteins VP4 and N-terminus of VP1. Presumably, interaction of these transiently exposed 
capsid proteins with membranes triggers particle alterations and leads to membrane 
permeabilisation. This observation of increased permeability due to externalisation of VP4 and 
VP1 was in agreement with findings of HRV breathing at room temperature (Lewis et al., 1998) 
and  uncoating being more efficient at temperature above 25°C (Nurani et al., 2003).  
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PV and FMDV have been shown to induce liposome permeability and release RNA at room 
temperature and in the absence of receptors or low pH (The Pirbright Institute and Jim Hogle’s 
lab, Harvard Medical School, USA, personal communication). Therefore, it seems that changes 
in particle conformation can be triggered by interaction with model membranes at room 
temperature and without the trigger normally required for uncoating. This was likely due to 
the differences between the nature of cell membranes and model membranes. Virus particles 
could bind naked membranes and undergo conformational alterations.  However, due to the 
presence of different phospholipids and proteins present in the cell membrane, receptors are 
required to act as “hooks” which concentrate the virus on the surface.  
The experiments described in this chapter have identified the N-terminus of VP4 as the region 
of VP4 most likely responsible for the induction of membrane permeability or the “business 
end” of VP4. In the future, a sliding window analysis of VP4 could be carried out and the 
corresponding proteins expressed and purified from E.coli or synthesised as peptides, which 
would help facilitate determining the minimal functional regions of VP4. In PV, mutations of 
threonine (amino acid 28) have shown that this amino acid at this position is critical for PV 
infection (Danthi et al., 2003). Future studies of PV VP4 wild type and PV VP4 mutant proteins, 
and their HRV equivalents will help shed light on the importance of this position or of the 
nature of the residue at this position for picornavirus VP4 membrane interactions during the 
cell entry process. 
Further work needs to be carried out to determine if membrane permeability induced by 
VP4N, VP4C, VP1N and HRV16 is by the formation of size-selective pores comparable to that 
formed by recombinant VP4 (sections 5.2, 5.3 and 5.4). Accompanying this, future studies 
could be carried out to characterise membrane pores formed by the different peptides (VP4N, 
VP4C, VP1N), recombinant VP4His and virus (HRV16).  
The findings in Figure 7.5 demonstrated an increase in the extent  permeability induced by 
VP4His upon addition of VP1 N-terminus specific peptide at pH 7.4. Bearing in mind the 
reported findings of HRV16 uncoating at acidic pH (Nurani et al., 2003) and the observations 
where VP4His and ΔVP4His induced enhanced membrane permeability at pH 5.5 (section 
4.2.3), future studies should be carried out to study the effect of pH on VP1 N-terminus 
modulated membrane permeability induced by VP4N. This will help further our understanding 
of the factors contributing to the optimal conditions under which membrane pore formation 
occurs. 
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8.1 Concluding remarks and future perspectives 
A fundamental step in the process of viral infection is the delivery of the virus genome across 
the host cell membrane to the site of replication. This step is well understood for enveloped 
viruses which use fusion of the virus membrane with the host cell membrane to transfer their 
genetic material to the cytoplasm. However, non-enveloped viruses lack a membrane and 
therefore must employ an alternative mechanism for delivery of their genetic material to the 
cytoplasm. Although studies of several non-enveloped viruses including poliovirus, reovirus 
and flock house virus have suggested the involvement of capsid proteins mediating membrane 
penetration for genome delivery (described in sections 1.6.3 and 1.6.4.2), the mechanism of 
this process remains to be understood. The work described in this thesis sought to further our 
understanding of the role played by the internal capsid protein VP4 in picornavirus cell entry. 
In this thesis, recombinant VP4 was generated and its interaction with membranes 
characterised. Recombinant VP4 interacted with and permeabilised membranes by 
amultimeric, size-selective pore (sections 5.2, 5.3, 5.4). At physiological temperature, 
membrane permeability induced by VP4His was similar to that observed with infectious virus 
(section 7.4), suggesting that the membrane pore formed by recombinant VP4 mimics that 
formed by the virus. This could be investigated further by characterising virus-derived pores in 
studies similar to those carried out with VP4His (section 5.3). In the future, the dextran dye 
release assay could be refined by using synthetic single stranded nucleic acids which more 
closely match the structure of RNA exiting from the membrane pore, as this will begin to 
answer the question of the effect of RNA structure on genome delivery.  
Chemical crosslinking and SDS-PAGE showed that recombinant VP4 formed a homo-multimeric 
complex comprised of five to six copies of VP4. The multimeric complex was visualised by TEM 
as a pore structure. The pore lumen diameter of approximately 5 nm, as suggested by dextran 
dye release studies and as visualised by TEM, is expected to be sufficient to allow the transfer 
of RNA across the membrane and into the cytoplasm. The site of exit of RNA from the capsid 
has long been debated. The RNA exit site was believed to be at the fivefold axis. However, 
recent research has led to the picornavirus cell entry model being updated and the evidence 
now suggests an opening at the twofold axis as the site of RNA exit (section 1.6.4.3). The site 
on the capsid from which VP4 is released is yet to be determined.  
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Membrane permeability was enhanced at an acidic pH of 5.5 and the presence of N-terminal 
myristoylation (section 4.2.3). Although the exact site for HRV16 uncoating is not known, 
findings from in-vitro studies of the effect of pH on VP4-induced membrane permeability 
(section 4.2.3) is consistent with the pH in late endosomes. This is also consistent with 
previous studies showing the requirement of acidic pH for HRV16 uncoating (Nurani et al., 
2003). Therefore, the combined evidence suggests the late endosome as a likely site for virus 
uncoating and formation of the VP4-membrane pore complex.  
During virus entry, both VP4 and the N-terminus of VP1 are exposed and are known to interact 
with membranes. Preliminary studies using synthetic peptides showed that membrane 
permeability induced by recombinant VP4 was enhanced by the addition of a peptide 
corresponding to the N-terminus of VP1 (section 7.3). Future work should be carried out to 
determine the interaction of VP1 N-terminus with VP4 to modulate VP4-mediated membrane 
permeability. It would be interesting to determine and compare the stoichiometry of the pore 
complexes formed by VP4, VP4 with VP1 N-terminus, and the native virus. A range of methods 
such as chemical crosslinking and SDS-PAGE, proteolysis followed by mass spectrometry to 
identify residual protein components embedded in the membrane, could be employed to 
identify the pore components and determine if VP1 N-terminus is required for recombinant 
VP4 to form a membrane-pore complex mimicking that formed by native virus. Extending this 
work to other species of the picornavirus family will help determine if VP4 from different 
picornaviruses form similar membrane pores by following similar mechanisms of membrane 
permeabilisation. 
Circular dichroism (CD) spectroscopy analysis of VP4 reconstituted in detergent micelles 
showed VP4 had a high alpha helical content, a feature typical of membrane binding proteins 
(section 6.3). 2D nuclear magnetic resonance (NMR) spectra acquired for reconstituted VP4, 
suggested VP4 to be a potential membrane binding protein (section 6.4). The 2D NMR spectra 
demonstrated the suitability of reconstituted VP4 for future structure determination of the 
VP4-membrane pore complex by 3D NMR. Similar structural studies carried out with 
myristoylated VP4 would closely mimic the uncoating process occurring in vivo. Furthermore, 
comparative NMR studies of the VP4-membrane pore complex and the VP4-membrane pore 
complex bound to potential entry inhibitors may facilitate understanding of the mechanism of 
inhibition of picornavirus uncoating.  
Membrane permeability induced by peptides corresponding to the N or C-terminus of VP4, 
showed that the N-terminus of VP4 was more active than the C-terminus, suggesting that the 
N-terminus was likely to be the “business end” of the protein. This would be in agreement with 
the transient externalisation of the N-terminus of VP4 observed during capsid breathing 
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(Katpally et al., 2009) and the fact that VP4 is N-terminally myristoylated which would 
contribute to targeting of VP4 to the membrane (section 4.1). Future mutagenesis studies 
should be carried out to map VP4 function by analysing the effect of mutations on VP4-
induced membrane permeability, multimerisation and pore size-selectivity.  
HRV VP4 is conserved across the approximately 150 virus serotypes and VP4 entry inhibitors 
therefore have the potential to be cross-protective. Thus, one obvious area of future focus 
should be on investigating VP4 as a candidate for the development of vaccines and antiviral 
drugs.  
The potential mechanism of VP4-induced membrane permeability was the formation of a size-
selective multimeric membrane pore, as shown by biochemical and structural approaches. 
Also, the conditions influencing VP4-induced membrane permeability were characterised. 
These findings have contributed to further our understanding of the role of VP4 in facilitating 
the transfer of RNA across the membrane and into the cytoplasm. This has highlighted a 
possible mechanism that may be used by several other non-enveloped viruses that have capsid 
proteins with characteristics similar to VP4 (section 1.6.3). It would be useful to extend these 
studies with HRV16 VP4 to other medically important members of the picornavirus family such 
as poliovirus and enterovirus 71, the causative agents of poliomyelitis and hand, foot and 
mouth disease, respectively.  
Bringing together the existing evidence for picornavirus cell entry and the findings described in 
this thesis, the following cell entry mechanism can be hypothesised. After receptor binding 
and/or exposure to acidic pH, the VP1 N-terminus is released at or near the twofold symmetry 
axis and the first 30 residues predicted to form an amphipathic helix insert into the membrane 
to anchor the virus. The remaining residues may contribute to form the umbilicus connecting 
the virus particle to the membrane. VP4 is also released, inserts into the membrane to form a 
pore comprising of five to six copies of VP4. RNA is released from the capsid from an opening 
at the twofold symmetry axis closest to the membrane, and may exit with its less structured 
3’end first. As the RNA passes through the umbilicus (RNA may be shielded from enzymatic 
degradation by VP1 and/or VP4 forming the umbilicus) in a ratchet-like movement, it becomes 
unwound and once in the cytoplasm it regains its structure. Upon delivery into the cytoplasm 
the RNA is likely to refold, for the process of translation to begin. 
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